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Abstract 
Clostridium difficile (C. difficile) infection (CDI) is an antibiotic-associated intestinal disease and 
is considered to be the main cause of healthcare-associated infections. The typical symptom 
of CDI manifests as mild to moderate diarrhea and pseudomembranous colitis. The hallmarks 
of the disease include neutrophil infiltration, and lesions in the colonic epithelium. C. difficile 
produces two major virulence factors, named TcdA and TcdB. Both toxins translocate the N-
terminal glucosyltransferase domain (GTD) into the cytosol of target cells and inactivate Rho 
GTPases by glucosylation. This inactivation causes cell rounding, a redistribution of the actin 
cytoskeleton, and further an apoptotic cytotoxic effect.  
 
Although metronidazole and vancomycin remain the main drugs to treat CDI in the last three 
decades, new treatments or non-antibiotics agents are needed due to the emergence of 
hypervirulent strains. In the first part of this study, a stable transgenic zebrafish that expresses 
the GTD of TcdA/B under the control of a hatching gland specific enhancer was established. 
This model would be used for screening and identifying pharmacological substances against 
Tcd toxicity. Meanwhile, this zebrafish model was co-expressed a fluorescence-based 
apoptosis biosensor with the GTD of TcdA/B. Thus, the physiological condition of hatching 
gland cells was monitored by fluorescent signal.  
 
The innate immune system plays a crucial role in CDI onset and progression. In the second 
part of this study, the response of macrophages and neutrophils against C. difficile was 
analyzed. Using the Gal4/UAS system, a stable transgenic zebrafish line with expression of 
yellow Citrine fluorescent protein in neutrophils was generated. To combine this line for 
monitoring macrophages simultaneously, the binary transcriptional LexA/lexAop system was 
applied to express the fluorescent red tagRFP-T protein in macrophages. Both macrophages 
and neutrophils were able to phagocytose C. difficile. Furthermore, to unravel the function of 
macrophages in C. difficile elimination, Tamoxifen-inducible Caspase was co-expressed in the 
macrophage transgenic strain to trigger apoptosis (ATTACTM). The ablation and regeneration 
kinetics of macrophages were characterized by counting the number of RFP-positive cells. This 
model represents a tool to analyze the progression of CDI in the presence or absence of 
macrophages.
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Abbreviations  
bp Base pair  PCR  polymerase chain reaction 
BSA  Bovine serum albumine  PFA Paraformaldehyd 
DNA Deoxyribonucleic Acid  PTW PBS with Tween 
DNase  desoxyribonuclease  NBT  nitro-blue tetrazolium 
chloride 
dNTP Deoxynucleotide 
triphosphate 
 n nano- 
dpf days past fertilization  Tween 20  poly(oxyethylen)n-sorbitan- 
monolaurate 
DMSO Dimethylsulfoxid  p65 Nuclear factor NF-kappa-B 
p65 subunit 
DPBS  Dulbecco's Phosphate 
buffered saline 
 RT-PCR Reverse polymerase chain 
reaction 
E. coli Escherichia coli  rpm Rounds per minute 
GFP  Green fluorescent protein  PTU Phenylthiourea 
HE Hatching gland  UAS Upstream activating 
sequence 
h hour  Tris 2-Amino-2-hydroxymethyl- 
1,3-propandiol 
hpi hours post-infection  RNA Ribonucleic acid 
LB Luria-Bertani medium  4OHT  4-hydroxy-tamoxifen 
lexAop lexA operator  RFP Red fluorescent protein 
kD  kilo dalton  UV Ultra-Violette 
μ micro-  YFP Yellow fluorescent protein 
MeOH methanol  V Volt 
NGS normal goat serum  UTP Uridine Triphosphate 
 
 Introduction 
 
 5 
1 Introduction 
1.1 Clostridium difficile and Clostridium difficile infection (CDI) 
C. difficile is a Gram-positive, rod-shaped, and toxin-producing bacillus. In the past 30 years, 
C. difficile has emerged as major enteric pathogen in the  world (Longo et al., 2015). In 2012, 
there were more than 185,000 cases of CDI in Europe, which cost estimated 3 billion Euros 
(Bouza et al., 2012). This figure is likely to rise in line with an ageing population: more than 
134 million Europeans will be aged over 65 years by 2050 (Figure 1) (Bouza et al., 2012). The 
increased incidences and severity of CDI can be attributed to two reasons; the emergency of 
hypervirulent strain of C. difficile and the abuse of antibiotics (Di Bella et al., 2016; Lessa et al., 
2012; Shen, 2015). Novel therapeutic strategies, or non-antibiotics are urgently needed.  
 
 
Figure 1 Incidence of nosocomial C. difficile Infection  
 
The overall incidence of nosocomial C. difficile infection is shown by year (blue), as is the incidence 
according to patient age (black). Adapted from Longo et al., 2015.  
 
1.1.1 Biology and phylogeny 
Clostridium difficile is a member of the family Peptostreptococcaceae, and the genus 
Clostridium (Yutin et al., 2013). Colonies of C. difficile have ground glass appearance (Delmée, 
2001). They are usually around 4mm in diameter on blood agar plate after 24 hour incubation 
and emit a horse stable odour (George et al., 1979). C. difficile vegetative cells are typically 2 
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to 8μm in length and 0.5μm in width. C. difficile are strictly anaerobic and are very sensitive 
even to low levels of oxygen (Holý et al., 2012). However, some C. difficile vegetative cells can 
survive at least 24 hours in hamster faecal pellets (Edwards et al., 2016). When C. difficile is 
stressed or exposed in aerobic environments, they enter a dormant state by forming resistant 
spores (Yutin et al., 2013). These resistant spores are considered to be the form to dismiss C. 
difficile via patient-to-patient contact (Yutin et al., 2013). Once reaching the anaerobic 
environment, i.e. the colon of a host, the ingested C. difficile spores germinate to form toxin-
producing vegetative cells (Paredes-Sabja et al., 2014).  
 
A variety of genotype-based techniques have been applied to identify the different strain of 
C. difficile, including PCR ribotyping, restriction endonuclease analysis, and pulsed-field gel 
electrophoresis (Killgore et al., 2008). PCR ribotyping is widely used in Europe, whereas 
pulsed-field gel electrophoresis is preferred in the US (Maiden, 2006).  C. difficile strain 630 is 
a PCR-ribotype 012, virulent, and multidrug-resistant strain. It was isolated from a patient in 
Zurich, Switzerland in 1982 (Stabler et al., 2010).  In 2006, the genome sequencing of C. difficile 
630 was completed, which revealed a large proportion of mobile genetic elements, and also 
some adaptations to the gastrointestinal lifestyle (Sebaihia et al., 2006). Since the genome is 
amenable for genetic manipulation, C. difficile 630 has turned into a model strain that is 
utilized to generate different mutants. For example, C. difficile 630Δerm is a spontaneous 
erythromycin sensitive derivative by serial passaging in antibiotic-free media (Hussain et al., 
2005). C. difficile 630ΔermΔperR is oxygen-stressed, while C. difficile 630ΔermΔfur is affected 
by iron metabolism (T. D. Ho et al., 2015; van Eijk et al., 2015).  
 
In 2003, outbreaks of severe nosocomial diarrhoea, which were reported in North America 
and Europe, were caused by a new hypervirulent C. difficile strain (Pépin et al., 2005). This 
new hypervirulent C. difficile strain belongs to pulsed-field type 1 (NAP1), PCR-ribotype 027, 
or group BI by restriction endonuclease analysis, which is referred to as C. difficile 
BI/NAP1/027 (Shen, 2012). C. difficile BI/NAP1/027 contributes to prevalence of CDI in many 
countries (Freeman et al., 2010). Compared to other strains, BI/NAP1/027 produces a much 
higher level of toxins, which causes a severe morbidity and mortality (Freeman et al., 2010). 
This strain encodes an additional toxin know as binary toxin, or C. difficile transferase (CDT), 
which has been shown to enhance colonization of C. difficile in the gut by increasing its 
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adherence to the epithelial cells (Cowardin et al., 2016; Gerding et al., 2014). CDI caused by C. 
difficile BI/NAP1/027 is characterized by elevated severity and mortality, intractability by 
traditional antibiotic treatments, and great risks of relapse (Depestel et al., 2013). More 
recently, a new hypervirulent strain, PCR-ribotype 078, has been reported to cause a severe 
CDI in the younger population of the Netherlands (Goorhuis et al., 2008).   
 
1.1.2 Sporulation and germination of C. difficile  
Due to the strict anaerobic nature, C. difficile vegetative cells are unable to survive under 
aerobic condition. Therefore, it forms infective spores. It is well accepted that hosts acquire 
the C. difficile spores from the environment, and then spores germinate to form vegetative 
cells in the gut of the hosts (Paredes-Sabja et al., 2014). C. difficile spores are resistant to high 
temperature, and many physical or chemical treatments, such as disinfectants (Edwards et al., 
2014). Furthermore, spores are highly infectious, allowing C. difficile to transmit and spread 
in healthcare facilities (Lawley, Croucher, et al., 2009). The mechanism of C. difficile 
sporulation is mainly obtained from research in Bacillus subtilis, and Clostridium perfringens 
(Paredes-Sabja et al., 2014).  Sporulation of C. difficile is initiated by transcription factor stage 
0 sporulation protein A (Spo0A), which is phosphorylated and activated by sensor histidine 
kinases (Edwards et al., 2014). Spo0A is essential for C. difficile sporulation. Mutants without 
Spo0A are unable to form spores. Interestingly, the functional Spo0A gene is required for 
recurrence of CDI after vancomycin treatment (Deakin et al., 2012).  
 
C. difficile spores are unable to produce toxins, but spores that germinated into vegetative 
cells in the gastrointestinal tract produce toxins. Toxin production is defined as the onset of 
CDI. Upon arriving in the duodenum, C. difficile spores are stimulated to germinate by a 
combination of specific bile salts (Francis et al., 2013). Sodium Taurocholate (TCA) is one of 
the most potent and rapid germinant (described in 1.5.1). However, by analyzing 29 isolated 
strains, Heeg et al found that C. difficile strains respond differently to TCA. Some C. difficile 
are even able to germinate in rich medium without TCA (Heeg et al., 2012). TCA initiates the 
germination by binding to bile acid receptor, CspC, which transduces the signal to activate 
CspB. CspB further activates cortex hydrolase, SleC, which degrades the cortex and releases 
germ cells into the environment (Figure 2) (Edwards et al., 2014)
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signalling pathways involved in germination of C. difficile remain to be investigated (Abt et al., 
2016).  
  
 
Figure 2 Sporulation and germination of C. difficile.  
 
A limited nutrient environment induces sporulation. The transcription factor stage 0 sporulation protein A 
(Spo0A) is phosphorylated by histidine kinases, activating a cascade of signalling and morphological events that 
create a forespore within the mother cell of the bacterium. After lysis, the spore is released into the environment. 
Germination of the spore can be initiated by bile acids, such as taurocholate, which signal through the CspC 
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receptor. Activation of the SleC enzyme by CspB leads to the degradation of the cortex of the spore and 
eventually leads to outgrowth of a new vegetative cell. From Abt et al., 2016.   
 
1.1.3 The virulence of C. difficile 
C. difficile produces three different secreted toxins: TcdA, TcdB, and CDT (Jank et al., 2008). 
CDT is an actin-specific ADP-ribosyltransferase, which mostly present in hypervariant strains, 
like C. difficile BI/NAP1/027 (Gerding et al., 2014). Cowardin et al reported that CDT enhances 
the virulence of two C. difficile strains in mice by suppressing protective colonic 
eosinophilia response (Cowardin et al., 2016). However, the role of CDT in pathogenesis needs 
to be further investigated.  
 
TcdA and TcdB are the major toxins of C. difficile. TcdA consists of 2710 amino acid residues, 
while TcdB consists of 2366 amino acid residues (Jank et al., 2007). The encoding genes tcdA 
and tcdB have been sequenced respectively, which are located in a pathogenicity locus 
together with other additional genes (tcdC, tcdR) encoding negative (tcdC) and positive (tcdR) 
regulating factors (Jank et al., 2007; Mani et al., 2001). TcdA and TcdB belong to a large 
clostridial cytotoxin family. The homologous toxins from the same family inactivate Rho and 
Ras family guanosine triphosphatases (GTPase) by glucosylation (Pruitt et al., 2012). The TcdA 
and TcdB protein have been purified, and the crystal structures of the catalytic fragment have 
also been analysed by two groups in 2005 (J. G. S. Ho et al., 2005; Reinert et al., 2005).  
 
The structure and function of these toxins has been described as the ABCD model (A: biological 
activity; B: binding; C: cutting; D: delivery) (Figure 3A) (Pruitt et al., 2012). The N-terminus 
contains the glucosyltransferase domain (GTD), which is the biologically active domain 
(Hofmann et al., 1997). Region B, located on the C-terminus, harbours receptor binding 
domain (RBD) and combined repetitive oligopeptides (CROPs) (Jank et al., 2007). Region C is 
the protease domain (CPD) that is involved in the auto-catalytic cleavage of toxin processing 
(Egerer et al., 2007). Region D is the translocation domain (TD) that delivers the 
glucosyltransferase domain into the cytosol of the targeted cell (Genisyuerek et al., 2011). 
Once bound to the receptor on a target cell surface, the toxins enter the cell by endocytosis. 
The translocation requires an acidified endosome (Pruitt et al., 2012). Toxins change their 
structure between CROP and CPD region in acidified endosomes, which is accompanied by 
membrane insertion (Barth et al., 2001). In the target cell cytosol, toxins undergo InsP6-
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dependent autocatalytic cleavage, and then the GTD is released, which targets Rho proteins 
(Egerer et al., 2007) (Figure 3B).  
 
 
 
Figure 3 TcdA and TcdB primary structure and mechanism of cellular intoxication.  
 
A) TcdA and TcdB consist of four domains. The N-terminus is the glucosyltransferase domain (GTD) (red). 
Receptor binding domain (RBD) (green) locates in the C-terminus. Between the RBD and the GTD include delivery 
domain or pore-forming domain (TD) (yellow), and the protease domain (CPD) (blue). The orange box represents 
the hydrophobic region of the TD domain that has been proposed to form part of the transmembrane pore. (B) 
The delivery process is divided into four main steps that are mediated by each of the four domains. (1) The toxin 
binds to the surface of the cell and is internalized by receptor-mediated endocytosis. (2) Acidification of the 
endosome triggers the formation of a pore through which the GTD is translocated. (3) The GTD is released into 
the cytosol by InsP6 dependent autoproteolysis. (4) The GTD glucosylates Rho family GTPases at the cell 
membrane.  Adapted from Pruitt et al., 2012.  
 
In the host cell, the enzymatic domain glycosylates Rho/ Ras family GTPases to irreversibly 
inactivate them (Di Bella et al., 2016) (Figure 4). Rho GTPases are molecular switches that 
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control numerous signal transduction pathways, including actin cytoskeleton regulation, cell 
proliferation, migration, phagocytosis, and immune cell signalling (Etienne-Manneville et al., 
2002; Hall, 2012). 
 
 
Figure 4 GTPase cycle and inhibition by TcdA and TcdB. 
 
Rho GTPases are inactive in the GDP-bound state and active when GTP bound. Guanine nucleotide exchange 
factors (GEFs) activate Rho proteins by GDP/GTP exchange. GTPase-activating proteins (GAPs) facilitate GTP 
hydrolysis and inhibit the active state of Rho proteins. Active Rho proteins interact with multiple effectors to 
control fundamental cellular functions. Glucosylation of RhoA blocks the interaction with effectors; several 
signalling pathways and cellular functions are thereby affected that are crucial for host-pathogen interactions. 
On the other hand, inactivation of RhoA by glucosylation activates the inflammasome. From Aktories et al., 
2017.  
 
The inactivation of GTPases causes the disruption of cytoskeletal structure and cell-cell tight 
junctions (cytopathic effect), leading to cell shrinkage, rounding, and ultimately cell death 
(Jank et al., 2007). Besides cytopathic effects, the C. difficile toxins also induce cytotoxic 
effects, such as induction of apoptosis, and activation of the inflammasome (Huelsenbeck et 
al., 2007; Shen, 2012).  
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Gerhard et al. observed that TcdA-induced apoptosis in human intestinal epithelial cells T84 
are through the activation of the caspase-8 and cytochrome C/caspase -9 pathway, which 
depends on monoglucosylation of Rho protein (Gerhard et al., 2008). They further confirmed 
that the activation of downstream executioner, caspase 3, 6, 9, and activation of Bid is also 
detected (Brito et al., 2002). This finding is supported by other study showing that TcdA 
induces apoptotic monocytes death in a time- and dose-dependent manner (Solomon et al., 
2005).  Interestingly, this research found that macrophages are more sensitive to toxin A 
than lymphocytes, but the mechanism is still unclear (Solomon et al., 2005).  TcdA is also 
able to induce the activation of caspase 3, 8, and 9 in HT-29 cells (a colon cell line), which is 
p53-independent but dependent on glucosylation of Rho GTPases (Nottrott et al., 2007).  
 
TcdB also triggers apoptosis. When exposed to TcdB, IEC-6 cells (rat intestine cells) exhibit 
nuclear fragmentation and chromatin condensation (Fiorentini et al., 1998). TcdB is not only 
able to induce caspase-independent apoptosis, but also able to induce caspase-independent 
cell death through substrate inactivation, for instance, Bcl-2 family members that may be 
involved such cell death (Qa’Dan et al., 2002). Proteomic analysis of TcdB-treated cells 
showed fragments of vimentin-type intermediate filaments which are cleaved by caspase-3  
(Qa’Dan et al., 2002). Matarrese et al. demonstrated that TcdB induces apoptosis via 
mitochondrial ATP-dependent potassium channels, which are associated with regulation of 
calcium concentration and mitochondrial membrane potentials (Matarrese et al., 2007).  
 
1.1.4 Cell surface receptors for TcdA and TcdB  
Previous studies have shown that the TcdA and TcdB have different receptors. Glycoprotein 
96 (gp96), expressed on human colonocyte apical membranes, has been identified as a TcdA 
receptor that participates in colonic signal transduction pathways and apoptosis (Na et al., 
2008). Other TcdA receptors which have been proposed are rabbit membrane-bound 
sucrase-isomaltase, and blood antigens I (Charalabos Pothoulakis et al., 1996; Tucker et al., 
1991). The sucrase-isomaltase is expressed in rabbit intestinal epithelial cells but not in 
human. Two TcdB receptors have been reported: chondroitin sulfate proteoglycan 4 (CSPG4) 
and Poliovirus receptor-like 3 (PVRL3) (LaFrance et al., 2015; Yuan et al., 2015). CSPG4 is 
initially identified from a human shRNAmir library screen. It is confirmed to be a functional 
TcdB receptor in HeLa cells and HT-29 cells (Yuan et al., 2015). PVRL3, which is identified 
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from a gene-trap insertional mutagenesis screen, has been reported to function as a 
receptor for TcdB-mediated cytotoxicity (LaFrance et al., 2015). However, none of the above 
receptors is expressed in the colonic epithelium of human. Using unbiased genome-wide 
CRISPR–Cas9 screenings, Tao et al reported that Wnt receptors of frizzled family (FZDs) are 
colonic epithelial TcdB receptors involved in TcdB uptake (Tao et al., 2016). In the study, they 
identified that FZD1, 2, and 7 play critical roles in TcdB-induced cytotoxicity, and FZD1/2/7 
triple-knockout cells are highly resistant to TcdB (Tao et al., 2016).  
 
However, more solid data concerning the nature of toxin receptors are urgently required to 
further understand the virulence of C. difficile.  
 
1.1.5 Risk factors associated with CDI 
The highest risk factor associated with CDI remains to be the use of antibiotics (Figure 5) 
(Longo et al., 2015). More than 90% of CDI occur during, or shortly after antibiotic treatment 
(Barbut et al., 2001). Ampicillin, cephalosporins, amoxicillin, and fluoroquinolones are the 
most frequently used antibiotics to treat infections, or diseases caused by bacteria, but 
almost all those antibiotics have been reported to increase the risk of CDI (Longo et al., 
2015). Some studies demonstrated that by reducing the use of high-risk antibiotics 
significantly decreases the healthcare acquired nosocomial Clostridium difficile –associated 
disease (n-CDAD) (Carling et al., 2003; Valiquette et al., 2007). Antibiotic use disrupts the 
intestinal commensal flora—microbiota and reduces colonisation resistance, resulting in 
colonization of C. difficile and CDI associated disease symptoms (refer to section 1.3.1) 
(Buffie et al., 2012).  
 
Besides antibiotic use, aging is considered as another risk factor for CDI. C. difficile is 
primarily considered to infect the elderly ( > 65 years old), with higher severity and incidence 
in this population ( figure 1) (Simor et al., 2002). This may also be due to the more frequent 
hospitalization, antibiotic treatment, and immune senescence of elder people. However, as 
hypervirulent strains emerge, the susceptibility of infection has shifted from the elderly to all 
age groups (Simor et al., 2002).  
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Two factors exert major influences on clinical CDI; the virulence of the infection strain, and 
the host immune response (Longo et al., 2015). Patients who become asymptomatic carriers 
have significantly increased IgG antibodies against TcdA than those who develop diarrhea 
within 3 days of C. difficile colonization (Kyne et al., 2000). Antibodies against TcdA/TcdB 
prevent toxins from binding to cell surface receptors, which stops toxins entering targeted 
cells (Orellana et al., 1992).  
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Figure 5 Pathogenesis of CDI  
 
Colonization of the C. difficile is prevented by microbiota. Weakening of this barrier by antibiotics is the major 
risk factor for the disease. If patients fail to mount an anamnestic serum IgG antitoxin to TcdA and TcdB, they 
develop CDI. If patients mount an effective immune response to C. difficile toxins, they become asymptomatic 
carrier. From Longo et al., 2015.  
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1.1.6 Treatment for CDI 
For more than 30 years, metronidazole and oral vancomycin are used as the main 
antimicrobial agents to treat CDI. Despite the fact they have been used by millions of 
patients, resistance to either vancomycin, or metronidazole has not been reported (Longo et 
al., 2015). However, the rate of clinical failure associated with metronidazole, especially for 
patients with the BI/NAP1/027 strain, has risen in the past decade (Pépin et al., 2007). 
Furthermore, treatment for CDI with either metronidazole, or vancomycin is associated with 
20%-30%  recurrence in an initial episode, and second recurrences are observed in a rate of 
40%-60% (Cornely et al., 2012; Leong et al., 2013).  There is no alternative therapy to cure 
the recurrence of CDI. In 2011, the US Food and Drug Administration (FDA) approved 
fidaxomicin for CDI treatment (Weiss et al., 2014). Fidaxomicin is a novel macrocyclic 
antibiotic against anaerobic gram-positive bacteria by inhibiting nucleic acid synthesis 
(Crawford et al., 2012). Although fidaxomicin is superior to vancomycin in clinical trials with 
narrower spectrum, recurrence rate is still high, and above than 10% (Weiss et al., 2014). 
Furthermore, widespread application of fidaxomicin is limited by its high cost (Kociolek et al., 
2016).  
 
Due to antibiotic-resistant of C. difficile, non-antibiotic treatments are pursued to diminish 
gut microbiota disruption. Probiotics, defined as live microorganisms, are applied 
additionally to antibiotic treatments (Hickson, 2011; Liao et al., 2015). The benefits of 
probiotics are: inexpressive, and no drug interaction. The drawbacks of probiotics are:  poor 
standardization, heterogeneous trials, and adverse reaction in patients (McFarland, 2009).  
 
Antibody treatment has been demonstrated to be effective both in research and clinical 
trials (McFarland, 2009). A study demonstrated that administration of two human 
monoclonal antibodies against TcdA and TcdB reduces their cytotoxicity and secretory 
activity in hamsters, which also reduces recurrent CDI in humans (Lowy Israel et al., 2010). In 
2016, Bezlotoxumab, a human monoclonal antibody against TcdB, was  approved by the FDA 
to treat recurrent CDI (Wilcox et al., 2017).  
 
With the understanding of the relationship between gut microbiota and CDI, faecal 
microbiota transplant (FMT) becomes a novel treatment, especially for recurrent CDI (Rohlke 
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et al., 2012).  When the microbiota is disturbed by antibiotics, patients are in a state of 
microbiota dysbiosis, which means commensal gut flora are unable to protect the host 
against C. difficile invasion (refer to section 1.1.5). FMT restores the damaged 
gastrointestinal microbial community (Lagier, 2016). FMT involves the administration of gut 
microbiota from a healthy donor into the patient’s colon to re-establish the normal 
composition of the gut flora  (Agito et al., 2013). A study reported that in 317 patients across 
27 case series, FMT shows disease resolution in 92% patients (Gough et al., 2011).  However, 
protocols and reported effectiveness of FMT differ widely,  and the precise mechanism of 
why FMT is effective also needs to be appreciated (Dowle, 2016; Gough et al., 2011). These 
reasons restrict FMT to be a routine therapy for CDI.  
 
1.1.7 Animal model for the study of CDI  
CDI has been studied in a number of animal species, including rat, hamster, rabbit, and 
mouse (Abrams et al., 1980; X. Chen et al., 2008a; Czuprynski et al., 1983; Hirota et al., 
2012). Each animal model has its own advantages and disadvantages. The hamster CDI 
model has been used most extensively (Best et al., 2012). Hamster models share many 
clinical features of CDI as in human. After pretreatment with clindamycin, and challenge with 
C. difficile, CDI is initiated in the hamster (Abrams et al., 1980). However, hamsters also 
display many symptoms that do not present in human. For instance, the appearance of the 
gastrointestinal tract is changed,  and the colon is enlarged (Best et al., 2012). In addition, 
the disease develops very rapidly in hamster, and even kills the host quickly when the host is 
challenged with toxigenic stains (X. Chen et al., 2008a). Lack of immunological reagents to 
study hamster immune response also limits the hamster to be utilized to study CDI host 
response. (Hutton et al., 2014). Moreover, the major drawback is that CDI hamsters do not 
develop diarrhea, or only exhibit wet tail, while diarrhea is the main pathophysiological 
feature in CDI (S P Sambol et al., 2001). Despite these disadvantages, the hamster has been 
used for more than 3 decades to study C. difficile.  
 
To overcome the constraint of hamster models, improved infection methods have allowed 
mouse models to be used to study C. difficile pathogenesis (X. Chen et al., 2008b; Hutton et 
al., 2014). Unlike hamster, neither mouse nor rat is susceptible to C. difficile (X. Chen et al., 
2008a). This is most likely due to the colonization resistance possessed by mouse or rat 
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intestinal microbiota (Lawley, Clare, et al., 2009). Although gnotobiotic mice can be 
colonized by C. difficile, and displays symptoms, germ-free animals are more expensive and 
less amenable than conventional animals (Pawlowski et al., 2010). Therefore, mice are 
induced to be susceptible to C. difficile by disrupting the normal intestinal microflora 
through antibiotic treatments (X. Chen et al., 2008a). After challenge with C. difficile, mice 
develop key CDI features as in human, including diarrhea and weight loss (Hutton et al., 
2014; Lawley, Clare, et al., 2009). Mouse models provide a new insight into CDI 
pathogenesis. Acute CDI induces weight loss, a relatively minor neutrophils infiltration, and 
eventually, death of aged gnotobiotic mice (Pawlowski et al., 2010).  Even brief exposure to 
environmental spore contamination results in CDI, which demonstrates that C. difficile 
spores are effective to transmit CDI (Lawley, Clare, et al., 2009).  
 
Zebrafish embryos have also been utilized to study TcdB toxicity in vivo (Hamm et al., 2006). 
Hamm et al found that TcdB localizes at the pericardial region. TcdB-treated embryos exhibit 
specific cardiovascular damage (Hamm et al., 2006).  This finding could explain many 
observed clincal symptoms of CDI, as patients with severe CDI experience multiorgan failure, 
including cardiac defects.  
 
1.2 Zebrafish model of drug discovery  
1.2.1 The Advantage of the Zebrafish in Drug Discovery 
Drug discovery and development is a complex, long and risky process, which involves the 
design and synthesis of compound libraries, biochemical and cellular assays, preclinical 
animal testing and ultimately clinical trial in human (Huiting et al., 2015; MacRae et al., 2015; 
Orry et al., 2006). The time-consuming pipeline faces increasing cost and additional 
challenges, such as insufficient knowledge of pathogenesis and lack of targets. (Hughes et 
al., 2011).  
 
In the last decade, zebrafish has become a prominent vertebrate model for drugs 
identification due to its high fecundity, and morphological /physiological similarity to 
mammals (Lieschke et al., 2007). It has already contributed to several successful drug 
discoveries, such as Prohema (MacRae et al., 2015; North et al., 2007; Rennekamp et al., 
2015). Proheam is a stable derivative of prostaglandin E2 (PGE2) (North et al., 2007)
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Prohema improves kidney marrow recovery after irradiation injury in adult fish and also 
promotes reconstitution of the haematopoietic system (North et al., 2007). Prohema is in 
Phase II clinical trials in patients undergoing umbilical cord blood (Hagedorn et al., 2014).. 
 
Zebrafish possess a number of unique advantages making them suitable for rapid drug 
discovery and development: (i)The maintenance of zebrafish is cheaper than other 
vertebrate models (Avdesh et al., 2012). (ii) Zebrafish produces a large number of progeny, 
which offers a high confidence in statistical analysis (Goessling et al., 2007). (iii)The optical 
transparency of zebrafish permits noninvasive imaging, which facilitates drug toxicity assays 
on organ development (Mathias et al., 2012). (iv)Zebrafish shows high biological similarity to 
human. Approximately 70% of human genes have at least one zebrafish orthologue (Howe et 
al., 2013). (v) Zebrafish embryos can absorb compounds solubilized in water (MacRae et al., 
2015).  
 
Screening in zebrafish is considered to be physiologically relevant (Taylor et al., 2010). Cell-
based assays only provide restricted information about the absorption, distribution, 
metabolism, and excretion (ADME) of screening compounds (MacRae et al., 2015). A large 
number of compounds are excluded at the late stage of animal testing, due to failure to 
meet standards of ADME in vivo (Huiting et al., 2015). Zebrafish screens are carried out in 
living embryos, offering an advantage to test compounds in the context of a whole organism 
(Rennekamp et al., 2015). To perform drug screening in zebrafish, compounds must be easily 
absorbed and eventually reach the targeted organs. In addition, drug screening in zebrafish 
provides an insight into toxicity of selected compounds during the early process of drug 
discovery (Zon et al., 2005). These facts allow compounds screened from zebrafish to be 
rapidly reproduced in mammalian models. 
 
Fluorescent labeling of a specific cell type is frequently used in the zebrafish community, 
with thousands of fluorescent-labeled-reporter fish lines available. The combination of 
transparent embryos and florescent labeling strategy makes zebrafish an ideal model to 
conduct drug screens. Several successful chemical screens have been carried out in zebrafish 
(Ridges et al., 2012; Saydmohammed et al., 2011; Wang et al., 2015). Wang et al. created a 
double fluorescent reporter line to search for compounds that induce pancreatic β-cell 
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growth: a yellow fluorescent protein (PhiYFP) glows when new β-cells form, and red 
fluorescent protein (tagRFP) glows when pancreatic δ-cells are stimulated. 24 drugs were 
identified and confirmed from a collection of 3348 compounds, most of those candidates are 
approved for clinical use in human. Until 2015, more than 65 compound screens have been 
reported in the literature (MacRae et al., 2015).   
 
1.2.2 Basic process of compound screens in zebrafish 
The goal of compound screens is to identify a great number of small molecules which can 
‘hit’ or modulate the endogenous or exogenous zebrafish proteins (W Patrick Walters et al., 
2003).  Therefore, the success of the compound screens greatly relies on the small-molecule 
library (Orry et al., 2006). A good library should include as much chemical diversity as 
possible to maximize hit rates. Better knowledge of target structure or drug-target structure 
enables drug discovery more easily and efficiently. With the DIVERSet E library designed by 
Chembridge, Peterson et al identified two structurally related suppressors of aortic 
coarctation from over 5,000 small molecules (Randall T Peterson et al., 2004).  
 
Drug screens can be divided into two ways: target-based screening and phenotype-based 
screening (Figure 6). The target-based approach is to discover compounds that modulate 
defined signaling pathways or specific molecular targets (Sams-Dodd, 2005). Most target-
based screens have very clear readouts and relatively high screening throughput. This 
approach was the mainstay used in both the pharmaceutical industry and academic 
translational research center (Seay et al., 2015). However, efficiency of target-based 
screening is questioned in light of declines in pharmaceutical R & D efficiency (Williams et 
al., 2016). Although target-based screening can be very efficient to search for novel 
compounds for a validated target or signaling pathway, off-target effects, or side effects are 
usually not evaluated (Zon et al., 2005). Furthermore, most target-based chemical screens 
are carried out in cell culture or in silico, in which might not hold true in vivo.  
 
To overcome the shortcomings of target-based screening, phenotype-based screening is 
utilized. Phenotype-based screening is approached by evaluating phenotype rescue of a 
specific disease, which is more physiologically relevant, but not target-related (Competition 
et al., 2008). Generally, a disease model with a characteristic symptom is set up in zebrafish, 
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this can then be used for compound screens in an unbiased means. Zebrafish phenotype-
based screens are often combined with other analyses. For example, safety evaluation of the 
drug substance which can discover compounds that produce a desired treatment, while 
parsing out compounds with undesirable qualities (MacRae et al., 2015). In 2000, R T 
Peterson et al demonstrated firstly the feasibility of using zebrafish embryos for bioactivity 
compound screening (R T Peterson et al., 2000). They proposed a concept called ‘chemical 
genetic’, where zebrafish embryos or larvae are arrayed into multi-well microtitre plates, 
and small-molecule libraries are robotically dispensed into the media (Figure 7) (R T Peterson 
et al., 2000). This approach can target every gene in the genome. 
  
 
Figure 6 The pros and cons of target-based and phenotypic drug discovery.  
 
Phenotypic screens and in vitro target-based screen have advantages and disadvantages. Understanding of the 
disease, validation of a given target, and robustness of a screening assay all factor into the choice of technique. 
In either approach, at least one roadblock must be overcome to validate hits and support their further 
development or early lead compounds. Abbreviation: SAR: structure-activity relationship. From Khurana et al., 
2015. 
 
The new techniques developed in biological research, including full genome sequencing and 
metabolomics analysis, enable researchers to investigate diseases at the molecular level (J. 
C. Davis et al., 2009). This brings a new insight into molecular mechanisms of phenotype-
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based screening (J. C. Davis et al., 2009; Goessling et al., 2007). This notion also enables the 
discovery of new drugs by target-based approach which are more physiologically relevant. 
 
Over the past two decades, high-throughput screening (HTS) has gained widespread 
popularity in biological and chemical science, which has also become a common method 
applied in the pharmaceutical industry (Macarron et al., 2011). HTS employs automation to 
measure biological/biochemical activity of a large number of drug-like compounds in living 
cells, or whole-organism rapidly (Hughes et al., 2011). Transparent embryo and fluorescent 
labeling technique make fluorescence-based screens in zebrafish a perfect system for HTS 
(Figure 7) (Walker et al., 2012). Fluorescent read-out enables high speed screening by 
performing the assay in multi-well plates processed by automated confocal laser scanning 
microscopy (Hughes et al., 2011). Fluorescent-based assays produce not only quantifiable 
outputs, but also qualifiable phenotype of fluorescent labeling cells. Furthermore, several 
cell types/ biological processes indicated by different fluorescent proteins/ fluorescence 
based bio-sensors within the same zebrafish, such as apoptosis/ necrosis, can be analyzed 
simultaneously (Huiting et al., 2015).   
 
Figure 7 The fluorescence-based drug discovery in zebrafish.  
 
Once a zebrafish disease model is identified, a chemical-suppression screen can be implemented. Characterized 
phenotypes can be screened against small-molecule libraries. Zebrafish embryos or larvae are arrayed in 96-well 
plates and different concentration of compounds are robotically added into the raising media in each well. 
Throughput can be assessed directly by using fluorescent read-outs.  Adapted from Lieschke et al., 2007.  
 
1.3 Innate immune response to CDI  
The innate immune system is the first defense against the pathogenic microorganisms in the 
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body, which also plays a critical role in shaping the adaptive immune response (Sickles et al., 
2017). The innate defence against C. difficile includes gut microbiota, mucus barrier, the 
intestinal epithelium, and the mucosal immune system (Madan et al., 2012).  The C. difficile 
toxins have multiple effects on all innate immune defences, including the damage of 
intestinal epithelial cells and the recruitment of immune cells into the intestine (Abt et al., 
2015).  In fact, before C. difficile encounter intestinal epithelial cells, they firstly contact with 
intestinal microbiota. In addition to preventing pathogen colonization in the intestines, gut 
microbiota also regulate and shape the immune response to pathogenic bacteria (Perez-
Lopez et al., 2016). The immune cells include macrophages, neutrophils, eosinophils, 
basophils, and natural killer cells, among which neutrophil and macrophage are key 
components in numerous infectious diseases (Sekirov et al., 2010).  
 
Figure 8 General overview of mucosal immunity to intestinal pathogens and microbiome 
 
Dendritic cells (DCs) sample intestinal microorganisms. Upon sampling the resident microbiota, DCs induce  
T (TReg) cells to secrete interleukin-10 (IL-10). Resident macrophages and DCs are activated by pathogens and 
secrete IL-23, which stimulates several subsets of T cells including T helper 17 (TH17) cells, γδ T cells, natural 
killer (NK) cells, natural killer T (NKT) cells. These cell subsets promote amplification of the host response by 
stimulating the intestinal epithelium to secrete CXC-chemokines that attract neutrophils. Plasma cells also 
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control the microbiota and pathogens via secretory IgA (sIgA).; NLR, NOD-like receptor; PMNs, 
polymorphonuclear cells; ROS, reactive oxygen species; TLR, Toll-like receptor; TNF, tumour necrosis factor. 
From Perez-Lopez et al., 2016.  
 
1.3.1 Gut microbiota, bile acids and mucosa  
The gut microbiota refers to an enormous population of microorganisms, including bacteria, 
fungi, archaebacteria, viruses, and protozoans that colonize in the human gastrointestinal 
tract (GI) (Sekirov et al., 2010). Over the last decade, a combination of innovative 
metagenomics analysis and conventional approach, have greatly expanded our knowledge of 
the relationship among the microbiota, the host, and pathogenic bacteria (Thursby et al., 
2017). More evidences proved that in addition to providing nutrients, microbiota also play 
important roles in the immune development, neurological diseases and inflammatory bowel 
diseases (Hooper et al., 2012; Sartor et al., 2012; Sommer et al., 2013).  
 
Protection of the host intestine from exogenous bacteria by commensal microorganisms, 
termed colonization resistance, is first described in 1950s (Vollaard et al., 1994).  Recent 
studies indicated that microbiota-mediated colonization resistance prevent the invasion by 
pathogenic bacteria, particularly pathogens that are broadly resistant to antibiotics, such as 
C. difficile (Buffie et al., 2013). Change of the composition of the gut microbiota might lead 
to  pathological outcomes (Sekirov et al., 2010). For instance, Ferreira et al found that the 
disruption of the microbiota after antibiotic treatments makes mice more susceptible to 
Salmonella enterica serovar Typhimurium (Ferreira et al., 2011). Another prominent example 
is CDI, which can be induced when the diversity of microbiota is reduced in the host. CDI 
occurs when the natural flora is disrupted by antibiotics. Antibiotic abuse is still regarded as 
the major risk factor for CDI (Figure 9) (Longo et al., 2015; Rupnik et al., 2009). Due to loss of 
colonization resistance, antibiotic induced CDI has been demonstrated in hamster and mice 
(X. Chen et al., 2008b; Razaq et al., 2007). Notably, different composition of the intestinal 
microbiota enables host resistance to different pathogenic species more easily, and it also 
affects inflammation response (Belkaid et al., 2014; Ferreira et al., 2011). Utilizing the 
microbiota to combat CDI represents an important therapeutic method, with many 
promising clinical results obtained from treatment for C. difficile colitis (van Nood et al., 
2013). 
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Figure 9 Treatment with antibiotics decreases the diversity of the microbiota and leads to expansion of the C. 
difficile population.  
 
Toxins that are released from C. difficile (TcdA and TcdB) enter and damage the cells of the epithelium, which 
leads to inflammation (colitis) and cell death. From Bäumler et al., 2016. 
 
Some mechanisms have been proposed to explain why antibiotic induced change in the gut 
microbiota leads to CDI, for instance, the niche exclusion and unbalance of bile acid 
metabolism (Figure 10) (Britton et al., 2012).  
 
The niche exclusion is proposed based on the fact that hospitalized patients with 
asymptomatic colonization of C. difficile displays a lower risk to develop subsequent C. 
difficile associated disease (CDAD) (Shim et al., 1998). Studies in hamsters proved that pre-
colonization with even nontoxigenic C. difficile protects hamsters from lethal toxigenic C. 
difficile (Merrigan et al., 2003; Susan P. Sambol et al., 2002). One mechanism of C. difficile 
colonization resistance might be that commensal microflora outcompetes C. difficile 
colonization by limiting carbon sources that favours C. difficile growth (Britton et al., 2012).  
Another study demonstrated that colonization of gnotobiotic mouse gut with a single 
Bacteroides species prevents subsequent colonization of an isogenic strain (S. M. Lee et al., 
2013). Whitake et al proved that a successfully colonized RFP-expressing Bacteroides strain 
outcompeted a sequential GFP-expressing strain in intestinal crypts, where C. difficile is able 
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to reproduce (Whitaker et al., 2017). These findings suggest that colonization of symbiotic 
bacteria in specific intestinal structure is a key step to prevent invading pathogens.  
 
 
Figure 10 Potential mechanisms by which the indigenous microbiota can mediate colonization resistance 
against C. difficile.  
 
Specific members of the microbiome can either directly, or indirectly interfere with the colonization of C. 
difficile in the gut. Direct inhibition can occur via competition for nutrients or by primary microbial products 
that inhibit C. difficile. Indirect inhibition can occur via interaction between the gut microbiota and the host 
that results in the host products that can control C. difficile colonization and proliferation. MMAP: microbial- 
associated molecular patterns. SCFA, short-chain fatty acids. From Britton et al., 2012.  
 
Another proposed mechanism is that the transformation of bile acids affects C. difficile spore 
germination, and the vegetative cell growth (Figure 11) (Bäumler et al., 2016; Britton et al., 
2012). Bile acids are water-soluble, amphipathic biological detergents that are synthesized 
exclusively in the liver, and then secreted into the intestinal lumen (Figure 11A). Cholate (CA) 
and chenodeoxycholate (CDCA) are the two primary bile acids in human and rodent (Ridlon, 
2005). The host further metabolizes primary bile acids to form conjugated bile acids, such as 
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glycocholate (GCA) and taurocholate (TCA). The major function of bile acid is to emulsify and 
solubilize fat. Besides, they also possess antimicrobial properties. When primary bile acids 
enter the intestine, they induce the expression of antimicrobial peptides, which aids the host 
defence system against pathogens (Inagaki et al., 2006). Importantly, some bacterial species 
that reside in the caecum and colon dehydroxylate the 7α-carbon of CA and CDCA to 
produce secondary bile acids, deoxycholate (DCA) or lithocholate (LCA), respectively (Ridlon 
et al., 2005). GCA and TCA can be de-conjugated to produce unconjugated counterparts by 
bile salt hydrolases (BSH), which are secreted by the commensal bacteria in the gut (Abt et 
al., 2016). Mammals also rely on the intestinal microbiota to synthesize essential amino 
acids and vitamins, and to break down undigested food such as plant polysaccharides 
(Bäckhed et al., 2005).  
 
In 1982, Wilson et al. demonstrated that addition of TCA to cycloserine cefoxitin fructose 
agar (CCFA) media, which is used to culture C. difficile, greatly stimulated germination of C. 
difficile spores (Wilson et al., 1982). When antibiotic-induced mice are challenged with C. 
difficile, Theriot et al showed that the level of TCA and other tauro-conjugated bile acids 
increases, while the level of secondary bile acid deoxycholate decreases (Theriot et al., 
2014). Darkoh et al. purified native TcdA and TcdB from culture supernatants, and 
characterized toxins activities by Cdifftox activity assay in 2011, where they found that TCA 
inhibits the activities of C. difficile toxins in vitro (Darkoh et al., 2011).  However, it is well 
accepted that TCA triggers C. difficile germination and permits outgrowth of vegetative cells 
(Theriot et al., 2015). Various efficiency of primary bile acids to stimulate germination in 
vitro are also documented in clinical isolates of C. difficile (Carlson et al., 2016; Heeg et al., 
2012).  
 
Antibiotic treatment with metronidazole and vancomycin is still considered as an effective 
method to treat CDI. However, this therapy further disrupts the gastrointestinal microbiota 
composition, and is associated with more than 20% of case recurrence (Figueroa et al., 
2012). Despite that primary bile acids initiate C. difficile germination, some secondary bile 
acids act as inhibitors of spore germination and vegetative growth of C. difficile (Sorg et al., 
2008, 2010; Wilson, 1983) . Many secondary bile acids are reported to interfere the growth 
of C. difficile in vitro, for instance, hyodeoxycholate (HDCA), ursodeoxycholate (UDCA), 
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deoxycholate (DCA) and lithocholate (LCA) (Carlson et al., 2016; Heeg et al., 2012; Sorg et al., 
2008; Weingarden et al., 2014; Winston et al., 2016). Buffie et al showed that restoration of 
secondary bile acid by Clostridium scindens, a bile acid 7a-dehydroxylating intestinal 
bacterium, helps to regain colonization resistance against C. difficile in mice (Buffie et al., 
2014). More recent in vivo studies also supported this concept (Theriot et al., 2015; 
Weingarden et al., 2014). In summary, the previous and current studies suggest that 
secondary bile acids have a direct impact on the C. difficile life cycle in vitro, ex vivo, and in 
vivo (Winston et al., 2016). Bile acid might provide a novel approach for the treatment of 
CDI.  
 
 
Figure 11 Formation of microbial derived secondary bile acids  
 
A) Production of microbial derived secondary bile acids. Primary bile acids, chenodeoxycholate (CDCA) and 
cholate (CA) are synthesized from cholesterol by hepatocytes in humans and rodents. Within the GI tract, the 
gut microbiota can convert host derived primary bile acids (represented in darker shades) into secondary bile 
acids (represented in lighter shades). Microbial derived secondary bile acids can also be unconjugated or 
conjugated to taurine or glycine.  B)  Effects of various secondary bile acids on the life cycle of C. difficile in vitro. 
TCA is essential for germination of C. difficile spores (green arrow). TCA-mediated spore germination can be 
blocked by specific secondary bile acids (red box). DCA can also stimulate germination of C. difficile spores, a 
process that is inhibited by ωMCA in mice. Outgrowth of C. difficile vegetative cells is inhibited by multiple 
   Introduction 
 29 
secondary bile acids (red box). Abbreviations: CA, cholate; CDCA, chenodeoxycholate; DCA, deoxycholate; HCA, 
hyocholate; HDCA, hyodeoxycholate; LCA, lithocholate; MDCA, murideoxycholate; UDCA, ursodeoxycholate; 
αMCA, α-muricholate; βMCA, β-muricholate; ωMCA, ω-muricholate. From Winston et al., 2016.  
 
1.3.2 Innate immune cells: Neutrophil 
Neutrophils are the most abundant granulocytes in circulation, which are critical for host 
innate immune defence (Amulic et al., 2012). Neutrophils were believed to survive from 6 to 
8 hours in the bloodstream. However, recent evidence indicated that they are able to survive 
even longer, 13–19 hours for human neutrophils (Lahoz-Beneytez et al., 2016). Circulating 
neutrophils are pre-programmed to die by apoptosis, which are further cleared by 
macrophages in the liver, spleen, and bone marrow (McCracken et al., 2014). This prevents 
toxic neutrophil contents from inducing harmful inflammatory response (Fox et al., 2010).   
 
Highly abundant neutrophils in circulation are keeping with the fact that these cells are the 
first responders to be recruited to the sites of inflammation, playing a primary role in the 
clearance of pathogens (C Nathan, 2002). Typically, neutrophils phagocytose pathogens, and 
also produce antibacterial proteins and/or cytokines to attract other myeloid cells (Amulic et 
al., 2012).  
 
An intestinal inflammatory response with neutrophil infiltration and tissue damage is one 
characteristic of acute CDI (Ciarán P. Kelly et al., 2011). Neutrophils do play an important role 
in the defence of C. difficile (Figure 12). But the exact role of neutrophils in the context of CDI 
remains unclear. 
 
Neutrophil infiltration is one of the major pathological feature in CDI and is critical for the 
early defence against C. difficile (Madan et al., 2012). Jarchum et al found that depletion of 
neutrophils results in markedly increased mortality followed infection in mice (Jarchum et al., 
2012). Likewise, C. difficile-induced NOD1 activation leads to increased chemokine production 
and neutrophil recruitment. NOD1−/ − mice displays less neutrophil recruitment, and enhanced 
lethality, which is accompanied by impaired C. difficile clearance (Hasegawa et al., 2011).  
Multiple signalling pathways and chemokines, are involved in neutrophils recruitment after 
CDI, for instance, the MyD88-CXCL signalling pathway and chemokine, Interleukin-23 (IL-23) 
(Jarchum et al., 2012; McDermott et al., 2016). In a study of hematopoietic stem cell 
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transplants, researchers found that individuals with neutropenia are more likely to have 
recurrent CDI than non-neutropenic patients (A. M. Huang et al., 2014). Therefore, neutrophil 
recruitment seems to be a protective mechanism to the host.  
 
However, inhibition of neutrophils infiltration to the intestine by blocking CD18, a neutrophil 
adhesion molecule, results in a reduction of TcdA-induced tissue disruption in rabbit (Ciaran 
P. Kelly et al., 1994).  Similarly, TcdA-induced neutrophil recruitment is augmented in CX3CR1 
-/- ( inflammatory chemokine ) mice, which increases disease severity (Inui et al., 2011).  In 
patients with C. difficile colitis, a higher neutrophil level is associated with more severe disease 
and increased mortality (Koon et al., 2013).  
 
Collectively, these studies reveal that neutrophils act as double-edged swords in CDI, 
representing the critical first defense against C. difficile while possessing the potential to 
induce tissue damage.  
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Figure 12 Innate immune-mediate defences against C. difficile. 
 
The acute immune response to C. difficile is initiated by toxin-mediated damage and disruption of the epithelial 
integrity. Intoxicated intestinal epithelial cells and resident innate immune cells release pro-inflammatory 
chemokines and cytokines, which leads to the recruitment of more neutrophils and macrophages. Infiltrated 
neutrophils generate inflammatory mediators, perform phagocytosis of the pathogen and toxins, and in severe 
cases lead to pseudomembranous colitis. Apoptotic neutrophils and subsequent phagocytosis by macrophages 
kicks in the resolution phase. Phagocytosis of apoptotic neutrophils coincides with surge in pro-resolution 
molecules and reduction in inflammatory cytokines and chemokines leading to tissue and systemic homeostasis. 
 
Although neutrophil-mediated inflammation is critical for the host defence, it is also crucial to 
clear the neutrophils after they exert their pro-inflammatory effects (Jose et al., 2016). 
Regulation of neutrophil apoptosis is essential for regulating neutrophil-induced tissue 
damage or promote wound healing (Carl Nathan, 2006). Defective apoptosis or failure of the 
clearance of neutrophils leads to secondary deleterious tissue injury (Lucas et al., 2014). As 
terminally differentiated cells, neutrophils quickly undergo spontaneous apoptosis after their 
release into the blood stream (B Geering et al., 2011). The initial trigger of apoptosis remains 
unclear. Unresolved neutrophils inflammation or delayed neutrophils apoptosis is associated 
with many diseases, like sepsis, and rheumatoid arthritis (Munoz et al., 2010).  
 
Previous researches have shown that neutrophils apoptosis can be driven by cyclin-dependent 
kinase (CDK) inhibitors, such as roscovitine (Strowig et al., 2012). Hoodless et al reported that 
CDK9 inhibitor (AT7519, flavopiridol ) induces neutrophils apoptosis in vitro and promotes 
resolution of inflammation in rodent models (Hoodless et al., 2016). In zebrafish tailfin injury 
model, the inhibitor enhances resolution of inflammation by reducing neutrophil number via 
apoptosis (Hoodless et al., 2016). Lipoxins A4 (LXA4) mediator promotes resolution of 
inflammation through increasing phagocytosis of apoptotic neutrophils by macrophages 
(Godson et al., 2000). In the clearance of apoptotic neutrophils, there are two routes: systemic 
recirculation and local death by phagocytosis of recruited macrophages (Serhan et al., 2007). 
Once phagocytosis is completed, the macrophages exit the inflamed site and acute 
inflammation is resolved (Serhan et al., 2007). Similar cooperation of macrophage and 
neutrophil might exist in CDI but have not been investigated.  
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1.3.3 Innate immune cells: Macrophages  
Much attention in inflammation research has focused on the recruitment of leukocytes 
(Muller, 2003). However, a rapid immune response requires sentinel cells at the site of 
inflammation. Such cell type is represented by mast cells and macrophages (C Nathan, 2002).  
 
Macrophages are classified as part of the mononuclear phagocytic system, which are 
generated from bone marrow (Murray et al., 2011). They are characterized by avid 
phagocytosis that ingests and degrades dead cells and debris, and organizes inflammatory 
processes (Varol et al., 2015). Monocytes, dendritic cells (DCs), macrophages, along with 
neutrophils, and mast cells are recognized as professional phagocytic cells (Murray et al., 
2011). When mature monocytes migrate from peripheral circulation, and extravasate through 
endothelium, they differentiate into tissue-resident macrophages, as well as DCs (Gordon et 
al., 2005).  
 
The GI hosts the largest pool of macrophages in the body, which are essential for maintaining 
mucosal homeostasis in response to pathogens or inflammation (Mowat et al., 2011). As 
described above about the phagocytosis of apoptotic neutrophils (Figure 12), macrophage 
activation is an important step in the pathogenesis of C. difficile toxin-induced colitis (Linevsky 
et al., 1997). 
 
The role of macrophages has mainly been acquired from in vitro, or ex vivo studies using 
human or mouse macrophage cell lines. These studies showed that C. difficile toxin stimulates 
the secretion of macrophage-derived chemokines. Both TcdA and TcdB can activate IL-8 
production by macrophage-differentiated THP-1 cells (Linevsky et al., 1997). C. difficile toxins 
also trigger interleukin-1β (IL-1β) secretion and caspase-1 activation in both mouse 
macrophages and human colon biopsy specimens by ASC-containing inflammasome (Ng et al., 
2010). Similarly, the murine macrophage cell line RAW 264.7 produces high amount of 
secreted TNF-α after treatment with either TcdA or TcdB (Sun et al., 2012). In another report, 
using the RAW 264.7 cell line, researchers found that despite efficient phagocytosis of C. 
difficile spore by RAW 264.7 cells, spores are able to survive and produce cytotoxic effects on 
RAW 264.7 cells themselves (Paredes-Sabja et al., 2012). However, the exact role of 
macrophage is shrouded in mystery. 
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As described, animal models have been used for CDI research, such as hamster, and pig. 
However, there are not so many in vivo reports about the role of macrophage in CDI in vivo. 
Hirota et al developed a novel mouse model that introduced intrarectal instillation of C. 
difficile toxins into the mouse colon (Hirota et al., 2012). They found that TcdA/B trigger the 
infilatration of macrophage into the colinc tissue in a time-dependent manner, enhance 
epithelial barrier permeablitly and increase intestinal epithelial cell death, which is a hallmark 
of human CDI (Hirota et al., 2012).  
 
Therefore, the macrophage response plays critical roles in the host immune response to C. 
difficile and resolution of inflammation, but the precise mechanism of macrophages in CDI is 
less understood. Furthermore, the behavior and cooperation between neutrophils  and 
macrophages remains largely speculative.  
 
1.4 LexA/lexAop expression system and ATTACTM ablation system  
1.4.1 LexA/lexAop system 
Spatial and temporal control of transgene expression is essential for the functional study of 
genes, subcellular structures monitoring, and selective cell ablation. Binary expression 
systems such as the Gal4-UAS, the LexA/lexAop and the Q-system offer powerful tools to 
manipulate target tissue in a targeted manner.  
 
The Gal4-UAS system is derived from Saccharomyces cerevisiae. Gal4 is a transcription factor 
that contains a DNA-binding domain and a transcription activation domain. Gal4 binds UAS 
and activates transcription of its target gene placed downstream of the UAS sites (Duffy, 2002; 
Traven et al., 2006). Gal4-UAS turns to be the workhouse of Drosophila genetics firstly (del 
Valle Rodríguez et al., 2012), and it has also been successfully adapted to zebrafish (Halpern 
et al., 2008). Hundreds of Gal4 driver stains or UAS strains have been established and are 
available, each of which shows distinct expression profile.  
 
Another binary expression system that has been used in zebrafish is LexA/lexAop system. With 
the same principle of Gal4-UAS, the LexA/lexAop expression system consists of two main 
components: the transcription activator of LexA is expressed in a cell type specific pattern, 
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and coupled with transgenes expression under the control of LexA operator DNA fragment/s 
(lexAop) to achieve a precise temporal and spatial control of gene expression (del Valle 
Rodríguez et al., 2012). The LexA and LexAop, like Gal4-UAS, is also absent in higher 
eukaryotes. Therefore, it is unlikely to bind to the cis-elements of endogenous promoters in 
zebrafish (Emelyanov et al., 2008).  
 
LexA protein is a bacterial repressor, which regulates SOS response to DNA damage 
in Escherichia coli (John W. Little et al., 1982). When the DNA is damaged, the SOS response 
is induced. The SOS system is controlled by two regulatory proteins, a repressor LexA and an 
inducer RecA (Butala et al., 2009). The DNA damage signal reversibly activates the protease 
activity of RecA. Then RecA mediates a self-cleaving activity in LexA, which inactivates the LexA 
(Butala et al., 2009; J. W. Little, 1991; John W. Little et al., 1982). In consequence, the SOS 
regulon is induced and the DNA damage is repaired (J. W. Little, 1991).  
 
The LexA protein is a 202-amino-acid protein consisting of three domains: an N-terminal DNA-
binding domain, a dimerization domain, and A latent protease domain (Figure 13) (A. P. P. 
Zhang et al., 2010). The first two domains are connected by a short flexible linker, with 
autoproteolytic  sites within the C-terminal domain (Butala et al., 2009). In E. coli or in vitro, 
LexA protein binds as dimer with various affinities to single or multiple lexAop sites (J. W. Little, 
1991; Mohana-Borges et al., 2000). Since LexA binds operators with different affinities, 
different strain-derived operators were developed. Lai et al have developed colE1-binding 
lexAop with a Drosophila LexA reporter, which turned to possess one of the highest affinities 
to LexA (Lai et al., 2006). Although the colE1-drived motif permits strong expression, the 
toxicity and leaky expression was found Drosophila (Yagi et al., 2010). Yagi et al tested other 
LexA-binding sites from sulA, umuDC, or a synthetic lexA operator. They identified that the 
sulA-derived LexA-binding motif showed strong transgene expression, as well as no expression 
in the LexA absent situation (Yagi et al., 2010).   
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Figure 13 Sequence of LexA protein and its secondary structures.  
The DNA binding domain (NTD) is in light grey. The hinge region is shaded dark grey, followed by the carboxy 
terminal domain (CTD), dimerization domain. Black shading highlights residues Ser119 and Lys156 (the catalytic 
dyad) and Ala84 and Gly85 (which flank the peptide bond that is cleaved by the catalytic dyad). The triangles 
above residues indicate positions of substitutions that enhance (solid symbols) or prevent (open symbols) DNA 
binding. From Butala et al., 2009.  
Ever since the LexA/lexAop interaction was elucidated (Butala et al., 2009), the potential of 
applying this binary system to manipulate gene expression in vivo has been well appreciated 
(Figure 14). It is reported that the LexA linked to the Gal4 activation domain or the 
transactivation domain VP16 from the herpes simplex virus is able to obtain the expression of 
transgenes in distinct pattern in Drosophila (Lai et al., 2006; Szüts et al., 2000). In Gal4-UAS 
applied Drosophila, LexA/lexAop is primarily used to manipulate additional gene expression 
simultaneously (del Valle Rodríguez et al., 2012).  
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Figure 14 Binary expression systems 
 
Two-component expression systems such as GAL4-UAS, LexA/lexAop or QF-QUAS consist of a transcriptional 
activator expressed in a specific pattern and a transgene under the control of a promoter that is largely silent in 
the absence of the transcriptional activator sometimes. These systems can be repressed by specific molecules 
such as GAL80 or QS. From del Valle Rodríguez et al., 2012. 
 
In 2008, Emelyanov et al demonstrated that the LexA-based transcriptional system can be 
used in zebrafish in vivo (Emelyanov et al., 2008). In this report, the LexA DNA-binding domain 
is fused to a truncated ligand-binding domain of the progesterone receptor, and the activation 
domain of human p65 protein to compose a hybrid transcription factor, LexPR transactivator 
(Figure 15). Transgene expression is strictly controlled and induced in embryos and adult fish 
through the administration of mifepristone in media (Emelyanov et al., 2008). Mazaheri et al 
reported that they modified the LexPR (ΔLexPR ) activator, and placed it under the control of 
a promoter to acquire a constitutive activation in the central nervous system of zebrafish 
(Mazaheri et al., 2014).   
 
 
Figure 15 Schematic representation of the mifepristone-inducible LexA-based gene expression system 
 
Schematic representation of the mifepristone-inducible LexA-based gene expression system. The LexPR driver-
reporter binary cassette contains two transcription units: the gene encoding a chimeric LexPR transactivator 
(Lex
DBD
-PR
LBDΔ
-p65
AD
) under the control of an enhancer-trap promoter (PET) and the EGFP reporter gene under 
the control of a minimal promoter (miniP35S) fused to a synthetic LexA operator. The LexPR transactivator binds 
to the LexA operator sequence to activate the transcription of the downstream genes only in the presence of 
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mifepristone (RU 486). From Emelyanov et al., 2008.  
 
The availability of Gal4-UAS and LexA/lexAop system in zebrafish allows us to perform 
multicolour imaging or manipulate two cell types simultaneously in the same organism.  
 
1.4.2 ATTACTM ablation system 
Targeted cell ablation is a useful method to study cell function, interaction, and regeneration 
in the context of a whole organism. In addition, recovery analysis might uncover new cellular 
and molecular mechanisms in the regeneration process.  
 
To ablate a specific cell type in a spatially and temporally controlled manner, several inducible 
genetic ablation methods have been developed. The nitroreductase (NTR)-mediated 
technique has been widely used in zebrafish in a specific and inducible manner (Pisharath et 
al., 2007). This technique relies on NTR that can convert prodrug metronidazole into cytotoxic 
metabolite (Curado et al., 2007). However, as metronidazole is an effective agent for the 
treatment of CDI, this method cannot be used in this study.  
 
Our group recently developed a novel ablation system based on tamoxifen-inducible Caspase 
8 activity, refer to as ATTACTM ablation system (Weber et al., 2016). In this approach, Caspase 
8 is fused to a mutated tamoxifen-interacting estrogen receptor ligand-binding domain (ERT2), 
Caspase8-ERT2, that renders Caspase 8 active by tamoxifen-induced dimerization (Figure 16) 
(Chu et al., 2008).  The ERT2 mutant prevents the binding to natural ligand but retains normal 
affinity to the synthetic ligand, 4-hydroxy tamoxifen (4-OHT) (Littlewood et al., 1995). After 4-
OHT treatment, Caspase8ERT2 forms a homotypic dimer and triggers an apoptosis pathway, 
resulting in cell death. Our group has successfully transferred this ablation system to living 
zebrafish and specifically ablated Purkinje cells in an apoptotic manner (Weber et al., 2016). 
Notably, after removal of tamoxifen, the fluorescent reporter facilitates the monitoring of the 
regeneration processes.  
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Figure 16 Mechanism of Caspase8ERT2 ablation system.  
In the presence of 4-OHT, Caspase8ERT2 fusion proteins dimerize via the ERT2 domain, leading to proteolytic 
Caspase self-activation that triggers apoptosis. From Chu et al., 2008.  
 
1.5 The aims of the study  
1.5.1 Establishment of zebrafish model to screen antagonists of TcdA and TcdB 
Based on TcdA and TcdB structure and mechanism of cellular intoxication, the N-terminal 
glucosyltransferase domain (GTD) was delivered into cytosol of target cell to inactivate host 
GTPases by glucosylation. The inactivation of GTPases results in disruption of actin 
cytoskeleton, cell rounding and eventually death of the targeted cell, which cause symptoms 
of CDI. Therefore, a transgenic zebrafish stain expressing the GTD domain will be established 
to mimic pathogenesis of CDI. The zebrafish model will be utilized to identify antagonists of 
TcdA and TcdB. Because of cellular intoxication, the cell type or tissue that target expression 
of GTD domain would be dead by apoptosis. Therefore, hatching gland will be selected as the 
target tissue. Hatching gland is required only at the first 48 hours after fertilization. Zebrafish 
embryos that have malfunctioned hatching gland could be hatched by treatment of pronase. 
A zebrafish hatching gland specific enhancer has been identified, which makes targeted 
expression of GTD in hatching gland cell possible.  
 
In order to monitor the morphological change of apoptotic hatching gland cells, a fluorescent 
protein and an apoptosis sensor will be co-expressed with GTD domain in the hatching gland. 
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Combine with confocal scanning microscopy, the fluorescence-based screening would enable 
high-throughput compound analysis. 
  
1.5.1 Analysis of neutrophil and macrophage behaviour upon C. difficile infection 
The innate immune cell response plays a crucial role in CDI. Neutrophil and macrophage have 
been proved to engage in CDI. In the animal models of CDI, the infiltration of neutrophil is one 
of the major pathological findings. However, the specific function and behavior of both cell 
types is less understood.  
 
A stable transgenic zebrafish strain with the expression of yellow fluorescent protein in 
neutrophil will be established. To monitor macrophages simultaneously, the other strain that 
express a red fluorescent protein in macrophage will also be generated. Confocal time-lapse 
imaging in embryos of each strain after C. difficile infection will reveal the response of 
macrophage or neutrophil, their time course recruitment, and their phagocytic behaviour. 
Dual fluorescence time-lapse analysis in double transgenic embryos will uncover the 
cooperation of these innate immune cells upon C. difficile invasion.  
 
Furthermore, the macrophage and neutrophil transgenic train will co-express a Tamoxifen-
inducible caspase to trigger apoptosis (ATTACTM). I will use this technique to eliminate either 
neutrophil or macrophage, which will reveal their roles at different stage of CDI. Double 
ablation of both cell types will expose the role of innate immune response to C. difficile 
infection. 
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2. Materials and methods 
2.1 Materials 
2.1.1 Bacterial strains and cell lines 
2.1.1.1 Bacterial strains 
Commercially NEB 5 α and NEB Turbo Competent E. coli were used for transformation and 
flowing plasmid purification.  
 
XL1-Blue Competent Cells was utilized for bacterial infection of zebrafish.  
Table 1 
Strain genotype 
NEB 5 α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17 
NEB Turbo F' proA+B+ lacIq ∆lacZM15 / fhuA2 ∆(lac-proAB) glnV galK16 
galE15 R(zgb-21:Tn10)TetS endA1 thi-1 ∆(hsdS-mcrB)5 
 
2.1.1.2 C. difficile strains 
Table 2 
Strain Ribotype Isolated Toxinotype 
630      012 Switzerland  TcdA+/TcdB+ 
630Δerm 012 UK TcdA+/TcdB+ 
R20291 027 UK TcdA+/TcdB+/CDT+ 
  
2.1.1.3 Cell line 
HEK293T cell is a highly transfectable derivative of human embryonic kidney 293 cells.  
 
2.1.2 Chemicals and reagents 
2.1.2.1 Chemicals  
Table 3 
Chemicals Manufacturer 
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1kb DNA ladder  New England Biolabs (NEB) 
6x Gel loading dye Purple NEB 
m7G(5’)G RNA cap structure analogy NEB 
(Z)-4-Hydroxytamoxifen (4-OHT) Sigma-Aldrich 
Dimethyl formamide (DMF) Sigma-Aldrich 
Phenol Red Sigma-Aldrich 
(N)-Phenylthiourea (PTU) Sigma-Aldrich 
Sodium chloride (NaCl) Sigma-Aldrich 
Sodium citrate Sigma-Aldrich 
Torula-RNA (tRNA) Sigma-Aldrich 
Tween 20 Merck 
Magnesium chloride (MgCl2) Roth 
Magnesium sulfate (MgSO4) Roth 
Ribolock, RNase-Inhibitor Thermo Fisher Scientific 
Dithiothreitol (DTT) 100 mM Promega 
Ethanol (EtOH) Sigma-Aldrich 
Normal goat serum (NGS) Vector laboratories 
Nitro blue tetrazolium chloride (NBT) Roth 
Paraformaldehyde (PFA) Roth 
Tricaine Sigma-Aldrich 
HPLC water Roth 
Torula-RNA (tRNA) Sigma-Aldrich 
Methanol (MeOH) VWR 
Glycerol Roth 
Heparin Sigma-Aldrich 
 
 2.1.2.2 Enzymes  
Table 4 
Enzyme Manufacturer 
DNase I, RNase-free Thermo Fisher Scientific 
Proteinase K Promega 
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T3 RNA-Polymerase Promega 
T7 RNA-Polymerase Promega 
Sp6 RNA-Polymerase Promega 
T4 Ligase Thermo Fisher Scientific 
Klenow NEB 
Phusion DNA Polymerase Thermo Fisher Scientific 
 
2.1.2.3 Bile acids  
Taurocholic acid sodium salt hydrate (TCA), T4009, SIGMA, CAS Number 345909-26-4 
  
Sodium tauroursodeoxycholate (TCDCA) T0266, SIGMA, CAS Number 14605-22-2  
 
Sodium tauroursodeoxycholate (TUDCA) T0266, SIGMA, CAS Number 14605-22-2 
 
2.1.2.4 Staining reagent 
BacLight™ Red Bacterial Stain, Thermo Fisher Scientific, Catalog number: B35001 
 
2.1.2.4 Antibody 
Table 5  
Name Host 
Species 
Antigen Dilution Supplier Product code 
Anti-Caspase-3 
antibody 
 
Rabbit 
a cleaved 
form of 
Caspase 3 
 
1:1000 
 
Abcam 
 
ab13847 
Alexa 
Fluor 488 anti-
Rabbit IgG  
 
Donkey 
 
Rabbit IgG 
 
1:500 
 
Thermo 
Fisher 
 
A-21206 
Alexa 
Fluor 488 Goat 
anti-mouse 
 
Goat  
 
Goat IgG 
 
 
1:1000 
 
Invitrogen 
 
 
Anti-Digoxigenin-
AP Fab 
sheep digoxigenin 1:1000 Roch 1093274910 
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Fragments 
 
2.1.3 Media and solutions 
2.1.3.1 Fish media  
Table 6 
30 % Danieau 0.12 mM MgSO4 
0.18 mM Ca (NO3)2 
0.21 mM KCl 
1.5 mM HEPES (pH 7.2) 17.4 mM NaCl 
The solution was filled up to 1000 ml with 
ddH2O. 
0.3% PTU 1.2 g PTU in 400 ml 30 % Danieau 
30 % Danieau/PTU 990 ml 30 % Danieau with 10 ml 0.3 % PTU 
(f.c. 0.003 %) 
Egg water 0.04 g/l Sea salt in ddH2O 
0.4% Tricaine 400 mg tricaine powder 
97.9 ml ddH2O  
Adjust pH to ~7 with 1 M Tris (pH 9) 
Phenol Red  
 
0.5 % Phenol Red in 1x PBS  
1 mM 4-OHT 5 mg (Z)-4-Hydroxytamoxifen (4-OHT) 
diluted in 12.9 ml absolute Ethanol 
4 % PFA 40 g Paraformaldehyde 
1000 ml ddH2O and the pH was adjusted 
to 7.2 
 
   Materials and methods 
 44 
2.1.3.2 E. coli & Cell Culture Media 
Table 7 
LB-Medium 10g Bacto-tryptone. 
5g yeast extract 
10g NaCl 
Adjust pH to 7.4 and add water to 1 L. 
LB Agarose 10 g Bacto-Trypton 
5 g Yeast Extract 
10 g NaCl 
15 g Agar 
In 1 L ddH2O 
Cell Culture Medium DMEM, high glucose medium  
10% Fetal Bovine Serum (v/v) 
1% Penicilin/Streptomycin (v/v) 
1% Glutamin/Glutamax (v/v) 
 
2.1.3.3 Histology Solution 
Table 8 
20x SSC 
 
175.3 g Sodium chloride 
88.25 g Sodium citrate dehydrate 
Add ddH2O to 1 l and adjust pH to 7 with 
citric acid 
Citric acid (1 M) 105.07 g Citric acid 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Add ddH2O to 500 ml. 
Sodium chloride (5 M) 46.1 g Sodium chloride  
Add ddH2O to 500 ml 
Magnesium chloride (1 M) 101.65 g Magnesium chloride  
Add ddH2O to 500 ml 
Tris (1 M, pH 9.5) 121.14 g Tris  
Add ddH2O to 1000 ml and adjust pH to 
9.5 
20 % Tween20 10 ml Tween20  
Add ddH2O to 50 ml 
TE buffer for PK 6.1 g Tris base  
0.37g EDTA 
5ml Trion X-100 
Add ddH2O to 1000 ml and adjust pH to 
8.0.  
Proteinase K stock solution (20X) 
 
8mg Proteinase K 
10ml TE buffer for PK 
10ml Glycerol 
Hybridization Buffer 50% Formamide (v/v) 25% 20x SSC (v/v) 
150 μg/mL Heparin  
5 mg/mL Torula-RNA 0.1 % Tween20 (v/v)  
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PBST 
 
0.3% Tween20 in PBS (v/v) 
Fixation Buffer  4% PFA in PBST (v/v)  
NGS Blocking Solution 10% NGS (Normal Goat Serum) in PBST 
DMSO (v/v) 
BCIP stock solution 50 mg/ml BCIP in 100 % DMF  
NBT stock solution 50 mg/ml NBT in 70 % DMF/ddH2O (v/v) 
Staining solution 3.75 μl BCIP and 5 μl NBT per 1 ml AP 
buffer  
 
2.1.3.4 Protein Biochemistry 
Table 9 
1. 10x Running Buffer   30.03 g Tris  
144 g Glycine 
10 g SDS  
Add ddH2O to 1L. 
2x SDS Sample Buffer 125 mM Tris-HCl   
5 %(w/v) Glycerol   
4 %(w/v) SDS   
0,1 %(w/v) Bromphenol blue  
5 %(v/v) β-Mercaptoethanol  
Filled up with ddH2O  
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5x SDS Sample Buffer 312.5 mM Tris-HCl   
20 %(w/v) Glycerol   
4 %(w/v) SDS   
0,5 %(w/v) Bromphenol blue  
10 %(v/v) β-Mercaptoethanol  
Filled up with ddH2O  
 
Semi-Dry Transfer Buffer 25 mM Tris  
192 mM Glycine   
20 % (v/v) Methanol  
Separating Gel (10%) 5 ml 30% Acrylamide   
3.75 ml 1M Tris-HCl pH 6,8   
0.15 ml 10% Ammonium persulfate  
0.15 ml 10% SDS   
0.006 ml TEMED   
5.94 ml ddH2O  
2. 10x Transfer Buffer   30.2 g Tris  
144 g Glycine  
Add ddH2O to 1L 
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Skim Milk Blocking Buffer 5 %(w/v) Dry Skim Milk powder in TBS-
Tween  
TBS-Tween 20 mM Tris-HCl (pH 7.6)  
150 mM NaCl   
0.1 %(v/v) Tween20 
 Filled up with ddH2O  
 
2.1.2 Equipment  
Table 10 
Device Modell Manufacturer 
Centrifuge  5415C eppendorf 
Confocal Laser-scanning- 
microscope 
TCS SP8 DMI 6000 Leica 
Incubator B 6120 Heraeus 
Gel electrophoresis 
chamber 
40-0708 peQlab Biotechnologie GmbH 
Horizontal needle puller P-87 Sutter instrument 
Micro injector FemtoJet express eppendorf 
Pipetboy ACU2 Integra 
Rotator LD-79 Labinco BV 
Stereo fluorescence 
microscope 
M205 FA Leica 
Stereo microscope S8 APO Stereo zoom 1.0x- 
8.0x 
Leica 
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Vortex REAX2000 Heidolph 
Thermomixer Thermomixer 5436 eppendorf 
photometer DS-11 DeNovix 
 
2.1.3 Plasmids  
# 2 pCSII  
pCS2+ is a multipurpose expression vector, useful for high-level transient expression in a wide 
variety of mammalian cells. 
 
#3403 pBS-fyntagRFT:HE-HE:GFP 
Hatching gland enhancer driving the expression of RFP and GFP in bidirectional manner, 
flanked by To2 500 arms.  
 
#3395 pUC57-KozTcdA-HA 
N-terminus of TcdA toxin HAtag of C. difficile, named as NTcdA, with optimized codon usage 
for zebrafish. 
 
#3396 pUC57-KozTcdB-HA 
N-terminus of TcdB toxin HAtag of C. difficile, named as NTcdB, with optimized codon usage 
for zebrafish,  
 
#3475 pCSII-NTcdA 
The N-terminus of TcdA was cloned into pCSII vector with EcoRI/XbaI.  
 
#3476 pCSII-NTcdB 
The N-teiminus of TcdB was cloned into pCSII vector with EcoRI/XbaI.  
 
#3483 pBS-NTcdA-2HE-GFP 
The NTcdA was cloned into #3403 pBS-fyntagRFO-T2HE-GFP with EcoRV/Asp718.  
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#3484 pBS-NTcdB-2HE-GFP 
The NTcdB was cloned into #3403 pBS-fyntagRFO-T2HE-GFP with EcoRV/Asp718.  
 
#3477 pCDH-CMV-MCS-EF1-Puro (a kind gift from Pro. Dr. Binghui Li ) 
Venus-based apoptosis biosensor VC3AI was inserted in pCDH.  
 
#3518 pCSII-VC3AI-T2A-tagRFP-T 
It drives the expression of VC3AI and tagRFP fluorescence protein, to monitor apoptosis and 
observe cell morphology via RFP. 
 
#3519 pBS-TcdA: HE-HE: VC3AI-T2A-tagRFP-T 
HE enhancers drive the expression of NTcdA, VC3AI and tagRFP in bidirectional manner.  
 
#3520 pBS-TcdB: HE-HE: VC3AI-T2A-tagRFP-T 
HE enhancers drive the expression of NTcdB, VC3AI and tagRFP in bidirectional manner.  
 
#3757 pDESTnbtLexAdeltaTALexOPSecA5BFP 
It contains the sequence of LexA operator, a kind gift from P Francesca Peri 
 
#4089 pCS-mycCaspase8ERT2GIpA 
myc tag was added in front of Caspase8ERT2. The intron sequence of rabbit β-globin was used 
in 5’ position.  
 
#4090 pBS-LysC-KalTA4GIpA 
LysC, neutrophils specific promoter, drives the expression of KalTA4 GIpA.  
 
#4091 pBS-LysC-KalTA4GIpA-spacer 
LysC, neutrophils specific promoter, drives the expression of KalTA4 GIpA. A spacer sequence 
was amplified from #2212 using primer #1940/#1941. PCR product was digest with EagII/NotI 
and inserted into #4090.  
 
#4092 pCS-FyntdCitrine 
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tandem Citrin fluorescent protein containing fyn membrane localization signal was inserted 
into pCSII.  
 
#4099 pC-5UAS:FyntdCitrine 
tandem Citrin was isolated from #4092 wtih EcoRI/NotI and then cloned into #3421.  
 
# 4100 pC-Caspase8ERT2-5UAS-FyntdCitrine 
Caspase8ERT2 fragment was isolated from #4089 with EcoRV/Asp718 and cloned into #4099.  
 
#4101 LysC-KalTA4GIpA-UAS: FyntdCitrine/Caspase8ERT2 
Gal4 activator was under control of LysC promoter, which drive the expression of fluorescent 
protein Citrine and Caspase8ERT2. This construct was used for establishment of neutrophil 
stable transgenic line.  
 
# 4104 pCS-LexABDp65 
LexA DNA-binding domain fused the activation domain of human p65 was inserted into pCSII.  
 
#4105 pB-mpeg1:LexABDp65 
mpeg1, macrophage/microglia specific promoter, drive the expression of LexABD-p65.  
 
#4106 pB-mpeg1:LexABDp65-spacer 
mpeg1, macrophage/microglia specific promoter, drive the expression of LexABD-p65.  
A spacer sequence was amplified from #3757 using primer #1940/#1941. PCR product was 
digest with EagII/NotI and inserted into #4105. 
 
#4317 pCSII-2lac 
The oligo of tandem lac operators was annealed and inserted into empty pCSII vector by 
BgIII/BamHI.  
 
#4318 pCSII-4lac 
The oligo of tandem lac operators was annealed and then inserted into #4317 with 
BgIII/BamHI.  
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#4319 pCSII-rpl9-4lac-mseCFP 
The quadruple lac operator was inserted before CFP fluorescence in #3993, where lac 
operators are flanked by intron of rpl9.  
 
#4321 pBS-tagRFP-T: HE-HE:rpl9-4lac-mseCFP 
HE enhancers drive the expression of tagRFP-T, rpl9-4lac-mseCFP in bidirectional manner.  
 
#4322 pCSII-AnnexinV-T2A-H2B-tagRFP-T 
HE enhancers drive the expression of apoptosis sensor AnnexinV and a nuclear localized 
tagRFP-T in bidirectional manner. 
 
#4507 pCSII-rpl9-4lac-TcdA  
It drives the expression of NTcdA with rpl9-4lac. The rpl9-4lac fragment was PCR amplified 
from plasmid #4321 using primers #2309/#2310. The PCR produce was inserted into # 3475 
with EcoRI/EcoRV.  
 
#4508 pCSII-rpl9-4lac-TcdB 
It drives the expression of NTcdA with rpl9-4lac. The rpl9-4lac fragment was PCR amplified 
from plasmid #4321 using primers #2309/#2310. The PCR produce was inserted into # 3476 
with EcoRI/EcoRV.  
 
#4509 pBS-AnnexinV-T2A-H2B-tagRFP-T-2HE-GFP 
HE enhancers drive the expression of apoptosis biosensor AnnexinV, tagRFP-T, and GFP 
fluorescence protein. tagRFP-T indicate the expression of AnnexinV.  
 
#4510 pBS-AnnexinV-T2A-H2B-tagRFP-T-2HE-rpl-4lac-TcdA 
HE enhancers drive the expression of apoptosis biosensor AnnexinV, tagRFP-T, and NTcdA 
within which rpl-4lac was introduced in front of TcdA. #4507 was digested with EcoRI/NotI to 
isolate rpl-4lac-TcdA fragment and the fragment was inserted into #4509.  
 
#4511 pBS-AnnexinV-T2A-H2B-tagRFP-T-2HE-rpl-4lac-TcdB 
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HE enhancers drive the expression of apoptosis biosensor AnnexinV, tagRFP-T, and NTcdB 
within which rpl-4lac was introduced in front of TcdB. #4508 was digested with EcoRI/NotI to 
isolate rpl-4lac-TcdB fragment and the fragment was inserted into #4509.  
 
#4513 pBS-mpeg1 
mpeg1 promoter was isolated from #3257 with XhoI/EcoRI and then inserted into #3822.  
 
#4723 pBS-tagRFP-E1b 2xCar8-4xLexOPE1b-E1b-GFP 
4xLexAOP was amplified from plasmid #3757 using primer #2431 #2432. The PCR product was 
digested with PacI/PstI and was inserted into #4141.  
 
#4724 pBS-tagRFP:E1b-SCP-spacer-4xLexOPE1b:mClover 
This construct two reporter genes, tagRFP driving by SCP minimal promoter and mClover 
driving by E1b minimal promoter. They were linked by a spacer sequence. 4xLexOP E1b 
fragment was isolated from #4723 with PacI/EcoRI and inserted into #4049.  
 
#4725 pBS-tagRFP:E1b-8xLexOP-E1b:mClover 
This construct two reporter genes, tagRFP and mClover. Both were derived by E1b minimal 
promoter. 4xLexAOP was amplified from plasmid #4724 using primer #2434 #2435. The PCR 
product was digested with PacI/PstI and was inserted into #4724. 
 
#4726 pBS-fyntdRFP:E1b-8xLexOP-E1b:mClover 
Tandem tagRFP-T containing fyn membrane localization signal was inserted into plasmid 
#4725 to replace tagRFP.  
 
#4727 pBS-fyntdtagRFP:E1b-8xLexOP-E1b:Caspase8ERT2 
Myc-Caspase8ERT2GIpA fragment was Isolate from #4089 with EcoRI/NotI and then inserted 
into #4726.  
 
#4728 pBS-mpeg:LexABDp65-spacer 
LexABDp65-spacer was isolated from #4106 with EcoRI/NotI and inserted into #4513.  
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# 4731 pBS-mpeg1:LexABDp65-fyntdtagRFP:E1b-8xLexOP-E1b:Casoase8ERT2 
LexABDp65 transactivator was under control of control of an enhancer-trap promoter, mpeg1. 
tagRFP reporter gene and Casoase8ERT2 was under the control of a minimal promoter E1b 
fused to 8LexA operator. This construct was used for macrophage stable transgenic stain.  
 
#5141 pB-tagRFP:E1b:8xLexOP:E1b:4lac-TcdA 
rpl9-4lac-TcdA fragment was isolated from #4507 with EcoRI/NotI and inserted into #4725. 
 
#5142 pB-tagRFP:E1b:8xLexOP-E1b:4lac-TcdB 
rpl9-4lac-TcdB fragment was isolated from #4508 with EcoRI/NotI and inserted into #4725. 
 
#5143 pB-AnnexinV-T2A-RFP:8xLexOP-E1b:4lac-TcdA 
AnnexinV-T2A-fyntagRFP-T was isolated and inserted into #5141.  
 
#5144 pB-AnnexinV-T2A-RFP:8xLexOP-E1b:4lac-TcdB 
AnnexinV-T2A-fyntagRFP-T was isolated and inserted into #5142.  
 
#5145 pHE-cmlc2:BFP2 
Heart specific promoter (cmlc2) drive the expression of fluorescent protein mtagBFP2. cmlc2 
fragment was amplified on #3759 with primer #3041/#30421 and inserted into #2918 with 
SalI/AvrII.  
 
#5146 pB-AnnexinV-T2A-RFP:8xLexOP-E1b:4lac-TcdA, cmcl2:BFP2 
BFP2 driven by cmlc2 was inserted into #5143.  
 
#5147 pB-AnnexinV-T2A-RFP:8xLexOP-E1b:4lac-TcdB, cmcl2:BFP2 
BFP2 driven by cmlc2 was inserted into #5144.  
 
#5148 pB-2HE:LexAp65GI 
LexAp65GI fragment was isolated from #4789 with XbaI\NotI and inserted into #3402.  
 
#5148 pB-BFP: 2HE:LexAp65GI 
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HE enhancer drive the expression of BFP and LexAp65GI. BFP was isolated from #2918 and 
inserted into #5148.  
 
2.1.4 Oligonucleotides for cloning and sequencing 
Table 11 
Stock Name Sequence 
1622 spacer/Bam  CCGGATCCGCAGCACTGGGGCCAGATGG 
1623 spacer/SalI GGGTCGACAAACTTGGTCTGACAGTTACC 
1624 HE/Eco-lo GCGAATTCCCCTAGGGTTGCCTCAGTG 
1625 HE/As/EV /Pm-
lo  
GCGGTACCGGATATCGTTTAAACCCCTAGGGTTGCCTCAGTGTGTA
G 
1626 HE/Bam-up GGGGATCCAACCACTCCAGGCATAGCTAG 
1701 VC-Apo sensor 
part1 up 
CCCATCGATTCGAATTCCCACCATGATCAAGATCGCCACCAGGAAG 
1702 VC-Apo sensor 
part1 down 
TGGGCACCACCCCGGTGAAGCCGTCCACCTCGTCGATCCCGG 
1703 VC-Apo sensor 
part2 up 
GTGGTGCCCATCCTGGTCGAGCTGGAC 
1704 VC-Apo sensor 
part1 down 
GCTCTAGACTACAGGTCCTCCTCGCTGATC 
1719 VC-Apo sensor 
lower primer 
GGACTAGTCAGGTCCTCCTCGCTGATC 
1720 JL Cas8 SpeI up 
primer 
GGACTAGTATGAGTGAGTCACGGACTTCAG 
1721 JL Cas8 XhoI 
down primer 
CCCTCGAGGGGAGGGAAGAAGAGCTTC 
1722 JL tagRFP-TXhoI 
down primer 
CCCTCGAGCTTGTACAGCTCGTCCATGCC  
1787 miniCMV MfeI 
SpeI up 
CGCAATTGGACTAGTGGGCTGCAGGAATTAATTCAAG 
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1788 ERT sequencing 
down 
CTCCATGGAGCGCCAGACGAGAC 
1789 linker F primer CGGTCGACATTTAAATGTTTAAACCTCGAGCCGACCTGTCCGGTGC
CCTG 
1790 linker R primer CGGTCGACCTGCCCCGGCACTTCGCCCAATAG 
1791 tdRFPT-Bam up CCGGATCCGGCTCAAGCGGTCGCGTGTCTAAGGGCGAAGAGCTG 
1792 tdRFPT-Bam lo CCGGATCCAGTTGAGCCGGTGCCATGCCCCTTGTACAGCTCGTCCA
TGCCATTAAG 
1929 cmv enhancer 
up primer  
CCCTCGAGGAGTCAATGGGAAAAACCCATTG 
1930 cmv enhancer 
up primer  
CCCTCGAGCACCCCTATTGACCTTATGTATG 
1931 miniCMV real 
EcoRI down 
CGGAATTCGGCGATCTGACGGTTCACTAAAC 
1932 LexA OP KpnI 
SpeI up 
GGGGTACCCTCCACTAGTCGCATTATCATCCCCTCGACGTACTGTAC
A 
1933 LexA OP EcoRI 
down 
CGGAATTCTTCAGCGTGTCCTCTCCAAATGAAATG 
1934 LexA BD Kozak 
EcoRI up 
CGGAATTCGCAAACATGGCACCCAAGAAGAAGAGG 
1935 LexA BD XhoI 
down 
CCGCTCGAGGTACCGGCGCTCGACGGTTCACCGGC 
1936 mpeg1 probe 
up 
CATGAAGTCAAGAGCATTTC 
1937 mpeg1 probe 
down 
CACTGTTGAAGCCAATTTGTTC 
1938 ERT2+myc up 
XhoI 
CCGCTCGAGCCATCTGCTGGAGACATGAGAGCTGCC 
1939 ERT2+myc 
down stop SpeI 
GGACTAGTTCACAGGTCCTCCTCGCTGATCAGCTTCTGCTCAGCTGT
GGCAGGGAAACC 
1940 lysC Gal4 spacer 
up EagI 
TTCGGCCGAATAAAATATCTTTATTTTCATTACATC 
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1941 lysC Gal4 spacer 
down NotI 
TTAGCGGCCGCAGAGAAATGTTCTGGCACCTGC 
2136 1xLO-BaEv-up  GATCCGATATCGTGGAATTGTGAGCGCTCACAATTCCACAC 
2137 1xLO-BaEv-
down 
AATTGTGTGGAATTGTGAGCGCTCACAATTCCACGATATCG 
2138 2xLO-BaEv-up GATCCGATATCGTGGAATTGTGAGCGCTCACAATTCCACAGTCGAC
CCTAGGTTGTGGAATTGTGAGCGCTCACAATTCCAC 
2139 2xLO-BaEv-
down 
AATTGTGGAATTGTGAGCGCTCACAATTCCACAACCTAGGGTCGAC
TGTGGAATTGTGAGCGCTCACAATTCCACGATATCG 
2140 Intron up1 
EcoRI PmeI 
CGGAATTCATGTTTAAACGCGTCTCAGCCTCACTTTGAGCTC 
2141 Intron up2 
EcoRI PmeI 
CGGAATTCATGTTTAAACCCCCAAACCTAAGGTGAGTTGATC 
2142 Intron down 
EcoRV 
CGGATATCCGGCTGAACTGTAAATGAATGAG 
2143 PflFI SwaI SphI 
up 
CAGATTTAAATGAGCATGCCG 
2144 PflFI SwaI SphI 
down 
GCGGCATGCTCATTTAAATCT 
2145 2Lac up SphI CGTGGAATTGTGAGCGCTCACAATTCCACAGTCGACCCTAGGTTGT
GGAATTGTGAGCGCTCACAATTCCAA 
2146 2Lac down AgeI CCGGTTGGAATTGTGAGCGCTCACAATTCCACAACCTAGGGTCGAC
TGTGGAATTGTGAGCGCTCACAATTCCACGCATG 
2147 Lex OP Rever 
XbaI up 
TGCTCTAGAGAGGTAAGATTAGATATGGATATGTATATGG 
2148 Lex OP Rever 
KpnI EcoRV 
CCGGTACCAAGATATCGGGTTTAAACTTCAGCGTGTCCTCTCCAAA
TG 
2149 zebrafish fyn 
Kozak up 
CGGAATTCAGCAAACATGGGCTGTGTGCAATGTAAGGATAAAGAA
GC 
2150 LexOP SCP NheI 
up 
GGGCTAGCCGCATTATCATCCCCTCGACGTACTGTACA 
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2151 LexOP SCP SbfI 
down 
GGCCTGCAGGTAATCTTACCTCGACTGCTGTATATAAAACC 
2299 2Lac up Bam GATCCGTGGAATTGTGAGCGCTCACAATTCCACAGTCGACCCTAGG
TTGTGGAATTGTGAGCGCTCACAATTCCAA 
2300 2Lac down Bglii GATCTTGGAATTGTGAGCGCTCACAATTCCACAACCTAGGGTCGAC
TGTGGAATTGTGAGCGCTCACAATTCCACG 
2301 CG free EagI 
linker up 
TTCGGCCGCTGCTACCTCTGTGACCTGAAAC 
2302 CG free NotI 
linker down 
TTAGCGGCCGCTATTATTTATTGGGTAGTGTGAT 
2303 LexA 8OP XbaI 
up 
GCTCTAGATTCAGCTCTCTGTTTCTATAAATATGTACCAGTTTTATTG
TTTTTAGTGGTTATCATCCCCTCGACGTACTGTAC 
2304 LexA 8OP NheI 
down 
CGGCTAGCACCATATACATATCCATATACATATCCATATCTAATCTT
ACCTCGACTGCTGTATAT 
2305 Top strand 
converted up 
ATATAGAATGTAGGTATTAGTTAGTGGATTT 
2306 Top strand 
converted down 
TCGATCTTCGCCCTTAAACACCATATTTA 
2307 Bottom 
converted up 
TCTCAAAAAACAACTATAACCACATAAAATA 
2308 Bottom 
converted down 
TCGGTTTTCGTTTTTAGATATTATGTTTG 
2309 rpl9 up EcoRI CGGAATTCAAGACCATTCTCAGTAACCAG 
2310 rpl9 down PmeI TTGTTTAAACACTGTGCGGCCCTTGAGGGAC 
2431 8LexOP E1b up 
PacI 
CGTTAATTAACTAATCGCATTATCATCCCCTCGACGTAC 
2432 8LexOP E1b 
down PstI 
AGCTGCAGGTCGAGCATATTACATGGCATTACCACC 
2434 8LexOP E1b up 
PpuMI 
GGTAGGTCCTAACTAATCGCATTATCATCCCCTCGACG 
2435 8LexOP E1b do 
PmeI SwaI 
ATGTTTAAACGATTTAAATGTGTGGAGGAGCTCAAAGTGAG 
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2436 14UAS-Tau Seq 
up 
GAAGCGCATGAACTCCTTGATGACGTCCTCGGAGG 
2437 14UAS-Tau Seq 
down 
TGATCTTCCATCACTTCGAACTCCTGGCGGGGCTC 
2438 mpeg frag Xho 
1.4 
GCCGCTCGAGGTGAACAAAAAAACAAACAAACCTTATTTCCTTTTG 
2439 mpeg frag Xho 
1.0 
ACCGCTCGAGTGGTGTAGTGATTAGTGTGTTGACACAAGGCAC 
2440 mpeg frag Xho 
0.5 
GCCGCTCGAGCACAGCAGTTTTAGGAGATGCTTATAATAAAGAG 
2631 TcdA-RT primer 
up 
GAAAGCAGTACGACAGAGGCACTGC 
2632 TcdA-RT primer 
lo 
CGCAGAGAATTGGTCCGATAGCTTTC 
2633 TcdB-RT primer 
up 
CTGGACGTCGATATGCTGCCAGG 
2634 TcdB-RT primer 
lo 
GCCTCCATGTCTCCAAGTGAACTG 
2635 RT-PCR Exon 
TcdA/B up 
ACCATTCTCAGTAACCAGACAGTGG 
2636 RT-PCR Exon 
TcdA lo 
GCGATGTCAGACACTTCGCCTCC 
2637 RT-PCR Exon 
TcdB lo 
CTGTATCGTTGATCTGTCCTCCG 
2638 mfap4 Xho up TGTTCTCGAGGCGTTTCTTGGTACAGCTGG 
2639 mfap4 Eco lo GTGGAATTCCACGATCTAAAGTCATGAAGAAAGA 
3041 cmcl2 up AvrII TGCCTAGGGGTCACTGTCTGCTTTGCTG 
3042 cmcl2 lo Not Sal ATGTCGACATGCGGCCGCAAAGCTTAAATCAGTTGTG 
 
   Materials and methods 
 60 
2.1.5 Fish strains  
2.1.5.1 Wild type 
The wild type Brass line, deficient in melanin synthesis, was used for DNA/mRNA 
microinjection and for transient transgene assay, to generate stable transgenic lines.  
 
2.1.5.2 Transgenic lines  
Tg(5×UAS-E1b:EGFP) 
This transgenic effector line was generated to set an EGFP reporter gene.  
 
Tg[mpeg1:KalTA4,Insulator,HE:BFP] 
Macrophage specific enhancer (mpeg1) drive the expression f KalTA4, while hatching gland 
enhancer (HE) drive the expression of blue fluorescent protein (BFP) as screening marker. 
Insulators are DNA-protein complexes that act as an enhancer blocker or serve as barriers 
against the spreading of heterochromatin in reporter system. They allow the two different 
expression units working independently. 
 
Tg(lysC:KalTA4,Insulator,HE:BFP) 
Neutrophils specific enhancer (lysC) drive the expression f KalTA4, while hatching gland 
enhancer (HE) drive the expression of blue fluorescent protein (BFP) as screening marker. 
Insulator was described as above.  
 
Tg(lysC:KalTA4, fyntdCitrin:E1b-5UAS-E1b:Caspase8ERT2) 
This transgenic line was generated to obtain fluorescent protein Citrine and fusion 
Caspase8ERT2 expression in neutrophils cells. The membrane localized fyntdCitrine was used 
to observe the morphology of expressing neutrophils to monitor their behaviour during C. 
difficile infection.  
 
Tg(mpeg1:LexABDp65, fyntdtagRFP-T:E1b-8LexAOP-E1b:Caspase8ERT2) 
This transgenic line was generated to obtain fluorescent protein RFP and fusion Caspase8ERT2 
expression in macrophage cells. The membrane localized fyntdtagRFP-T was used to observe 
the morphology of expressing macrophage to monitor their behaviour during C. difficile 
infection.  
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Tg(krox20:KalTA4) 
1.5 kb downstream of the zebrafish egr2b gene known as krox20, which was expressed in 
rhombomere 3 and 5 during developmental stages of the hindbrain, drive the expression of 
KalTA4. 
 
Tg(shhb:KalTA4)  
sonic hedgehog b (shhb) gene, drive the expression of KalTA4. 
 
2.2. Experimental Procedures 
2.2.1. Nucleotide handling and cloning procedures 
2.2.1.1 Mini DNA preparation 
The Macherey Nagel Nucleobond Midi Kit was used with a modified protocol to purify plasmid 
DNA. 1 ml of LB Medium with Ampicillin were inoculated and shake at 180 rpm at 37 °C 
overnight. The overnight culture was transferred into 1.5 ml tubes, spun down at 14000 rpm 
for 1 min and the supernatant was discarded. The bacterial pellet was resuspended in 150 μl 
of Resuspension Buffer and lysed in 150 μl of Lysis Buffer. Then 150 μl of Neutralization Buffer 
was added and mixed by inverting. The obtained cell debris was spun down at 14000 rpm for 
5 min and the supernatant was transferred into a new 1.5 ml reaction tube. This tube was 
filled up to 1.5 ml with 100% ethanol and was vortexed followed by centrifugation at 1400 
rpm for 5 min. The supernatant was removed and the dry DNA pellet resuspended in 30 μl 
HPLC water. The purified plasmid DNA can be used for test digestion with restriction enzymes. 
 
2.2.1.2 Midi DNA preparation 
For large scale purification of plasmid DNA an individual E. coli colony was cultured in 100 mL 
LB medium supplemented with the respective antibiotic in a 500 mL flask on a shaker over 
night at 37°C. The midi DNA preparation was prepared with the Macherey Nagel Nucleobond 
Xtra Midi Kit. The bacterial was harvested in a 50 ml tube by centrifugation at 4500 rpm at 
4 °C for 30 min. The bacterial pellet was resuspended in 8 ml Resuspension Buffer and 
vortexed. Cell lysis was achieved by adding 8 ml Lysis Buffer, inverting and incubation for 3-5 
min at room temperature. The reaction was stopped by adding 8 ml Neutralization Buffer. To 
purify the DNA from cell debris the solution was added onto a column activated by 12 ml 
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Equilibritation Buffer; flow was discarded. The column was washed with 8 ml Equilibration 
Buffer afterwards. The purified DNA was eluted into a new 50 ml Falcon tube with 5 ml Elution 
Buffer. The DNA was precipitated with 3.5 ml Isopropanol. The 50 ml Falcon tube was 
centrifuged at 5000 rpm for 30 min and the supernatant was removed. The DNA pellet was 
transferred into a new 1.5 ml reaction tube and washed with 1 ml 70% ethanol. The DNA pellet 
was spun down for 5 min at 14000 rpm. The ethanol was removed. The dry DNA pellet was 
resuspended in 200 μl HPLC water. The concentration of purified plasmid DNA was measured 
in a photometer. The DNA was diluted to 1 μg/μl for storage.  
 
2.2.1.3 DNA digestion  
For testing enzyme digestion, add components to a clean tube in the order shown:  
                                          4 μl          DNA (Mini DNA preparation) 
                                        1.5 μl         10x buffer 
                                        0.3 μl         per restriction enzyme  
                                        fill up to a total volume of 15μl with HPLC water 
The digests were incubated at 37 °C for 30 min and the result was verified on an agarose TAE 
gel. The digested DNA was mixed with 6x loading dye then was loaded onto a 1% agarose TAE 
gel. A DNA marker (7 μl) is loaded to the gel to estimate the size of digested DNA fragments. 
Afterwards the DNA is stained with an Ethidium bromide solution (1:2000) for 10 min.  
 
2.2.1.4 Cloning  
                         Vector:  
                                        1 μl           DNA (1 μg/μl) 
                                        5 μl          10x buffer 
                                        1 μl          per restriction enzyme  
fill up to a total volume of 50 μl with HPLC water. Incubate at 37°C for at least 1 hour. 
                        Insert:  
                                        1 μl           DNA (1 μg/μl) 
                                        5 μl          10x buffer 
                                        1 μl          per restriction enzyme  
fill up to a total volume of 50 μl with HPLC water. Incubate at 37°C for at least 1 hour. 
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The digested DNA samples were run on a 1% agarose TAE gel and stained with ethidium 
bromide. The requested bands were cut out from the gel and transferred into a 1.5 ml reaction 
tube. Gel Extraction Kit was used to purify the DNA out of the gel. All further steps were 
performed as described by the manual. Afterwards the digested vectors or inserts were ready 
for ligation.  
 
T4 DNA ligase was used to ligate DNA fragments. The solution of vector and insert DNA were 
mixed between 1:3 to 1:4 mole ratio depending on their individual concentration. 1.5 μL 10 x 
ligase buffer and 1 μL T4 ligase were added. The total volume was adjusted to 15 μL with HPLC 
water. The reactions were incubated at 22°C for 30 min or at 16°C overnight. The ligation 
mixture was subsequently used to transform competent bacteria as described above. The 
bacteria were plated onto LB-agar plates and incubated at 37 °C overnight.  
 
2.2.1.5 PCR  
PCR reactions were done depending on the polymerase. The following was reaction setup for 
Phusion® High-Fidelity DNA Polymerase. 
                                      10 μl           5X Phusion HF or GC Buffer 
                                        1 μl            10 mM dNTPs 
                                     2.5 μl           10 µM Forward Primer 
                                     2.5 μl           10 µM Reverse Primer 
                                    variable        Template DNA 
                                    0.5 μl             Phusion DNA Polymerase 
                                     Add HPLC water to 50 μl.  
Thermocycling conditions for a routine PCR was in the following example:  
                   Initial Denaturation     98°C     5 minutes 
                              Denaturation     98°C     30 seconds 
                              Annealing           98°C     30 seconds 
                              Elongation          72°C      30 seconds 
                         Final elongation     72°C       5 minutes   
                                   Hold               4°C          infinite 
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2.2.1.6 DNA blunting by Klenow Fragment 
Ligation of non-complementary double strand DNA ends can be achieved by blunt end cloning. 
The 5’-DNA overhangs were filled by using the Klenow fragment. dNTPs (final concentration: 
33 μM), 10x restriction buffer H, 1 μL Klenow and purified DNA were mixed (total volume was 
30 μL). The reaction mix was incubated at 25°C for 15 minutes. The reaction mixture was 
purified for further processing using gel extraction or nucleotide purification kit.  
 
2.2.1.7 DNA dephosphorylation 
In order to prevent blunt end or single enzyme digested vector re-ligation, the digested vector 
was dephosphorylated by using calf intestinal phosphatase (CIP) from NEB. CIP is active in all 
NEB restriction enzyme buffers. Therefore, CIP can be added directly into the digestion 
reaction after DNA digestion. 0.5-1 μL CIP was added into digestion mixture and incubate extra 
1 h at 37°C. Subsequently, the reaction mixture was purified for further processing.  
 
2.2.1.8 Oligo Ligation 
For the 2×lac and 4×lac ligation, annealing oligo was used for cloning.  
The sense and antisense oligo were phosphorylated as in the following receipt:  
                                        Each oligo (50mM)                                  2 ul 
                                       10mM ATP                                                 1 ul 
                                       10×T4 Polynucleotide Kinase buffer     1 ul 
                                       T4 Polynucleotide Kinase                        0.5 ul 
                                       MilliQ                                                          5.5 ul 
The reaction buffer was incubated at 37°C for 1 h then mix sense and antisense oligo reaction 
buffer together. Set heat block to 99° and transfer tube containing sense and antisense oligo 
in it for 2min. Turn off the heat block and cool down to 55° C. Leave the mixture for 5min. 
Dilute 1 ul annealing oligo in 20 ul HPLC water and take 3 ul for ligation.  
 
2.2.1.9 Tol2 mRNA synthesis  
The mRNA for the Tol2 transposase was synthesized and later co-injected with vectors into 
zebrafish.  
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The plasmid #3816 was digested with XbaI, purified and 2 μl of the sample was examined for 
linearization with an agarose gel electrophoresis. 1 μg of this DNA was required for the RNA 
synthesis. The reaction mixture was set up as following.  
                                       10 μl           5X Transcription Buffer 
                                        1 μl            linearized DNA  
                                        5 μl           NTP/Cap mixture 
                                     1.5 μl           Ribolock RNase-Inhibitor (40 U/μl) 
                                     1.5 μl            T7 RNA-Polymerase (20 U/μl)  
                                       5 μl             DTT (100mM) 
                                     Add HPLC water to 50 μl.  
The reaction mixture was incubated for 2 h at 37 °C. To degrade the template DNA that was 
still present in the mixture, 2 μl of DNaseI was added into the reaction tube, mixed and 
incubated for another 30 min to 1 h at 37 °C. To purify the RNA afterwards, the RNeasy® kit 
was used.  
 
The quantity and size of the synthesized RNA was analyzed with an agarose gel electrophoresis 
and measured with the photometer.  
 
2.2.1.10 RNA synthesis for whole-mount in situ hybridization (WISH)  
RNA probes labeled with digoxigenin-conjugated uridine triphosphates were used in in situ 
hybridization. To generate these RNA probes, plasmid DNA containing T7/T3/Sp6 was 
linearized by enzyme digestion. The purified linearized DNA were used to create the different 
RNA probes. 
                                        4 μl             5X Transcription Buffer 
                                        2 μl            linearized DNA  
                                        2 μl            Digoxigenin RNA labelling mix  
                                        1 μl             Ribolock RNase-Inhibitor (40 U/μl) 
                                        1 μl            respective RNA-Polymerase (20 U/μl)  
                                        2 μl             DTT(100mM) 
                                     Add HPLC water to 20 μl.  
 
   Materials and methods 
 66 
The reaction mixture was incubated for 2 h at 37 °C. To degrade the template DNA that was 
still present in the mixture, 2 μl of DNaseI was added into the reaction tube, mixed and 
incubated for another 30 min to 1 h at 37 °C. RNeasy® kit was used to purify the RNA probe 
afterwards.  
 
2.2.2 Microinjection 
Microinjection is one of the most frequently used techniques. Besides introducing substances 
such as nucleic acids, proteins or drugs into fertilized zebrafish eggs, this technique can be 
used for infection of zebrafish with E. coli or C. difficile.  
 
2.2.2.1 Microinjection on one-cell stage cell 
In this thesis, the Tol2-system was used to introduce plasmid DNA into fertilized zebrafish eggs. 
To incorporate the target gene into the genome, a mixture of Tol2 transposase-encoding 
mRNA and plasmid DNA containing the target gene was injected into the eggs. The target gene 
in the plasmid was flanked by transposase recognition sites, Tol2 sequence, allowing the 
random integration into the genome. The introduced gene was retained and passed to the 
daughter cells during the division. If not, that would be cause mosaic expression of transgene.  
 
In order to position and hold the zebrafish eggs in place during microinjection, agarose plates 
with inserted grooves were generated. Therefore, 1.5 % agarose was melted in 30 % Danieau 
(w/v), poured into a petri dish (10 cm) and the mould was positioned on top to create the 
grooves. After solidification, the mould was removed, the plate was mounted with 30 % 
Danieau and stored at 4 °C. The microneedles were generated with a horizontal needle puller. 
Shortly before the microinjection, the injection mixture was mixed together and placed on ice. 
The injection mixture contained 250 ng plasmid DNA, 250 ng Tol2 mRNA and 1 μl Phenol Red 
in 10 μl HPLC water. Transfer embryos to the petri dish by using a pipette and sort them into 
the grooves. The cell on the yolk should be upside. Using a microloading pipette tip load 2 μl 
of the injection-mix into the injection needle. Fix the injection needle to the micromanipulator 
and insert its tip into the medium. Adjust the pressure of the injector for getting a slow outflow 
of solution out of the glass capillary. Using the micromanipulator inject a cell (not yolk) of 
fertilized eggs. A few nl injection are enough.  excess volume of injection mix (especially for 
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DNA injection) has toxic effect on embryos. When finished with injections, transfer the 
injected embryos into a new dish and incubate at 28°C.  
 
2.2.2.2 Infection of Zebrafish with E. coli or C. difficile 
I used a protocol modified from a method published by Benard et al.    
1. Prepare Injection Needles 
Both horizontal puller and vertical puller could be used for making needs. Open the needle tip 
with tip or tweezer to obtain a tip opening.  
 
2. Prepare C. difficile sample  
C. difficile is a strict anaerobe and is sensitive to even low concentration of oxygen. Bactera 
were cultured o/N in 10 mL BHIS liquid medium in an anaerobic hood without shaking. BHIS 
is BHI (brain-heart-infusion) supplemented with 0,5 % (w/v) yeast extract and 0,1 % (w/v) L-
Cysteine. BHI was purchased from Fluka or Carl Roth GmbH.  
 
1 g/L L-Cysteine was dissolved in 10 ml of ddH2O and added to autoclaved medium after sterile 
filtration. For agar plates 15 g/L agar was added before autoclaving. 
 
3. Prepare E. coli sample 
Transfected XL1-Blue Competent Cells with pBS-tdTomato vector. NEB 5α would be stick 
together to form a mass of cells, while it was easy to get a single and separately XL1-Blue cell. 
One colony was inoculated in 2ml LB medium for culture overnight. Centrifuge at 4000rpm for 
5 min to collect bacteria. Wash three times with PBS then resuspended in 200 µl PBS.  
 
4. Prepare zebrafish larvae for injections 
In this step, a hair loop tool was necessary. A piece of human hair was inserted as a loop into 
the opening of yellow tip and fixed in place with glue. It provided a convenient tool for gently 
manipulating fragile zebrafish embryos.  
 
Anesthetize the larvae with Tricaine approximately 10 min prior to injections. Please refer to 
article ‘Infection of Zebrafish Embryos with Intracellular Bacterial Pathogens’ for further 
information.  
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There was alternative route to mount zebrafish embryos. Transfer anesthetized larvae into 
petri dish and remove most of the water. Embed the larvae in 0.6-0.8% low melting agarose 
drop. After solidification, the larvae were ready for infection. This route was suitable for older 
larva.  
 
5. Injection of bacteria into zebrafish larvae 
Prepare the injection mixture by adding 1 μl Phenol Red to 9 μl E. coli or C. difficile solution. 
Load the injection mixture into injector and check the injection volume.  
 
2.2.3 Microgavage of Zebrafish Larvae 
Experiments for studying intestinal biology required the introduction of materials into the 
lumen of the intestine in vivo. Immersion and injection though the abdominal wall are the 
most common methods. Using immersion method, it is difficult to accurately control the 
amount or timing of material, or bacteria delivery into the intestine.  Although such problems 
are not encountered for injection though the abdominal wall, it is invasive and causes tissue 
damage which might affect experimental results. In order to safely and consistently deliver C. 
difficile directly to the lumen of the anterior intestine in larval zebrafish, I used a microgavage 
protocol modified from previous protocol published by Cocchiaro et al.. 
 
1. Preparation of low melting agarose, microgavage mould, and microgavage needle 
fabrication 
I used 1% low melting agarose instead of methylcellulose for mounting larvae. Prepare a 1.5% 
agarose gel mould in a Petri dish using a plastic cast with same shape with Adaptive Science 
Tools, TU-1. Add enough zebrafish medium to immerse the plate and store in 4 °C. The agarose 
plated can be re-used several times. Because the position of heat filament in the horizontal 
puller was not fixed, the programs I used for needle fabrication were also varied: Pressure 500, 
Heat 350-400, Pull 75-110, Velocity 50-75, Time 125-150. This setting might be optimized in 
different puller.  
 
2. Clipping and calibration of the microgavage needles 
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The needle clipping is a critical step. In order to obtain blunt and smooth needles, clip the 
needle using fine-tipped forceps. Align the tip of the needle under a stereomicroscopy and 
clip the needle at 1-2 mm from the tip. The needle should be blunt and smooth. Examine the 
tip of needle at highest 80x magnification under Stereo Microscope. Sharp or jagged needles 
should be avoided.  
 
Since our injector could not set the volume of solution to release, it was important to calibrate 
the microgavage needle. Wrap a plastic Petri dish with parafilm and aliquot 0.2 μl of the 
calibration testing solution onto the parafilm. The calibration testing solution contained 1x 
PBS/0.05% phenol red. Press the pedal of injector to release the testing solution onto the 
parafilm. Then compare the size of droplet with 0.2 μl solution to estimate the droplet volume 
and adjust the pressure.  
 
3. Anesthetizing and microgavage of Zebrafish  
The C. difficile or E. coli (referred to 2.2.2.2) was diluted at 1:10 dilution rate with phenol red 
and load the solution was loaded into microgavage needle.  
 
Anesthetize fish by mixing 0.4% of tricaine into petri dish for a final concentration of 0.02-
0.04%. When the zebrafish stop moving, transfer them onto of the groove of microgavage 
mould using Pasteur pipette. Add an amount of low melting agarose to cover the zebrafish. 
Gently adjust their position with their heads on the 45° or lesser angle of the groove.  
 
Set the pressure of injector and adjust the angle of needle pointed to the mouth of zebrafish. 
Gently put the needle into the mouth of zebrafish, through the esophagus, and introduce the 
tip of needle inside the anterior intestinal bulb. Then press the pedal to release the bacteria. 
The delivered volume should just fill the anterior bulb of the intestine, around 5nl.  Do not let 
it leak out of the esophagus or cloaca. Gently retract the needle. Neutrophil or macrophage 
reporter line was a good model to examine whether you make esophagus or esophageal 
sphincter damage. Upon injury, a larger number of neutrophils or macrophages would be 
recruited. The recruitment of several lymphocytes was acceptable. Rescued the fish from 
agarose and rinse them in fresh media.  
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2.2.4 Zebrafish methods  
The zebrafish (Danio rerio) in this laboratory were maintained according to the protocols 
published by Westerfield (Westerfield 2007). 
 
The adult zebrafish were housed in an aquarium connected to a tank filtering system to ensure 
the water quality. The temperature in the tanks was kept between 26-28 °C and a day-night 
circle of 14 h light and 10 h dark was applied. 
 
Zebrafish are photoperiodic and they produce eggs every morning shortly after the light 
comes on. One male and one female each were placed into mating tank the night before the 
collection and separated with a removable plastic disk. The next morning, the disk was 
removed. Collect eggs in 15 to 20 min later, washed with egg water, and transferred into a 
petri dish. For microinjection, this time span was crucial to maintain a single cell stage. If only 
a number of eggs were required, the mating was extended for 2 or even 3 more hours. 
 
For positive transgenic zebrafish larvae, they were transferred into fish room at 6dpf. In order 
to acquire high survival rate, they also could be transfer into fish room at 4dfp, but flowing 
water should be applied till 6dpf.  
 
2.2.5 Cell cultures and Western blot 
2.2.5.1 Culturing  
HEK 293T cells were kept at high Glucose or at low Glucose medium. HEK 293T cells grown 
much faster in high Glucose than in low Glucose medium. All cells were cultured at 37 °C with 
5 % CO2. 
 
2.2.5.2 Passaging cells  
Cells were cultured on 10 cm plates to about 80% confluence. The old medium was removed. 
Cells were washed with 1 ml 1x PBS or DMEM medium without FCS.  Trypsin EDTA (1x) was 
used to detach cells from the plate, incubated at 37 °C for 1 min. The reaction was stopped by 
adding 8 ml 1x DMEM. Cells were transferred to a 15 ml tube and collected by spinning for 3 
min at 1000 rpm. The supernatant was removed and the pellet was resuspended with 1 ml 
DMEM. The cells were transferred to a new 10 cm plate.  
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2.2.5.3 Freezing and thawing cells 
The cells were collected.  Then the cell pellet was resuspended in 1 ml Serumfree Type Cell 
Medium. Cyrotubes were filled with 200 μl of cell suspension. The Cyrotubes were transferred 
into a Cell Freezing Container and stored in - 80°C freezer.  
 
Cells were thawed fast by placing tubes at 37 °C. Afterwards cells were plated on 10 cm plates 
with DMEM Glucose medium. 
 
2.2.5.4 Transfection of HEK293T 
HEK 293T cells were used for western blot experiments. These cells were spread into 6 well 
plates. About 50 μl of cells were used for each well in 2 ml DMEM high glucose and were 
cultured overnight. Transfection of cell culture at 50-70% confluence. Transfection was 
performed as follows:  
                                                                     1-2 μg DNA  
                                                                    100 μl OptiMem  
                                                                     1.5 μl PEI  
                                  mixed by pipetting and incubation at room temperature for 15 min.  
After 6 h, 2 ml of DMEM containing 10% FCS was added to transfected cells. Medium was 
changed to DMEM one day later. Depending of cell growth, high or low glucose media was 
added. Cells were harvested 2 days after transfection. 
 
2.2.5.5 Preparation of cell lysates for western blots 
HEK 293T cells were transfected as described. All solutions were kept on ice to reduce protein 
degradation. Old media was removed and cells were washed with 1 ml PBS twice. Aspirate the 
PBS, then add 400 μl ice-cold lysis buffer. A scraper was used to detach cells from the plate. 
Cells were transferred to a new 1.5 ml cooled tube by pipetting and incubated for 15 min with 
inverting every 5 min to lyse the cells. Cell debris was spun down for 15 min at 4 °C. Aspirate 
the supernatant to new cooled tube and discard the pellet. discard the pellet. The supernatant 
was aliquoted and store in - 80°C freezer.  
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2.2.5.6 Gel preparation and running 
Two glass plates with a 1 mm spacer were assembled in a gel caster and were filled up to 2/3 
with separating gel solution. To prevent bubbles in the gel, isopropanol is added to cover the 
separating gel. After polymerization, the isopropanol was removed. Next, pour 5% stacking 
gel on top of separating gel. Insert comb at an angle (to ensure no bubbles) to create lanes. 
After polymerization, the gels could be stored at 4 °C.  
 
The samples were boiled at 99 °C for 5 min followed by centrifugation at 12,000 rpm for 5 min. 
The gels were removed from the gel caster and put into gel chambers that were filled with 1x 
running buffer. 30 μl was loaded onto the gel for each sample. The samples ran in the stacking 
gel with 70 V for about 30 min until the samples reached the separating gel. Then run at 95V 
until dye was all the way at end of gel.  
 
2.2.5.7 Semi dry transfer  
Four Whatman papers were cut to match the size of stacking gel (8.5 x 5.5) and all were 
moistened in 1x semi dry transfer buffer. A PDVF membrane with the same size was cut and 
moistened in 100 % methanol. 
 
To remove gel from between the glass plates, use a green wedge to gently pry the glass apart 
and let it slid into semi dry transfer buffer. Gels are very fragile, so be gently. 
 
The blotting stack was set up in the following order: 2 Whatman papers, membrane, gel and 
2 Whatman papers. To make sure there was no bubbles between each layer, use the glass rod 
to roll out any bubbles as you added layers. Close the cassette tightly. Run at about 100V and 
100 mA per gel for 1-2 h.  
 
2.2.5.8 Blocking and antibody staining  
The membrane was taken out form the transfer system and was washed with TBST. Then the 
membrane was blocked with 5 % Skim Milk/TBST for 1 h on the shaker. The membrane was 
washed with TBST and sealed with the primary antibody solution in a plastic bag. The primary 
antibody incubated on a rotator over night at 4 °C. Next morning, wash 3 times with fresh 
TBST, 10 min each, with shaking. 
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Then the secondary antibody was added and sealed in a plastic bag. Incubate 1 h at RT on 
rotator. Wash 3 times with fresh TBST, 10 min each, with shaking. Then the membrane could 
be used for detection of proteins bands using SERVALight Eos CL HRP WB Substrate Kit. 
 
 2.2.6 Histological Techniques 
 2.2.6.1 Whole-Mount Immunostaining 
5dpf zebrafish embryos were fixed at 4 °C in 4% PFA in PBST (PBS, 0.1-0.3% Triton X-100) on 
the shaker for 3h. They were washed once with PBST for 10min and incubated in cold-acetone 
at -20 °C for 15 min. Then they were washed once with PBST and twice with PBS-DT (PBS, 1% 
BSA, 1% DMSO, 1% Triton X-100) for 10min each, and subsequently incubated in 5% goat 
serum, PBS-DT at RT for 1 h. For primary Ab reaction, embryos were incubated with the Ab 
solution (PBS, 1% BSA, 1% DMSO, 0.1-0.3% Triton X-100, 1/1000 dilution rabbit anti-Caspase3 
Ab), at 4 °C overnight. In the next day, they were washes four times with PBST for 10 min each 
and then secondary antibody reaction is as follows: incubate with the Ab solution (PBS, 1% 
BSA, 1% DMSO, 0.3% Triton X-100), at 4 °C overnight. (1/500dilution, Alexa Fluor 488, anti-
Rabbit IgG). Four times washes with PBST for 10 min each. The fish were ready for observation.  
 
 2.2.6.2 Whole-mount in situ hybridization  
Most genes are expressed in a very specific spatio-temporal pattern within the organism. The 
whole-mount in situ hybridization (WISH) is used to detected the expression pattern of 
developmentally regulated genes with specific nucleic sequences.  
 
The method was executed as following. An antisense probe, which was labelled with 
digoxigenin covalently bound to UTP, was detected in situ with an antibody against the label. 
This specific antibody had its Fab-fragment fused to an alkaline phosphatase (AP). Upon the 
formation of a hybrid-nucleotide strand containing the endogenous RNA and the labelled 
antisense probe, the detection was accomplished by a chromogenic reaction carried out by 
the AP.  
 
1. Fixation and storage of zebrafish embryos 
Zebrafish embryos were fixed overnight in 4% PFA/PBST at 4°C or for 4h at RT on a shaker. 
They were washed two times in PBST for 5 min each and then dehydrated in 100% methanol. 
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The fixed larvae were then transferred into 100 % methanol and stored at -20 °C.  
 
2. Rehydration of the zebrafish larvae 
Before proceeding to the hybridization, the larvae needed to be rehydrated with a decreasing 
methanol series. The fixed larvae were incubated on a shaker for 5 min each in 75 %, 50 % and 
25 % MeOH/PBST (v/v) and four more times in PBST. 
 
3. Permeabilization of the zebrafish larvae 
To permeabilise the tissue for mRNA probes and antibodies, fixed embryos were treated with 
the proteolytic enzyme Proteinase K. The embryos were incubated in Proteinase K/ PBST (10 
μg/mL) for the respective time interval depending on the developmental stage of the embryos. 
The digest was stopped by washing in PBST and subsequent fixing in 4% PFA for 20min. To 
remove excessive PFA, embryos were washed 5 times in PBST for 5 min each.  
                Developmental stage                              Duration of Proteinase K treatment  
                              1dpf                                                                        5min     
                              2dpf                                                                        20min     
                              5dpf                                                                        40min     
                              8dpf                                                                        100min     
 
4. Hybridisation 
During the rehydration of the larvae, the water bath was preheated to 62 °C. PBST was 
removed and 500 μl hybridization buffer was added. Pre-hybridization lasted for 1-2 hours at 
60°C in the incubator. In the meantime, turn on the heating block to 90°C to denature probes. 
200 μl hybridization buffer was prepared and 8 μl of each probe was added in RNase free tube. 
The buffers containing probes was denatured for 5 min at 90 °C. The pre-hybridization solution 
is quickly removed and replaced by the hybridization buffer containing probe. Hybridization 
lasts over night at 60°C in the water bath or the air incubator. The following steps were 
performed in the water bath (60°C) and all solutions have to be preheated, starting with 45 
min in 50% FA / 2x SSC / 0.3% Tween for two times, 45 min in 2x SSC / 0.3% Tween for one 
time, and with 45 min in 0.2x SSC / 0.3% Tween for two times. 
5. Antibody detection 
The unspecific binding sites for the anti-dioxigenin Fab fragment were blocked with 1ml of 10 % 
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NGS/PBST for one hour at room temperature on a rotator. The solution was removed and the 
antibody diluted 1:3000 in 10 % NGS/PTW was added. The incubation was performed 
overnight at 4 °C on a rotator. To remove excessive unbound antibody, the larvae were 
washed 5 times in PBST for 15 min each on a shaker the next day. 
 
After the last washing step, the larvae were incubated in the staining solution. Importantly, 
the staining solution was always prepared fresh. Due to light sensitivity, the staining reaction 
was carried out in the dark for 1-2 hours until the desired intensity of the blue precipitate. To 
stop the reaction, larvae were transferred into 4-well plates and washed 3 times in PBST for 
10 min each. For long time storage, the larvae were transferred back into 2 ml tubes 
containing 90% glycerol (v/v) and kept at 4 °C. 
 
2.2.7 BacLight Red Staining C. difficile  
1. Prepare the solution of the BacLight bacterial stain  
Prepare a 1 mM stock solution of dye by dissolving the vial contents in 69 µL DMSO.  
Prepare a 100 µM working solution of the BacLightTM bacterial stain by adding 2 µL of the 1 
mM stock solution prepared to 18 µL of DMSO in a centrifuge tube and mix 
well.  
 
2. Prepare C. difficile sample  
Referred to 2.2.2.1 
 
3. Stain C. difficile with BacLight  
Bacteria in 1 mL of culture were harvested, once washed with 1 x PBS (5000 g, 3 min and room 
temperature), and resuspended in 1 ml of 1 x PBS. 1 µL of the working solution of BacLightTM 
was added to 1 mL of bacteria suspension. The sample was incubated for 15 minutes at room 
temperature in the dark. Stained C. difficile were washed once with 1 x PBS in order to remove 
residual dye and resuspended in PBS to OD600 of 1.0.  
 
2.2.8 Imaging  
1. Embedding 
Zebrafish were anaesthetized for 5-10 min with 0.004 % Tricaine. A hole was made on the 
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bottom of 35mm dish and a glass slide was attached, referred as imaging chamber. Embryos 
were transferred into the imaging dish. The 30 % Danieau was removed and 200-300 μl of 1 % 
low-melting agarose were added. The interested part was placed to touch the glass slide as 
close as possible. To solidify the low melting agarose, the dish was put on ice for 30-60 s. The 
agarose was covered with Tricaine in 30 % Danieau to suppress muscle spasms during imaging. 
 
2. Confocal microscopy  
The Leica Microsystems TCS SP8 inverted CLSM was utilized to make 3D and 2D images, and 
time-lapse imaging. Three objective lenses were used. One was a 20x oil immersion objective 
lens, which was used for the counting of the number of macrophage and neutrophil in 
zebrafish. The second was a 40x water immersion objective, which was used for the infection 
assay and the behavior assay of macrophage and neutrophil. The last one was 63x water 
immersion objective for the subcellular resolution images. The corrected laser and laser 
power should be selected as the following table (Table 12). For time-lapsing imaging, low 
power but high gain was used to protect zebrafish. To obtained detailed imaging of cell 
migration by increasing the image format, reducing the scan speed. But these settings would 
increase the acquisition time. Due to high migration speed of macrophages and neutrophils, 
it was necessary to set up the interval time shorter between 60 seconds to 120 seconds. For 
cell tracking, the interval time should be shorter than 90 seconds.  
Table 12 
Fluorescent Proteins Excitation (nm) Emission (nm) Laser 
CFP 405  477  405 
EGFP 488  508  Argon 
YFP 514  527  Argon 
Monomeric Citrine 514  529  Argon 
tagRFP-T 561  588  561 
 
2.2.9 Generating gnotobiotic zebrafish 
The protocol modified from previous method published by Pham et al., 2008.  
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1. Reagents setup  
Antibiotics: Amphotericin B stock (1 mg/ml), Kanamycin stock (50 mg/ml), Ampicillin stock (20 
mg/ml). Those antibiotics could be stored freezer for several years.  
 
10% (wt/vol) polyvinyl pyrrolidone-iodine complex (PVP-I) stocking solution was prepare and 
stored in dark at 4 ℃. Diluted as 1:100 to 0.1% PVP-I for working concentration.  
 
3% bleach stock solution and 0.003% bleach solution.  
 
0.22µm filter was used to sterilized at least four liter of zebrafish system water (for two 
breeding tanks).  
 
Autoclaved 30 % Danieau.  
 
The day before experiment, prepare AKA-Danieau: Add 50ul of Amphotericin B stock solution, 
20ul of Kanamycin stock solution, 50ul of Ampicillin stock solution into 50ml autoclaved 30 % 
Danieau. Store at 4 ℃. 
 
2. Procedure 
Transfer breeding pairs to a clean breeding tank with filter-sterilized system water. The 
sterilized system water should be warm-up in zebrafish room more than 5h. 
 
Transfer breeding pairs to an extra clean breeding tank with filter-sterilized system water and 
remove plastic disk.  
 
Collect embryos with a sterile pipette (collect eggs for no longer than 2 h) and transfer into a 
15-ml tube. Remove excess system water, replace with AKA-Danieau.  
 
Wash 3 times with AKA-Danieau in a culture hood and place the 15-ml tube into incubator for 
3-8h.  
 
At least 3h later, remove AKA-Danieau and gently immerse embryos with 0.1% PVP-I solution 
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for 1 min. Ensure that PVP-I incubation is no longer than 1.5 min and longer incubation cause 
increased fish mortality rates.  
 
Wash embryos 3 times in autoclaved 30 % Danieau.  
 
Immerse embryos with 0.003% bleach solution and incubate for 20 min at room temperature.  
 
Wash embryos 3 times in autoclaved 30 % Danieau and transfer embryos to a sterile petri dish.  
 
Change the media daily.  
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3 Results 
3.1 Establishment of zebrafish genetic model to screen antagonists of 
Clostridium difficile toxins  
3.1.1 Both TcdA and TcdB induced cardiac edema, cell death, and mortality in 
zebrafish embryos  
Hamm et al. identified that TcdB functions as a potent cardiotoxin in a zebrafish model of 
intoxication (Hamm et al., 2006). To find out whether TcdA shares similar function with TcdB, 
TcdA, TcdB, TcdA mutant, and TcdB mutant (recombinant proteins received from Prof. Dr. 
Gerhard) were used. TcdA D285/287N and TcdB D286/288N are mutants that are deficient in 
glucosyltransferase activity (Chumbler et al., 2016; Teichert et al., 2006). Zebrafish embryos 
were collected at 72hpf and exposed to medium containing different toxins. Both TcdA and 
TcdB mutants did not show toxicity in zebrafish (data not shown). However, both TcdA and 
TcdB lead to different mortality rates within 72h of exposure (Figure 17 A, B). 10 nM TcdB did 
not lead to zebrafish death, but 20 nM TcdB was associated with an increase in mortality, with 
a 14% mortality rate after 1 day of exposure and a 80% mortality rate after 3 days of exposure 
(Figure 17 B). For a long time TcdB has been believed to be more potent than TcdA in damaging 
some cell types, but TcdA was found to be more toxic than TcdB to zebrafish at the same 
concentration (Figure 17 A, B)  (Aktories, 1997; Chaves-Olarte et al., 1997). 10 nM TcdA caused 
100% mortality after 24h of exposure and was therefore not evaluated further (Figure 17 A). 
5 nM TcdA led to a mortality rate of 87% after 24h of exposure, and 100% mortality after 48h 
of exposure. This finding demonstrated that both TcdA and TcdB were toxic (depending on 
concentration and time) to zebrafish, which relied on the functional glucosyltransferase 
activity.  
 
Also, some TcdA-treated fish also exhibited pericardial edema (Figure 17 C). But acridine 
orange staining showed an increased cell death throughout the entire embryo (Figure 17 D). 
Interestingly, fluorescence signal was found predominately at pericardial region, indicating 
that TcdA might also lead to cardiovascular damage. This finding suggested that TcdA also 
possessed cardiotoxicity as TcdB did.  
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Figure 17 Survival rates and morphological changes of zebrafish after recombinant TcdA and TcdB treatment  
 
A) Percentage of surviving embryos at 72hpf upon treatment with TcdA or TcdA D285/287N at denoted 
concentrations for 3days. n=20 fish/treatment. B) Percentage of surviving embryos upon treatment with TcdB or 
TcdB D286/288N at denoted concentrations for 3days. n=20 fish/treatment. C) Brightfield image of zebrafish 
treated with 5nM TcdA for 24h. D) 72hpf embryo was treated with 5nM TcdA for 24h and cell death was detected 
by acridine orange staining. H: heart.  
 
3.1.2 Target selection for compound screening 
Drug discovery often begins with identifying a novel promising target. However, even though 
extensive work has been performed to validate useful targets that play critical roles in human 
diseases, or infections, the number of good targets remains low. Therefore, it is a considerable 
challenge to identify a right target.  
 
The two main toxins, TcdA and TcdB, have been studied intensively. They are identified as 
major C.difficile virulence factors. As mentioned, once C-terminal GROPS bind to the receptors 
of epithelial cells, the N-terminal GTD is delivered into the cytosol, inactivating host GTPases 
by glucosylation. The inactivation of GTPases results in the epithelial cell death and intestinal 
membrane damage, which induce inflammatory response, and furthermore leads to intestinal 
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hemorrhage and diarrhea. Based on this molecular pathogenesis, an inhibitor targeting GTD 
could further solve this disease. Therefore, we selected GTD as the target to screen 
antagonists of C. difficile toxins.  
 
Highly expressed prokaryotic genes have a biased codon usage compared to zebrafish. In 
order to obtain adequate toxin expression, we synthesized the N-terminal fragments of TcdA 
and TcdB cDNA with codon usage optimized expressions in zebrafish. I named them as NTcdA 
and NTcdB. 
 
The C. difficile 630 strain is used as the virulent and common strain for characterization of C. 
difficile. The DNA sequence of NTcdA and NTcdB are 72% and 75% identical to their 
corresponding toxins in C. difficile 630 strain respectively (Figure 18). The amino acid sequence 
of GTD in both NTcdA and NTcdB is 100% identical to their corresponding toxins sequence in 
the C. difficile 630 strain. At the C-terminal of NTcdA and NTcdB, an HA tag was fused, 
facilitating the detection of the toxins in zebrafish. 
 
Figure 18 The sequence comparison between NTcdA and NTcdB and C. difficile 630 TcdA and TcdB sequences.  
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A) 480bp upstream sequence of NTcdA compared with TcdA from C.difficile 630 strain. TcdA sequence that was 
used can be found in GeneBank under accession no. HG002394.1. B) 480bp upstream sequence of NTcdB 
compared with TcdB in GnenBank. TcdB sequence that was used can be found in GeneBank under accession no. 
CP022524.1.  
 
3.1.3 Bi-directional hatching gland specific promoter expression system 
To establish a transgenic zebrafish model to identify and validate antagonists of Tcds, the 
targeting cells are required to fulfill an important function during early embryogenesis to 
simplify antagonist evaluation. In addition, this cell population should be easily accessible for 
rescue approaches. Such an ideal cell type is represented by the zebrafish hatching gland.  
 
The hatching gland is a set of transversely oriented cells on the pericardial membrane, ventral 
to the head, where the hatching enzymes are produced and stored (Kimmel et al., 1995). The 
hatching enzymes are required to break down the chorion in the first 48 hours after 
fertilization, after which hatching gland is not further required. A malfunctioned hatching 
gland impairs embryo hatching, which can be overcome easily by pronase mediated enzymatic 
hatching. Particularly, a zebrafish hatching gland specific promoter (HE, kind gift from Dr. Jeff 
S Mumm) has been identified, which is exclusively expressed in hatching gland.  
 
GTD inactivates host GTPases and induces apoptosis in infected cells. To monitor the 
physiology of hatching gland cells simultaneously, an apoptotic reporter was co-expressed 
with N-terminal fragment of toxins in a bidirectional manner. For this purpose, the feasibility 
of a bidirectional expression unit was tested under the control of HE enhancer. The 
bidirectional cassette contains two HE enhancers that are flanked on either side by E1b 
minimal promoters driving fyntagRFP-T/ GFP fluorescent protein as shown in Figure 19 A. The 
vector named bi-HE, was used for injection at the one-cell stage. High levels of reporter gene 
co-expression were observed in hatching gland cells of injected embryos after 24h of injection 
(Figure 19 B). This indicated that HE enhancer drove adequate expression of both genes in 
those hatching gland cells. 
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Figure 19 bi-HE construct for simultaneous expression of multiple fluorescent proteins.  
 
A) Schematic representation of the bi-directional HE vector. B) In transient injection, RFP and GFP were co-
expressed simultaneously in hatching gland cells of injected embryos.   
 
To assess if the bidirectional HE cassette constitutively expressed two reporter genes, co-
expression activity was determined by the ratio of double-positive cells (red and green) to the 
total number of single- and double-positive cells (Figure 20 A). In 20 embryos, there were 605 
double-positive cells and 8 single-positive cells. This analysis demonstrated that the bi-HE 
construct reliably co-expressed two transgenes in vivo (co-expression rate 99%) (Figure 20 B).  
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Figure 20 Co-expression ration of two fluorescent proteins in bi-HE construct 
 
A) The image captured by confocal for counting. B) Bar chart illustrated the number of double positive 
(GFP+/RFP+) or single positive cell (GFP+/RFP- or GFP-/RFP+) in 20 injected embryos. 
  
In transient assays, several non-hatching gland cells of injected embryos expressed 
fluorescent protein. To examine the specificity of HE enhancer, whole mount in situ 
hybridization (WMISH) using antisense RNA probes against RFP or GFP mRNA was performed 
in bi-HE injected embryos (24 hpf). Intense signals were detected in hatching gland cells of in 
a half-moon shape on top of the yolk exclusively by using either probe (RFP/GFP) (Figure 21 
B, D). This result indicated that the HE enhancer has a specific expression in hatching gland 
cells.  
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Figure 21 Expression of GFP and RFP was detected by whole mount in situ hybridization.  
 
(A-B) In situ hybridization for RFP at 24 hpf. (C-D) In situ hybridization for GFP at 24 hpf 
 
Taken together, the HE enhancer has a restricted expression pattern in cells of hatching gland 
and could induce high level expressions of two transgenes specifically in a bidirectional 
manner. This should be applied to transgenic fish, in which the GTD of TcdA and TcdB would 
specific be expressed in hatching gland to trigger apoptosis, while the apoptosis would not 
diffuse to other organs to affect zebrafish embryogenesis. 
 
3.1.4 Establishment of transgenic fish lines for compound screening  
3.1.4.1 The leaky expression of toxins in NEB 5α competent cells  
In order to establish transgenic zebrafish lines, NTcdA or NTcdB was inserted into bi-HE vector, 
referred to as bi-HE-TcdA or bi-HE-TcdB, and subsequently these vectors were used for 
microinjection into one-cell stage of zebrafish embryos. It turned out that all the embryos died 
around within 7 hours after microinjection.  
 
Since the bi-HE vector alone was not lethal, we hypothesized that there might be leaky 
expression of toxins in bacteria used for plasmid preparation, which led to the death of 
embryo. To confirm this hypothesis, toxin expression was evaluated by western blotting using 
an anti-HA tag antibody. pCS-NTcdA or pCS-NTcdB were transfected into HEK293T cells, and 
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cells were harvested and lysed 48h later as positive control. NEB 5α cells were transformed 
with the bi-HE vector expressing GFP and RFP as negative control.   
 
Western blot analysis detected 2 prominent bands with molecular masses of approximately 
63kD in the lysates of HEK293T cells transfected with NTcdA and NTcdB. Also, slight but clear 
bands at the same size can be detected in the lysate of NEB 5α bacterial, indicating NTcdA and 
NTcdB were expressed in E. coli (Figure 22 A). I supposed the eukaryotic post-translation 
modification resulted in the different molecular weights of toxins purified from E. coli and 
HEK293T (Figure 22 A).  
 
 
Figure 22 Leaky protein expression of NTcdA and NTcdB in bacteria.  
 
A) Westernblot analysis with anti-HA antibody of lysates from HEK293T cells and NEB5α. Both pCS-NTcdA or pCS-
NTcdB were expressed in 293T cells. M, marker. B) A schematic diagram of Tol2 vector. The multiple cloning 
region was flanked by three promoters: T7, T3 and lac promoter.  C) lac operon. The lacI (lacI) gene, located near 
promoter (Plac), regulates operon by producing the lac repressor protein. In the absence of lactose, the repressor 
binds tightly to operator and prevents access of RNA polymerase to the promoter. Thus, translation is blocked 
and the operon is repressed.  
 
Some promoters or enhancers are not tightly regulated, which causes baseline gene 
expression before addition of inducers. To solve the leaky expression, constructs were 
analyzed by sequence to find out which enhancer or promoter might cause such leaky 
expression. The analysis identified 3 promoters in the bi-HE construct: a T3 promoter, a T7 
   Results 
 87 
promoter, and a lac promoter (Figure 22 B). T7 and lac promoters are used widely for protein 
expression, while the T3 promoter is not generally adopted. There is also no report about T3 
regulation problem.  
 
The T7 promoter has been commonly used in protein expression vector, for instance, 
reputably pET series vectors (Rosano et al., 2014). In this system, T7 promoter is recognized 
and activated by phage T7 RNA polymerase which is provided by either other vectors, or the 
host cell (like, BL21 DE) with T7 polymerase integrated  into the genome (Rosano et al., 2014). 
Since NEB 5α neither contains other T7 polymerase vectors nor has any T7 polymerase 
integrated into genome, T7 promoter was excluded from leading to the leaky expression. All 
evidences indicated that the leaking toxins transcription was induced by lac promoter.  
 
The lac promoter is a component of the lac operon. The lac operon consists of a set of genes 
that are involved in the metabolism of lactose. Inducer-repressor control of the lac operon is 
a classic example of gene regulation. The regulatory components of lac system include (Figure 
22 C):  
1) The lac promoter. Which is the site where RNA polymerase binds to initiate transcription. 
2) The lac operator (lacO), which is a short sequence to which repressor proteins bind. It is 
located between the promoter and inserted genes near the transcription start site.  
3)The lacI or lacIq repressor encode by lacI and laclq gene, which recognizes and binds to the 
lac operator and then turns off gene expression.  
 
However, only one lac operator, which was also far from transcription start site of NTcdA or 
NTcdB, was identified in the construct. The single operator could not provide tight regulation 
of the lac promoter. Furthermore, the NEB5α competent cells do not contain either the lacI 
or laclq gene, which causes inefficient regulation of the lac promoter. Overall, inefficient 
regulation of either the lacI/laclq repressor or the lac operator might cause low-level 
constitute toxins expression in NEB 5α bacterial cells.  
 
3.1.4.2 Application of NEB turbo and lac operator  
To test the hypothesis about the lac promoter, a different competent cell line, NEB turbo, was 
used to amplify the toxin constructs. NEB turbo features the ideal traits for cloning toxic genes 
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(Figure 23 A). NEB turbo cells show high expression of laclq to supress leaky expression of 
transgene, which allows potentially toxic genes to be amplified.  
 
Bi-HE-TcdA or bi-HE-TcdB vector were transformed into NEB 5α or NEB turbo. After plasmid 
purification, 5ng/µl of either NTcdA or NTcdB DNA was injected into one-cell stage embryos. 
The survival rate was recorded 24h after injection (Figure 23 B). 51% or 10% embryos survived 
with plasmid purified from NEB turbo, while all embryos were dead from NEB 5α-derived DNA 
injection. NTcdA injected embryos showed higher survival rate, supporting previous studies 
that TcdB was more toxic than TcdA (Carter et al., 2010; Voth et al., 2005). This result 
suggested that NEB turbo was suitable for the amplification of toxic constructs.  However, the 
survival rate of embryos was still low.  
 
 
Figure 23 Application of NEB turbo competent cells for constructs purification  
 
A) Genotype comparison between NEB turbo and NEB 5α. NEB turbo is characterized by high expression of the 
lac repressor protein. B) Survival rate of zebrafish embryos with plasmid purified from NEB turbo or NEB 5α. 
Control indicates un-injected embryos.  
 
Based on our sequence about the lac promoter, the second possible solution to supress the 
leaky toxins expression was to insert extra lac operators (lacO) near the transcription start site 
of the toxin transgenes. To confirm the feasibility of this hypothesis to acquire higher survival 
rate, lacO were inserted into the toxin-containing constructs to further suppress the activation 
of the lac promoter. lacO sequence is usually located between the promoter and the 
downstream gene, close to the transcription start site. 4 copies of the lac operator sequence 
(4xlacO) were placed in front of NTcdA or NTcdB transgenes. Indeed, survival rate of zebrafish 
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embryos after plasmid injection further improved than amplifying plasmid in NEB turbo cells 
without adding 4xlacO sequence (data not shown). However, we wondered if such repression 
effect would transfer from bacteria to zebrafish, which down-regulate the expression of toxins.  
 
To address this question, a new construct was created in which 4xlacO sequence were placed 
in front of tagRFP-T in the bi-HE vector (Figure 24 B). Zebrafish embryos were injected with 
this bi-HE-4xlacO construct or the bi-HE vector to evaluate the expression level of fluorescent 
protein (Figure 24). The fluorescent images were obtained 24h after plasmid injection, which 
revealed a visible difference in the RFP fluorescence level (Figure 24). Using the same expose 
time as for bi-HE injected-embryos, RFP fluorescence was barely visible in 4xlacO construct 
injected embryos. I was concerned about whether the decreased toxin expression level would 
cause non-cytotoxic effects in hatching gland cells.  
 
Figure 24 Comparison of fluorescent protein expression level in transient assay.  
 
A) Schematic representation of the bi-HE construct and an embryo injected with the bi-HE construct. B) 
Schematic representation of 4xlac construct and an embryo injected with bi-HE-4xlacO construct. Scale bar, 200 
µm. 
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In case the repression effect would transfer from bacteria to zebrafish, we used an Exon-Intron 
system to splice out 4xlacO in zebrafish (Figure 25 A). We therefore order the synthesis of 
DNA-fragment containing exon 2, intron 2, and exon 3 of zebrafish housekeeping gene rpl9. 
4xlacO sequence were inserted into the intron 2, where the 4xlacO sequence would be spliced 
out together with intron 2 in zebrafish after transcription. Notably, the size of exon2 or exon3 
was less than 50bp, which means 4xlacO was still close enough to the transcription start site 
to repress toxin production in bacteria. 
  
In order to confirm if the expression level of fluorescent protein could be restored, the 
construct was injected into one-cell stage zebrafish embryos. The images were taken 24h after 
injection. The mean fluorescent intensity was measured and calculated using ImageJ (Figure 
24 B). The fluorescent intensity of Exon-4xlacO injected group was set to 100 percent. the 
relative fluorescent intensity of the control group injected with bi-HE was 131%, which as still 
statistically insignificant (Figure 25 C). This result indicated that a slight fluorescent restoration 
after splicing out 4xlacO in zebrafish.  
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Figure 25 Schematic diagram of bi-HE vector containing 4xlacO and application of Exon-Intron system  
 
A) Schematic representation of the bi-HE construct containing the exon-intron-exon sequence and 4xlacO. B) 
Schematic representation of Exon-4xlacO and control construct injected embryo 24 hour later. C) The fluorescent 
intensities of the exon-4xlacO and control group injected with bi-HE was calculated by ImageJ. n.s.: no significant 
difference. mean +SEM. p< 0.05, statistically significant. 
 
3.1.4.3 Application of bile acid in the established transgenic lines 
As shown in Figure 23 B, the survival rate of NTcdB-injected embryos was lower compared to 
NTcdA injected embryos, which indicated that NTcdB was more lethal than NTcdA for 
zebrafish embryos (Chaves-Olarte et al., 1997). As mentioned in introduction 1.3.1, some bile 
acids prevent the onset of CDI. By testing three bile acids, Taurocholic acid sodium (TCA), 
tauroursodeoxycholate (TCDCA) and tauroursodeoxycholate (TUDCA), it was found that 
TUDCA was able to inhibit TcdB activity and rescue TcdB-induced cytotoxicity in cells (Genth’s 
unpublished data).  
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Before applying bile acids in zebrafish, whether NTcdB was expressed after microinjection was 
investigated by RT-PCR. Since intron2 of rpl9 was inserted into the construct, primers were 
designed to span the intron region. If the intron2 containing 4×lacO sequence were spliced 
out, RT-PCR would show a shortened DNA band without the intron sequence. Total RNA was 
isolated from bi-HE-TcdB injected embryos 5h after microinjection. Interestingly, RT-PCR 
detected a shortened band, indicating NTcdB was already expressed 5 hours after 
microinjection (Figure 26 A and A’). Sequencing of these RT-PCR products showed that intron2 
containing 4×lacO sequence indeed were spiced out. NTcdA was also detectable (data not 
shown). Besides, western blot already demonstrated that low level of the toxins was 
expressed in E. coli (Figure 22 A), this result indicated that toxins were also expressed in 
embryos. However, it was difficult to distinguish which was the main reason that leads to 
embryo mortality.  
 
Thus, to obtain higher survival rates and to get more healthy embryos after plasmid injection, 
three bile acids were tested in zebrafish (Figure 26). To assess the toxicity of the bile acids for 
embryos, one-cell stage embryos were injected with bile acids ranging from 0.2 mM to 22 mM. 
Mortality and malformations were recorded 24 h after injection. 4mM TUDCA, 0.8 mM TCDCA 
and 1 mM TCA was adopted respectively for co-injection with 5 ng/μl of bi-HE-TcdB construct. 
The survival rate was recorded 24 h later (Figure 26 B, C, and D). As Figure 26 B’ showed TCA 
did not rescue the NTcdB-induced embryos death (Figure 26 B’). The bi-HE-TcdB injected 
embryos treated with TCDCA showed an even little lower survival rate than control injected 
embryos (Figure 26 D’). In contrast, after treatment with TUDCA, the survival rate increased 
from around 20% to 40%, which was statistically significant (Figure 26 C’). These results 
indicated that TUDCA could confer protection against NTcdB-induced embryonic death, and 
also increase the ratio of visibly healthy embryos. This finding fit to previous studies in which 
TUDCA rescued TcdB-induced cytotoxicity in cultured cells. Therefore, 4mM TUDCA was 
applied to the injection mixture in further studies.  
   Results 
 93 
 
Figure 26 Application of bile acid in NTcdB injection. 
 
 A) Schematic representation of construct bi-HE-TcdB. Primers were designed to span the intron region. The size 
of the PCR product indicates whether NTcdB was expressed by the zygote. A’) NTcdB expression was measured 
by RT-PCR in injected embryos (n=3) Lane 1. Positive control using pcs-NTcd vector as template. Lane 2. TcdB 
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injected embryos. Note the reduced size of the RT-PCR product by about 100bp of Intron size. M: size marker. B) 
Survival rate after TCA injection. Serial dilutions of TCA from 1mM to 2mM were injected into one-cell stage 
embryos and the survival rate was recorded 24h later (n=3, 362 embryos). Dashed line indicated the highest non-
toxic concentration (1mM) which was applied in further studies. B’) Survival rate after co-injection of 5μg/μl TcdB 
vector and 1mM TCA (n=3 injections, 423 embryos). p=0.142696. C) Survival rate after TUDCA injection. Serial 
dilutions of TUDCA from 1mM to 12mM were injected into one-cell stage embryos and the survival rate was 
recorded 24h later (n=3, 558 embryos). Dashed line indicated the highest non-toxic concentration (4mM) which 
was applied in further studies. C’) Survival rate after co-injection of bi-HE-TcdB and TUDCA (n=6 injections, 929 
embryos). D) Survival rate after TCDCA injection. Serial dilutions of TCDCA from 0.2mM to 22mM were injected 
into one-cell stage embryos and the survival rate was recorded 24h later (n=3, 481 embryos). Dashed line 
indicated the highest non-toxic concentration (0.8mM) which was applied in further studies. D’) Survival rate 
after co-injection of 5ng/μl bi-HE-TcdB and 0.8mM TCDCA (n=6 injections, 392 embryos). p=0.1523. 
 
3.1.4.4 The apoptosis biosensor secA5-YFP 
After toxins are delivered into cells, GTD domains are released into the cytosol. GTD inactivate 
Rho GTPases in targeted cells. Inactivation of Rho proteins disrupts the organization of the 
cytoskeleton and induces apoptosis, eventually leading to cell death. Therefore, released GTD 
domain in hatching gland cells might lead to apoptotic cell death.  
 
In order to monitor apoptosis in hatching gland cells, a fluorescence-based apoptosis reporter 
was co-expressed with toxins in hatchling gland cells. Currently, several noninvasive apoptosis 
biosensors that monitor caspase activation, have been developed, such as, Apoliner and VC3AI 
(Bardet et al., 2008; J. Zhang et al., 2013). However, Apoliner and VC3AI either showed 
constant but weak signal, or no fluorescent signal at all in zebrafish (data not shown). Another 
apoptosis sensor, secA5-YFP, was tested, which had been demonstrate to work in zebrafish 
embryos (Figure 27 A) (van Ham et al., 2010). During apoptosis, phospholipid 
phosphatidylserine (PS) translocated from inner leaflet to outer leaflet of the plasma 
membrane. The calcium-dependent Annexin V (A5) binds PS with high affinity, which is utilized 
to detect apoptosis. secA5-YFP is a fusion of secreted Annexin V (secA5) and the yellow 
fluorescent protein (YFP), which specifically condenses and thereby labels apoptotic cells in 
living zebrafish (van Ham et al., 2010).  
 
SecA5-YFP mRNA was microinjected into one-cell-stage embryos. At 24hpf, the injected 
embryos were exposed to 5μM thapsigargin for 4 hours. Thapsigargin is a specific ER calcium-
ATPase inhibitor, which induces apoptosis in zebrafish embryos (Pyati et al., 2011). After 
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treatment with thapsigargin, green fluorescence intensity was enhanced markedly, and 
fluorescence-positive cells were also increased (Figure 27 B and C). This result confirmed that 
secA5-YFP labeled apoptotic cells in zebrafish embryos.  
 
Figure 27 secA5-YFP labelled apoptotic cells in live zebrafish embryos.  
 
A) Schematic representation of secreted secA5-YFP fusion construct. (From van Ham et al., 2010). B and B, C and 
C’) Fluorescence images (B and C) and bright field overlay images showing apoptotic cells after 4 hours of 5μM 
thapsigargin treatment. B and C were obtained with same microscopy setup.  
 
3.1.4.5 Establishment of toxins transgenic fish lines  
Using LexA/lexAop system (refer to section 3.2.4.1), establishment of NTcdA and NTcdB stable 
transgenic zebrafish lines are in progress.  
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3.2 C. difficile infection model for imaging innate immune response 
3.2.1 Neutrophils and macrophages responded to C. difficile in vivo  
Neutrophils and macrophages play critical roles in fighting against C. difficile infection, but 
their behavior in this defense needs to be better understood. Using Gal4/UAS system, a 
macrophage reporter strain and a neutrophil reporter strain were generated. lyz (lysC), a 
neutrophil specific promoter, was used to drive the expression of KalTA4 in neutrophil. mpeg1, 
a macrophage specific promoter, was used to drive the expression of KalTA4 in macrophages 
(Figure 28).  
 
The first step was to generate a macrophage specific KalTA4 activator strain and a neutrophil 
specific KalTA4 activator strain. An insulator and HE enhancer were used in these two 
constructs used for generating KalTA4 activator strains (Figure 28). Because of the invisibility 
of KalTA4 expression, every transgenic zebrafish is necessary to be confirmed as positive by 
crossing with UAS fish line. To get the positive KalTA4 activator zebrafish directly, these two 
constructs were introduced an insulator and HE enhancer driving BFP expression. BFP 
fluorescent signal would be the screening marker for the positive KAlTA4 activator zebrafish. 
HE enhancer would be silenced after 3 dpf, which means no BFP fluorescent signal would be 
detected after that. The insulator is DNA-protein complexes that act as an enhancer blocker 
or serve as barriers against the spreading of heterochromatin in reporter system. It allows the 
two different expression units working independently.  
 
Figure 28 Schematic structure of the plasmid used for generating macrophage and neutrophil KalTA4 activator 
strains.  
 
KalTA4 is under control of either lyZ or mpeg1 promoter and BFP fluorescent proteins is under control of HE 
enhancer. An insulator sequences isolates the two expression cassettes. The construct is flanked by Tol2 
recognition sites (Tol2) for transposase mediated integration. 
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These two vectors were co-injected into one-cell stage of zebrafish embryos with mRNA 
encoding Tol2 transposase. BFP fluorescent embryos were raised to adult stages after 3 
months later. Then they crossed with Tg(UAS-E1b:EGFP) to get macrophage reporter zebrafish 
strain Tg(mpeg1: Kalta4, UAS-E1b:EGFP) and neutrophil reporter strain Tg(lyZ: Kalta4, UAS-
E1b:EGFP). 
 
In order to detect and track C. difficile, the bacteria was labeled. Given that most fluorescent 
proteins require oxygen to mature their chromophore, made it difficult to use such 
fluorescent proteins in strict anaerobic C. difficile (Craggs, 2009). Ransom et al. developed a 
codon-optimized mCherryOpt to label C. difficile successfully, but cells had to be fixed before 
C. difficile exhibited fluorescence (Ransom et al., 2015).  Therefore, I used a fluorescent 
labeling reagent, BacLight, to detect and monitor living C. difficile. After staining with BacLight, 
C. difficile exhibited bright red fluorescence (Figure 29 A).  
 
The stained C. difficile were injected into the zebrafish intestinal tract of 5dfp macrophage or 
neutrophil transgenic larvae, and then zebrafish were imaged near the infection site after 1 
hour incubation (Figure 29 B) (Benard et al., 2012). Time-lapse imaging showed that 
neutrophils and macrophages were recruited to the inoculation site, and the number of these 
two innate cells increased over time till the C. difficile were cleared. When macrophages and 
neutrophils reached the infection site, they started to phagocytose and digest labeled C. 
difficile (Figure 29 C and D). This result demonstrated that zebrafish innate immune cell could 
recognize and phagocytose C. difficile cell in vivo.  
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Figure 29 Neutrophils and macrophages phagocytose of C. difficile in vivo 
 
A) Fluorescent BacLight labeled C. difficile cells. Scale bar, 5 µm. B) Confocal 3-D image showed that neutrophils 
accumulated in the C. difficile infection site (yellow arrow) Scale bar, 50 µm. C) Time-lapse image of GFP-labeled 
neutrophil ingesting red fluorescent C. difficile. Scale bar, 20 µm. D) Time-lapse image of GFP-labeled 
macrophage ingesting red fluorescent C. difficile. Scale bar, 20 µm 
 
Before phagocytosis of C. difficile, macrophages showed a characteristic macrophage 
morphology and behavior as indicated by long and branching pseudopodia and high motility. 
However, after phagocytosis of C. difficile, macrophages displayed markedly different cell 
behavior and a round morphology (Figure 30 A2, yellow arrow head). Simultaneously, they 
also turned to be immobile. In confocal microscopy image, the fragmentation of labeled C. 
difficile corpses was visible inside a macrophage, which indicated that C. difficile had been 
digested (Figure 30 A1, yellow arrow head). However, even after taking up several C. difficile 
cells, the macrophage still displayed normal morphology (Figure 30 A2, white arrow head). 
But C. difficile did not lose their rod shape, which indicated that they were just engulfed by 
the macrophage and phagocytic degradation had not started yet. This result demonstrated 
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that macrophage was able to digest C. difficile, but the degradation of C. difficile might be 
cytotoxic to macrophages, which was indicated by the morphology and mobility changes. 
 
 
Figure 30 Morphology of macrophage after phagocytosis of C. difficile  
 
A1) Red labeled C. difficile cells were engulfed by macrophage. A2) Macrophages showed different morphologies. 
A3) Merge of red and green channel. n = 4 larvae.  
 
3.2.2 Cooperation of neutrophils in the clearance C. difficile in vivo  
It is well accepted that neutrophils cooperate with macrophages to defend the invasion of the 
pathogen. It was not clear yet whether neutrophils interacted with each other to against 
infection. Our neutrophil infection model demonstrated that neutrophil interacted with other 
neutrophils when they were recruited to clean C. difficile (Figure 31). Three neutrophils 
migrated to the infection site as shown in Figure 31 a1, then two of them made contact to 
form a cell as shown in Figure 31 a2. The two joint neutrophils encountered another 
neutrophil to form a three-neutrophil-union (Figure 31 a4). This the union dissociated after 4 
minutes (Figure 31 a6). This finding suggested that the dynamic association and dissociation 
of several neutrophils might be a regular process in phagocytosis of pathogens.  
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Figure 31 Cooperation of neutrophils in the clearance of C. difficile  
 
A) Confocal time-lapse image of 5dfp zebrafish larvae injected with C. difficile. Image was recorded 2h after 
infection.  
 
3.2.3 Establishment of neutrophils ablation transgenic zebrafish  
To reveal the importance of neutrophils against C. difficile, a transgenic fish line that co-
expressed yellow fluorescent protein Citrine and the Tamoxifen-induced Caspase8ERT2 
Tg(lyZ:Kal4TA4, 5UAS-E1b:mCitrin, Casp8ERT2) , named Neu-ATTACTM strain, was established. 
The construct as shown in Figure 32 was co-injected into one-cell stage of zebrafish embryos 
with mRNA encoding Tol2 transposase. Fluorescent embryos were raised to adult stage, about 
10 adult zebrafish, and then crossed with wild type zebrafish to F1 generation. The larvae of 
F2 and F3 generation were used for this study (Figure 33 A). 
 
Figure 32 Construct design for the generation of a stable transgenic neutrophil ablation strains. 
 
KalTA4 is under control of lyZ promoter. 5×UAS drives the expression of fyndtdmCitrine and Caspase8ERT2 in 
bidirectional manner. fyndtdmCitrine, a membrane localization signal fused to tandem mCitrine fluorescent 
protein. The construct is flanked by Tol2 recognition sites (Tol2) for transposase mediated integration. 
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ATTACTM is a new genetic ablation technique, in which cells are driven into apoptotic cell death 
by tamoxifen-inducible Caspase 8 (Weber et al., 2016). Weber et al demonstrated that 5 μM 
4-hydroxy-tamoxifen (4OHT) induces near-complete loss of Purkinje cells in PC-ATTACTM 
larvae after 16h treatment (Weber et al., 2016). With this protocol, I found that the number 
of fluorescent neutrophils did not decrease after 4OHT treatment compared to a control 
group. 4OHT concentrations ranging from 5 μM to 10μM, followed by extended treatment 
time (16-24 hours) were tested, but neutrophils were not ablated (data not shown). 
 
Since a Myc-tag was inseted after ERT2 domain, I wondered whether Caspase8ERT2 was 
inactivated due to the Myc-tag. To rule out this possibility, the carriers of Neu-ATTACTM was 
crossed with the carrier of rhombomere reporter line Tg(krox20: KalTA4) or skeletal muscle 
reporter line Tg(shhb:KalTA4), which allowed embryos to express Caspase8ERT2 either in 
rhombomere 3 and 5, or in skeletal muscle cells specifically (Figure 33 B, C). After 6 h of 4OHT 
treatment, distinct cell death was detected in both rhombomere and skeletal muscle cells 
(Figure 33 B, C). All rhombomere cells elongated and lost their original shape, while apoptotic 
bodies appeared (Figure 33 B). Before treatment, muscle cells were thin and long with large 
spaces between them. Although some muscle cells still maintain their original morphology 
after 6h treatment, some muscle cells had formed apoptotic bodies (Figure 33 C). This finding 
demonstrated that Caspase8ERT2 triggered apoptosis in rhombomere and skeletal muscle cells 
and hence Caspase8ERT2 was functional. This result also suggested that rhombomere cells 
were more susceptible to 4OHT-induced apoptotic cell death than skeletal muscle cells and 
neutrophils.  
 
Furthermore, we wondered if 4OHT treatment could also trigger apoptosis in neutrophils. 
Given that caspase 8 directly activates downstream procaspase 3, activated Caspase 3 is 
considered to be the most direct executioner during apoptosis (Elmore, 2007). 
Immunostaining against activated Caspase 3 was performed. However, no apoptotic 
neutrophil were detected (data not show).  
 
To further determine whether 4OHT-treated neutrophils respond to inflammatory stimuli, we 
examined neutrophil recruitment in response to tailfin transection. At 3dpf, tailfin transection 
was performed using larvae of Neu-ATTACTM strain after Tamoxifen treatment (Figure 33 D). 
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After the initial transection, neutrophils were increased in wounded tailfin in control fish, 
peaking after around 4h. However, neutrophils also showed strong recruitment in 4OHT-
treated fish, which exhibited strong directionality and similar velocity as in control fish. This 
result indicated that 4OHT treatment did not impair chemotaxis of neutrophil to tail wound.  
 
Therefore, even though ATTACTM worked very well in rhombomeres and skeletal muscle cells, 
Caspase8ERT2 was incapable to induce apoptotic neutrophils death in the neutrophil reporter 
fish line. This could be due to the low activity of the lyz neutrophil promoter.  
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Figure 33 Application of ATTACTM in neutrophils 
  
A) Fluorescence and bright field overlay of 3dpf Tg(lyZ:Kal4TA4, 5UAS:mCitrin, Casp8ERT2) fish. Green 
fluorescence: neutrophils. B) Fluorescent cells in rhombomeres 3 and 5 before and after 4OHT treatment. C) 
Fluorescent muscle cells before and after 4OHT treatment. n=5. D) Confocal time-lapse analysis of neutrophils 
(green) in tail transection of zebrafish treated with or without 4OHT. hpt, hours post-treatment. n=3.      
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3.2.4 Generation of macrophage-ATTACTM transgenic zebrafish  
Neutrophils are engaged in phagocytosing of C. difficile after intestinal tract infection. 
However, the function of macrophages in CDI progression was less understood. Moreover, 
not much is known about the behaviour and cooperation of macrophages and neutrophils in 
clearance of C. difficile. To answer these questions, a new macrophage transgenic line was 
needed.  
 
3.2.4.1 Application of LexA/lexAop system in macrophage transgenic strain  
Gal4-UAS was already adopted for neutrophils strain, Neu-ATTACTM. In order to image and 
manipulate neutrophils and macrophages simultaneously in the same zebrafish, another 
binary expression system was required. Besides Gal4-UAS, there are two other binary 
transcriptional systems used in zebrafish: The QF transcriptional regulatory system and the 
LexA/lexAop system (Subedi et al., 2014; Emelyanov et al., 2008). Since high expression of QF 
might be toxic to early zebrafish development, the LexA/lexAop was chosen to establish a 
macrophage zebrafish strain (Subedi et al., 2014). Although the existence of a mifepristone-
inducible LexA system has been reported, this approach has not yet been widely used in 
zebrafish. It might due to the requirement of ligands to induce gene expression, or low level 
activation of LexA reported in Drosophila (Potter et al., 2011).   
 
In order to overcome these problems, a constitutive activated LexA/lexAop system was 
designed. This system contained a constitutively activated LexA transcription factor (residues 
1–87) and colE1-derived binding motif (colE1-lexAop) with high affinity to LexA (Figure 34D).  
 
The aim was to co-express a fluorescent protein and Caspase8ERT2 simultaneously. Therefore, 
whether 4×lexAop worked in a bi-directional manner was tested (Figure 34A). Emelyanov et 
al demonstrated that the transcriptional domain of the human p65 (residues 283–551) p65 
AD and the minimal 35S promoter (35S) worked for a mifepristone-inducible LexA system. 
p65AD and 35S were examined in bi-directional lexAop constructs. LexA-p65AD and lexAop 
constructs were either co-transfected into HEK293T cells or co-injected into one-cell stage 
zebrafish embryos. When 35S was placed downstream of 4×lexAop, GFP was detected in cells 
and embryos (lexAop-35S: GFP) (Figure 34 A). When another 35S was inserted upstream of 
4×lexAop, no transcription for both genes could be obtained (RFP:35S-4×lexAop-35S:GFP) 
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(Figure 34A). However, when another inverted 4×lexAop-35S fragment was inserted, formed 
back-to-back configuration, transcription of RFP and GFP was restored (RFP:35S-8×lexAop-
35S:GFP) (Figure 34A). These results suggested that transcription initiation of lexAop was 
controlled in an orientation-dependent fashion. Nevertheless, 8×lexAop in a back-to-back 
configuration worked in a bi-directional manner in both cells and zebrafish embryos.  
 
Besides 35S, there are other small basal promoters that have been used successfully in 
zebrafish and could be applied for the LexA/lexAop system, for instance, the super core 
promoter 2 (SCP2) and the minimal E1b promoter (Juven-Gershon et al., 2006; Zuo et al., 
2000). Co-transfected with pCS-LexA-p65AD, lexAop-E1b and lexAop-SCP2 were strongly 
activated in HEK293T cells (Figure 34B). In order to further test E1b and SCP2 in zebrafish, 
LexA-p65AD was put under the control of the mpeg1 macrophage-specific promoter. However, 
when co-injected with mpeg1-LexA-p65AD into embryos, lexAop-SCP2 were expressed in 
highly ectopically manner (data not shown). Therefore, compared with 35S and SCP2, the E1b 
exhibited strong and specific activity with lexAop motif and was chosen for further use.  
 
The transcription activating domain TA3 exhibits high transcription activation in the Gal4 
system. In order to obtain a strong transcriptional activator, LexA-p65AD and LexA-TA3 were 
constructed and their activity was compared in cell culture (Figure 34C). The LexA-p65AD-
transfected cells exhibited a much stronger GFP and RFP expression than LexA-TA3-
transfected cells, indicating that the p65AD had a higher activity than TA3 in the LexA system. 
Consistent with cell culture result, the same results were obtained in zebrafish (data not 
shown). 
 
This series of experiments conclusively demonstrated the feasibility of using a constitutively 
activated LexA binary expression system to generate a macrophage specific fish trains (Figure 
34D).  
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Figure 34 Establishment of a constitutive LexA-based binary expression system 
 
A) LexA-p65AD was placed under either CMV promoter or mpeg1 promoter. Different lexAop constructs 
containing 4 or 8 copies of lexAop flanked by the 35S minimal promoter. Driver construct and reporter construct 
were co-transfected into 293T cells or co-injected into one-cell stage zebrafish embryos. B) 8×lexAop fused to 
the E1b, 35S or the SCP2 minimal promoter, which was co-transfected with LexA-p65AD into 293T cells. Scale bar, 
75 µm. C) LexA-p65AD or LexA-TA3 were co-transfected with E1b:8×lexAop: E1b into 293T cells.  D) Schematic 
structure of the plasmid used for the generation of stable transgenic macrophage ablation strains. Scale bar, 50 
µm. 
 
3.2.4.2 Generation of a stable transgenic macrophage-ATTACTM zebrafish strain 
To address whether the ATTACTM transgene worked for macrophages, I established a zebrafish 
strain that co-expressed fyntagRFP-T together with Caspase8ERT2 under the control of mpeg1 
promoter, referred to as Mac-ATTACTM.  The construct as shown is Figure 34D was co-injected 
into one-cell stage of zebrafish embryos. Fluorescent embryos were raised to adult stage than 
then crossed with wild type zebrafish. The larvae of F1 and F2 generation were used for further 
study.  
 
The larvae of F1 generation were treated with 5μM 4OHT for 16h. Cell ablation was 
determined by fluorescent signal disappearing over the time course of treatment (Figure 35). 
Larvae incubated with 0.5% EtOH showed no signs of cell debris or decreased macrophage 
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number, indicating no leaky Caspase8ERT2 toxicity under the control of the mpeg1 promoter. 
The same result was obtained in 2dpf, 4dpf, and 5dpf larvae (data not shown). This result 
demonstrated that macrophage could be ablated by caspase8-mediated apoptotic cell death, 
and caspase 8 activity was strictly contained to macrophage.  
 
Figure 35 Tamoxifen-induced macrophage death in Mac-ATTACTM larvae  
 
A) Incubation of 3dpf Mac-ATTACTM embryos with 5μM 4OHT or 0.5% EtOH for 16h. scale bar, 250µm. hpt, hours 
post-treatment.  Scale bar, 250 µm 
 
A characteristic feature of apoptotic cells was the present of membrane blebbing, cell 
shrinkage and apoptotic body formation. After pre-treat 3dpf larvae with 4OHT for 3h, 
macrophage apoptosis was monitored by confocal time-lapse imaging (Figure 36 A). The 
apoptotic macrophages showed cell shrinkage and apoptotic body formation. First, the 
macrophage retracted lamellipodia (Figure 36 a1, white arrow), indicating it was in an early-
stage of apoptosis after 3h of 4OHT treatment. Lamellipodia retraction resulted in cell 
shrinkage and rounding (Figure 36 a2). Then macrophage entered a process of disassembly: 
formation of apoptotic membrane protrusion (Figure 36 a3-a4), and eventually apoptotic 
bodies broke down the cell (Figure 36 a5-a6). Probably, apoptotic macrophages released 
chemotactic signals that stimulated a nearby macrophage to migrate to the apoptotic 
macrophage (Figure 36 a6, yellow arrow). The apoptotic macrophage died and disappeared 
   Results 
 109 
quickly within around 45 minutes. The difficulty to determine the apoptosis starting time 
made it impossible to measure the duration of the whole process. 
 
AnnexinV-Cy5 is used as an apoptotic cell indicator. In order to illustrate that macrophages 
were eliminated via apoptosis, heterozygous Mac-ATTACTM larvae were treated at 4dpf with 
4OHT for 4h, and then incubated with AnnexinV-Cy5 for 2 h. Three red fluorescent 
macrophages were labelled by AnnexinV-Cy5, which demonstrated that apoptosis occurred in 
macrophages (Figure 36 B). Since Annexin V is an early apoptotic marker, those three 
macrophages were in an an-stage of apoptosis (G. H. Zhang et al., 1997). No AnnexinV-labelled 
macrophages were found in control larvae (data not shown).  This result demonstrated that 
apoptosis indeed occurred as a result of 4OHT activation of the ATTACTM gene to eliminate 
macrophages.  
 
Figure 36 Analysis of macrophage apoptosis.  
 
A) 3D confocal time-lapse imaging showed an apoptotic macrophage. White arrow: apoptotic macrophage; 
Yellow arrow: healthy macrophage. B) AnnexinV-Cy5 labelled apoptotic macrophages. fyntagRFP-T was 
expressed by macrophages and Cy5 fluorescence was presented a color in cyan. The larvae were treated with 
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5µm 4OHT for 4h and then incubated with 1/500 AnnexinV-Cy5 stock solution for 2h in dark box. Then extensively 
washed before mounting and confocal imaging.  
 
To quantify macrophage ablation, I analyzed one region of the caudal hematopoietic tissue 
(CHT) in the ventral mesenchyme of the tail, where the definitive waves of hematopoiesis take 
place during late stage of zebrafish development (Figure 37 A). Mac-ATTACTM heterozygous 
larvae were treated with 5μM 4OHT for 4,7,10 or 14h at 5dpf. RFP-labelled macrophages were 
counted from confocal z-stack images (Figure 37 A). 
 
Macrophages significantly decreased after 7h of 4OHT treatment, compared to the control 
specimens (p≤ 0.05) (Figure 37 B). After 10h of 4OHT treatment, macrophages were almost 
undetectable in Mac-ATTACTM larvae (Figure 31 A and B). This data suggested that most 
macrophages were triggered into apoptosis after 7h of 4OHT treatment and were further 
induced to cell death after around 10h treatment. After 14hof 4OHT treatment, the number 
of macrophage dropped to very low level below than 1% (Figure 37 A and B). This number 
might underestimate the efficiency of ablation, as macrophage progenitors which produce 
macrophages even when 31pdf, might counteract the loss of macrophages (Shiau et al., 2015).  
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Figure 37 The time course of macrophage ablation and macrophage regeneration in Mac-ATTACTM larvae 
 
A) Illustration of caudal hematopoietic tissue (CHT) in the ventral mesenchyme of the tail (white box), which was 
taken with the same magnification and field size of view at all stages. The size of the image was x, 775μm. y, 
775μm. z, 117.36-220 μm. B) Box plot of macrophages after 4, 7, 10, or 14h 0.5% ethanol (control), or 5μM 4OHT 
treatment.  C) Illustration of caudal hematopoietic tissue (CHT) in the ventral mesenchyme of the tail after 1, 2, 
3, or 4 days after withdrawal of 0.5% ethanol (control), or 5μM 4OHT treatment (white box), which was recorded 
with the same magnification and field size of view at all stages. The size of image was x, 775μm. y, 775μm. z, 130-
230 μm. dpt, days post-treatment. D) Box plot of recovery of macrophages over time after removal of 4OHT. n.s, 
not significant. * p≤ 0.05, ** p≤ 0.01, **** p≤ 0.0001. 
 
To figure out how long it took for macrophages to recover. 4OHT was removed from the 
culture medium, and the re-appearance fluorescent macrophages were counted in the CHT 
region at 1, 2, 3, and 4 dpt (days post-treatment) (Figure 37 C). Macrophage number increased, 
indicating that the regeneration of macrophages occurred soon after removal of 4OHT (Figure 
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37 D). RFP positive macrophages increased considerably at 2dpt in the 4OHT treated group 
compared to control group, which is, however, statistically insignificant (Figure 37 D). At 3dpt, 
macrophages in the4OHT treated group increased to a comparable level to the control group, 
which is statistically insignificant (Figure 37 C, D). This finding suggested that the regeneration 
of macrophages occurred rapidly and efficiently, which might be due to many different types 
of progenitors that macrophages have, such as , myeloid progenitors (CMPs), common DC 
progenitors (CDPs), and common monocyte progenitors (cMoPs) (Geissmann et al., 2010; Onai 
et al., 2014). Mac-ATTACTM shown as a suitable model to investigate ablation and regeneration 
of macrophages in vivo.  
 
3.2.4.3 The interaction of neutrophils and apoptotic macrophages  
Macrophages, neutrophils, dendritic cells (DCs), and monocytes mast cells are the 
professional phagocytic cells in the body (Murray et al., 2011). Following a common origin, 
macrophages and neutrophils share some overlapping and complementary features in the 
host defense against microbial infection. Several lines of evidence indicated that macrophages 
and neutrophils work in a cooperative manner against pathogen invasion (M. T. Silva, 2010). 
Macrophages are able to phagocyte apoptotic neutrophils in infection-associated 
inflammation and tissue regeneration (Ellett et al., 2011; Manuel T. Silva et al., 2012; Tan et 
al., 2006). Since macrophages and neutrophils are considered the main cells type at the 
phagocytic system, we wondered how neutrophils respond to apoptotic macrophages, and 
whether neutrophils are involved in clearance of apoptotic macrophages.  
 
To address these questions, Mac-ATTACTM carriers were crossed with neutrophils-reporter 
line Tg(lyZ:KalTA4, UAS-E1b:EGFP) . These double transgenic larvae were treated with 4OHT 
for 3h to trigger macrophage apoptosis (Figure 38 A). Confocal time-lapse imaging was 
performed (Figure 38 B). A neutrophil phagocytosing an apoptotic macrophage was observed 
(Figure 38 b4-b5). The neutrophil recognized and engulfed the apoptotic macrophage within 
6 minutes (Figure 38 b4-b5). Interestingly, before the macrophage was engulfed by the 
neutrophil, this macrophage split into two cells parts (Figure 38 b1-b3, white arrow and arrow 
head). Only one of them was engulfed by the neutrophil (Figure 38 b4, white arrow head and 
yellow arrow), whereas the other seemed healthy and was highly mobile (Figure 38 b4-5, 
white arrow). This finding suggested that neutrophils were indeed in clearance of apoptotic 
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macrophages. 
 
However, I was puzzled by the splitter of macrophage ‘division’ during the apoptosis (Figure 
38 B). I speculated that this split might be the dissociation of an apoptotic body from healthy 
macrophage. If this is the case, this should be observed regularly in the clearance of dying 
macrophages. To address this question, 5dpf larvae were treated with 4OHT for 1, 4, and 6h. 
After 6h pre-treatment, I only observed neutrophils phagocytosing apoptotic macrophages, 
but no other interactions between macrophages and neutrophils. However, macrophage-
neutrophil coordination was indeed recorded by time-lapse imaging in larvae treated with 
4OHT for only one hour (Figure 38 C). Two adjacent neutrophils contacted each other (Figure 
38 c1, yellow arrow and yellow arrow head) and then seemingly formed a complex neutrophil 
(Figure c2, yellow arrow). When the joint neutrophils approached a rounding macrophage 
(Figure 38 c2, white arrow head), another macrophage (Figure 38 c3, white arrow) migrated 
toward this macrophage, and subsequently formed macrophages-neutrophils complex (Figure 
38 c4, white arrow). However, following the neutrophil dissociation, the macrophages also 
dissociated (Figure 38 c5, yellow arrow and c6, white arrow head), where one neutrophil was 
still enwrapping the rounding macrophage (Figure 38 c6). More neutrophil-macrophage 
interactions were found in other larvae (data not shown). This result hinted at a cooperative 
behavior between neutrophils and healthy macrophages to clean apoptotic macrophages. 
However, as most macrophage went into apoptosis after around 4h 4OHT treatment, such 
cooperation only happened shortly after the onset of 4OHT treatment.  
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Figure 38 Interaction of macrophages and neutrophils to clear apoptotic macrophages 
 
A) LexA/lexAop Mac-ATTACTM strain was crossed with neutrophils line expressing KalTA4. B) Image sequence of 
a neutrophil phagocytosing an apoptotic macrophage. Confocal microscopy time-lapse imaging of 5dpf double 
transgenic larva treated with 4OHT for 3h to induce macrophage apoptosis. C) The cooperation of neutrophils 
and macrophages during macrophage phagocytosis. Confocal microscopy imaging of 5dpf double transgenic 
larva treated with 4OHT for 1h to induce macrophage apoptosis. 
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3.2.5 Establishment of a noninvasive C. difficile infection protocol by microgavage 
Injection is wildly used to induce infection in zebrafish disease models. However, injection is 
invasive and leads to tissue damage that trigger a wound healing response. Therefore, a non-
invasive microgavage infection protocol was established to deliver C. difficile into the intestine 
of zebrafish larvae (Cocchiaro et al., 2013) (Figure 39 A).  C. difficile was cultured for 48h and 
then was collected for BacLight staining. Set injector to deliver around 5nl BacLight-labelled C. 
difficile into the lumen of the intestine (Figure 39 B). For details, refer to section 2.2.3.  
 
Microgavage prevented tissue damage. Furthermore, it has been proven that C. difficile 
colonize in the host intestine and cause bowel infection (Nitzan et al., 2013). Microgavage 
nicely mimic the natural route of infection in humans, which allowed us to analyze if C. difficile 
can colonize on the zebrafish intestinal lumen and disrupt epithelial integrity.  
 
Figure 39 Microgavage of zebrafish larvae with BacLight labeled C. difficile  
 
A) Microgavage in zebrafish larvae. Bacteria or chemicals were administered into the intestinal lumen of 
zebrafish. (Adapted from Cocchiaro et al., 2013). B) Location of C. difficile after microgavage. C. difficile was 
delivered into the anterior intestine. Confocal image shown BacLight stained C. difficile in the posterior intestine 
3 hours after microgavage.  
 
3.2.4 Infection of zebrafish with C. difficile by microgavage 
In order to study the course of CDI and leukocyte recuitment in zebrafish, BacLight labeled C. 
difficile were delivered into the intestine of F2 generation macrophage or neutrophil reporter 
lines at 5dpf. However, neutrophils or macrophges did not show apparent migration to the 
gastrointestinal tract during 0-12h after microgavage (Figure 40). A potential explanation was 
that 12h incubation to activate an innate immune response is not sufficient in the intestine of 
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zebrafish.
 
Figure 40 Time-lapse imaging of macrophages motility  
 
A) Zebrafish larvae Tg(mpeg1: Kalta4, UAS-E1b:EGFP) at 5dfp was microgavaged with BacLight labeled C. difficile. 
Confocal time-lapse imaging of macrophage behavior was performed. hpi: hours post-infection. 
 
Due to unknown reason, the fluorescence labeled C. difficile was bleached in the intestine 
around 5h after microgavage probably due to enzymatic destruction or pH in the intestine. 
Therefore, another approach was needed to confirm if CDI could be achieved in zebrafish.  
 
After challenging mice with C. difficile spores, CDI is achieved after 2 days of incubation 
(Jarchum et al., 2012; Semenyuk et al., 2015). Therefore, I hypothesized that if C. difficile was 
detectable in the zebrafish intestine more than 2 days after challenging, CDI might be achieved 
in zebrafish gastrointestinal tract. To confirm this , the wile type zebrafish larvae were 
challenged with C. difficile strains R20291 cells, hypervirulent ribotype 027 
(TcdA+/TcdB+/CDT+), by microgavage (Jafari et al., 2013).  Zebrafish intestines were isolated 
at 24, 48, and 72h post-infection. The intestines were homogenized with pestles and then the 
homogenates were incubated in the C. difficile medium containing D-Cycloserine, Cefoxitin, 
and with or without TCA. However, C. difficile were detected at 24h, but not at 48h and at 72h 
post-infection (data not show).  
  
I speculated that the endogenous microbial community in the zebrafish larvae possessed 
colonization resistance, which prevented C. difficile invasion. Therefore, gnotobiotic zebrafish 
larvae were used. To determine whether germ-free larvae were susceptible to C. difficile, 5dpf 
gnotobiotic zebrafish larvae were challenged with C. difficile by microgavage. There was no 
death of larvae observed even when zebrafish larvae treated with 108 CFU of C. difficile for 
each (n=3). To test if C. difficile was able to reside in zebrafish, zebrafish intestines were 
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isolated 24, 48, and 72h after microgavage. No bacterial growth in un-challenged control 
zebrafish larvae, which indicated that our gnotobiotic larvae were highly sterile (Figure 41 A). 
24h incubated-sample grew in the media containing TCA or without TCA (data not show). 
However, 48 and 72h incubated-bacteria only grew in the media containing TCA (Figure 41 B). 
The grown bacterial were identified as C. difficile by 16S rDNA PCR, which yielded PCR 
amplicons at expected size, around 800bp (Figure 41 C). The bacterial cultures were plated on 
BHIS-plate. Then single colonies that showed typical C. difficile morphology was stroke on 
chromID plate which supported specific C. difficile growth. C. difficile grew into black colonies 
(Figure 41 D).  
 
As described above, TCA promotes germination of C. difficile spores in vitro. This finding 
suggested that strict anaerobic C. difficile formed spores in the zebrafish intestine 48h and 
72h after microgavage. This result also indicated that, compared to conventional larvae, 
gnotobiotic zebrafish were more likely to be an alternative animal model to study C. difficile 
infection process.  
 
Figure 41 Detection of C. difficile in zebrafish intestine after challenging 
 
A) Bacterial growth in the media containing TCA 72h after infection of gnotobiotic 5dpf zebrafish larvae with C. 
difficile by microgavage. 1, non-infected zebrafish control. 2, R20291-infected zebrafish. n=3. B) Schematic 
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illustration of overall experiment results after 24, 48, and 72h microgavaging with C. difficile. n=3. C) Bacterial 
samples were tested by 16S rDNA PCR after 72h after microgavage. n=3. D) The growth of C. difficile on chromID 
plate, note the indicative black color of C. difficile. n=3. 
 
3.2.6 Frizzled receptor in the gastrointestinal tract of zebrafish 
Wnt receptors, FZD1, 2, and 7 are involved in the binding and the uptake of TcdB in cells of 
the colonic epithelium in mouse. In order to investigate whether Frizzled receptors are 
expressed in the zebrafish gut, in situ hybridization was performed at 5dpf and 8dpf wild-type 
larvae with antisense RNA probe against the mRNA of FZD1, FZD2, FZD7a, and FZD7b. 
Intestinal fatty acid binding protein (ifabp gene) was used as positive control for in situ 
hybridization (Hong et al., 2008). Robust signal in the gut was detected in 5dpf and 8dpf 
embryos respectively (Figure 42 E, F, black arrow). However, in situ hybridization with FZD1, 
FZD2, FZD7a, and FZD7b probes did not reveal strong signal in the gastrointestinal tract of 
zebrafish (FZD2 and FZD7A not shown) (Figure 42 A-B), which suggested that FZD1, FZD2, 
FZD7a, and FZD7b were either not expressed or weakly expressed in zebrafish intestine at 
5dpf and 8dpf.  
 
Figure 42 Whole-mount in situ hybridization of frizzled receptors in zebrafish 
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Whole-mount in situ hybridization against FZD1(A, A’, B, and B’), FZD7b (C, C’, D, and D’), and ifabp (E and F) in 
5dpf and 8dpf wild-type embryos.  
 Discussion 
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4 Discussion  
4.1 Hatching gland-based zebrafish small molecule screen 
Whole-organism chemical screening can circumvent shortcomings of cell-based screening. 
Zebrafish has been proven to be an outstanding model for whole-organism small-molecule 
screening (Zon et al., 2005). Over the last ten years, phenotypic screening was revived in drug 
research and development (R&D) with the hope that this method increases the success rate 
of drug approvals (Swinney et al., 2011). The phenotypic approach identifies drugs that are 
relevant to physiological or disease processes, whereas a target-driven approach finds 
compounds that bind to specific targets but are not relevant to the pathogenesis of diseases 
(MacRae et al., 2015; Rennekamp et al., 2015; Williams et al., 2016). Zebrafish as a model has 
several advantages for phenotypic small-molecule screening over other approaches. Firstly, 
the completion of zebrafish genome sequence reveals that 82% of disease-associated human 
genes (2,601) have at least one zebrafish orthologue, implying that zebrafish proteins or 
disease related targets are similar to their human counterparts (Howe et al., 2013). Zebrafish 
possess a similar organ system as humans, which performs the same physiological function.  
Further, a broad range of biological processes can be assayed during screening, such as pain, 
which are not appreciable with cell-based assays (MacRae et al., 2015). In this study, I aimed 
to establish a transgenic zebrafish model to identify and validate compounds against TcdA or 
TcdB, the major toxins of C. difficile.   
 
4.1.1 The N-terminal glucosyltransferase domain of Tcd toxin is selected as the target 
for screening 
The phenotypic screens in zebrafish were carried out either in wild type or transgenic fish with 
diverse phenotypic readout ranging from morphological changes to alterations in behavior 
(Hao et al., 2013; S. Jin et al., 2013; Kokel et al., 2010; Sandoval et al., 2013). From 2000 to 
2015, 51% of chemical screens reported in the literature were performed in wild type 
zebrafish, while 35% in transgenic, and 14% in mutant animals (Rennekamp et al., 2015). 
However, application of mutant or transgenic lines with disease-relevant phenotypes has 
advantages over wild type fish. Rescue of mutant phenotypes or disease symptoms by specific 
compounds gives a hint to reveal relevant molecular pathways or biochemical events related 
to the mutations or diseases.  
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The key step of this study is to select a target that can recapitulate phenotypes of CDI in 
zebrafish. Some successful cases have been reported in the literature (MacRae et al., 2015).  
To identify the inhibitor of hepatocellular carcinoma (HCC),  Evason et al created a transgenic 
zebrafish expressing activated β-catenin under a hepatocyte-specific promoter (fabp10a), 
where 33% zebrafish develop HCC two months post fertilization (Evason et al., 2015). They 
successfully identified two N-terminal kinase (JNK) inhibitors and two antidepressants which 
suppressed HCC development (Evason et al., 2015).  
 
The major virulence factors of C. difficile are TcdA and TcdB. In animal models, TcdA or TcdB 
alone cause all the symptoms of CDI, including intestinal epithelial cell death, neutrophil 
infiltration, and fluid release (Shen, 2012). Both toxins have a classical ABCD domain structure 
(Jank et al., 2007). When the toxins are internalized by a receptor-mediated, the N-terminal 
GTD modifies and inactivates Rho GTPase, which leads to epithelial permeability and luminal 
fluid accumulation (Pruitt et al., 2012). Our primary experiment demonstrated that the GDT 
domain alone was able to induce dramatic HEK293T cell death. One day after transfection, 
HEK293T transfected with plasmid expressing the GDT domain of TcdA or TcdB respectively 
showed cell rounding and plate adhesion loss. When embryos were injected with the plasmid 
GDT in which was under the control of HE enhancer developed with a disrupted structure of 
the hatching gland.  
 
Based on these findings, I selected GTD domain of TcdA and TcdB as the target to screen the 
antagonists of the toxins. HE enhancer would drive the expression of GTD only in hatching 
gland cells. Since there was no C-terminal binding domain, modified toxins were not able to 
intoxicate other cell types and further affect embryogenesis.   
 
Although the GTD domain represents an ideal target, I cannot exclude that the C-terminus of 
TcdA and TcdB, such as combined repetitive oligopeptides (CROPs), is an alternative target for 
screening. Two human monoclonal antibodies, Actoxumab and Bezlotoxumabhave have been 
demonstrated to reduce the rate of CDI recurrence in clinical trials (Z. Yang et al., 2015). These 
two antibodies are designed to target the CROP domain of their respective toxins, actoxumab 
for TcdA and bezlotoxumab for TcdB (Hernandez et al., 2017; Orth et al., 2014).  However, 
TcdB CROP domain might be a good target for cell-based screening in vitro but is not suitable 
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for zebrafish whole-organism screening. Because the C-terminus did not contain any catalytic 
domain. If the C-terminus is selected as target for screening, it would be hard to choose a 
phenotype as readout. Furthermore, only several cell-surface receptors for these toxins have 
been proposed. Glycoprotein 96 (gp96) have been proposed as the receptor for TcdA, while 
three identified receptors CSPG4, FZD, and PVRL3 have been reported as TcdB receptors 
(Orrell et al., 2017). Therefore, using C-terminus as target might cause unexpected toxin-
receptor bindings and affect the embryogenesis.  
 
4.1.2 4xlacO suppress the leaky expression of toxins in NEB turbo competent bacteria 
To avoid the interference of early development, it is common to treat zebrafish with 
compounds after 1dpf (Evason et al., 2015; Hu et al., 2014; Setola et al., 2013). If the 
phenotypic readout is embryogenesis, compounds could be administrated within several 
hours after fertilization (Hao et al., 2013; Sandoval et al., 2013).  
 
Lethal gene expression could be controlled in a conditional manner that allows for the  
generation of a transgenic zebrafish strain (Evason et al., 2015; Gutierrez et al., 2014). Those 
lethal genes induce disease or symptoms either in the present of an inducer or at late 
developmental stages of zebrafish. Gutierrez et al developed a conditionally MYC-induced T-
ALL (acute lymphoblastic leukaemia) zebrafish model, in which 4-hydroxytamoxifen (4HT) 
treatment induces tumour, and withdrawal of 4HT results in tumour regression (Gutierrez et 
al., 2011, 2014). A zebrafish model of ACM (arrhythmogenic cardiomyopathy) expressing a 
mutant human γ-catenin was established, in which transgenic fish developed  the ACM 
pathophysiology within 4 to 6 weeks (Asimaki et al., 2015).  
 
In my study, glucosyltransferase, encoded by the GTD domain of TcdA or TcdB toxin, was 
proved to be toxic. When NTcdA or NTcdB construct was injected into one-cell stage embryos, 
it caused 100% mortality of embryo within 7 hours after microinjection. I firstly hypothesized 
that the DNA was not pure, which led to the 100% mortality of the embryos. Injection of 
purified the NTcdA or NTcdB construct by using other purification methods and endotoxin-
free plasmid kit, the mortality rate remained high. 
Then I assumed that there might be leaky expressed of GTD domain of TcdA or TcdB in bacteria 
used for plasmid preparation. This hypothesis was proved by western blot analysis.  
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Some promoters that have baseline expression in the absence of inducers have been reported. 
The lac promoter was identified by sequence analysis, which might cause the leaky expression 
of toxins. The regulatory components of the lac system include the lac repressor and its DNA-
binding sequence, the lac operator. The combination of NEB turbo competent E. coli and 
4xlacO supressed the leaky toxins expression successfully in bacteria. The NEB turbo strain 
contains the laclq gene encoding for the lacIq repressor, which achieved a tight expression 
control of genes downstream of lacO sites. 4xlacO were placed in front of NTcdA or NTcdB to 
further repress the leaky expression of toxins in E. coli. The application of these two 
approaches improved the overall survival and allowed us to get more healthy fish after 
microinjection. However, I wondered if 4xlacO downregulate the expression of downstream 
genes also in zebrafish. Therefore, a fluorescent gene was inserted behind 4xlacO sites hereby 
replacing the toxin encoding sequence. The fluorescent intensity was measured 24h after 
injection, which showed that the expression level of fluorescent protein was decreased 
compared the control without 4xlacO sites. To overcome this problem, the 4xlacO sites were 
inserted into an Exon-Intron sequence, which restored the expression strength of 
downstream genes of 4xlacO sites in zebrafish. This system could be a useful tool to study 
toxic genes in zebrafish.  
 
However, two questions remained to be answered. The first one is how many copies of lacO 
are appropriate to repress the leaky transcription in E. coli or zebrafish. The plasmids which 
are commonly used contain only one copy of lacO, such as the pET series or the pBluescript 
series, but the lacIq mutation is used to increase the expression of the lac repressor in these 
strains. The lac repressor binds to the lacO leading to a tightening regulation of the lac 
promoter in E. coli.  Besides E. coli, the lac operator-repressor system has also been used for 
gene regulation in mammalian cell culture, mice, and axolotl (Chang et al., 1996; Deans et al., 
2007; Edamatsu et al., 1997; Morton et al., 2014; Whited et al., 2012). Deans et al 
demonstrated that 3xlacO provided a greater repression in mouse and human cells (Deans et 
al., 2007). In transgenic mice, 3 copies of the lacO fully inhibited transgene expression (Morton 
et al., 2014). However, complete repression also requires a higher expression level of the LacI 
repressor in cells or transgenic mice (Cronin et al., 2001; Deans et al., 2007; Morton et al., 
2014). These findings suggested that 3xlacO could render the lac promoter tightly only under 
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high repressor expression conditions. Therefore, a tight regulation could be achieved by the 
application of 3xlacO sties together with the lacIq mutation.  
 
The second question is where to locate lacO(s) in the construct. The lac operon of E. coli 
actually contains three operator genes, but they bind to repressors with different affinities 
(Reznikoff et al., 1974). The primary operator is near the transcription start site, and the two 
auxiliary operators are located 401bp downstream and 93bp upstream of the primary 
operator (Glickman et al., 2002). An optimum distance between operator genes is reported to 
be 92.5bp (Müller et al., 1996). Morton et al reported that 3 copies of the lacO sequence, 
which were inserted at specific distant sites (positions -117, -25 and +67), achieved a full 
repression of a transgene without higher levels of the LacI repressor expression (Cronin et al., 
2001; Morton et al., 2014). Based on these findings, I assumed that a tight regulation could be 
achieved with fewer lacO sites by placing these lacO sites in a specific distance. This 
assumption could be tested by designing a series of vectors which contain different copy 
number of lacO at different distance between each other.  
 
4.1.3 Expression of lacO downstream genes was restored by Exon-Intron system  
In order to suppress the leaky expression of NTcdA and NTcdB in bacteria, lacO sites were 
placed upstream of the toxin genes. However, lacO sites not only suppressed the leaky 
transcription of NTcdA or NTcdB in bacteria, but they also down-regulated the expression of 
downstream genes in zebrafish. I was wondering which mechanisms caused the 
downregulation of downstream genes in these eukaryotic cells.    
 
The lac operon is well known to regulate gene transcription in prokaryote. One of the 
regulatory mechanisms involves the formation of a DNA loop (Cournac et al., 2013; Priest et 
al., 2014). The formation of this DNA loop is essential for lac operon function to regulate gene 
transcription. The DNA loop either represses or activates gene transcription, depending on 
the distance between protein binding sites and the transcriptional start site (Cournac et al., 
2013). The mechanisms of transcriptional repression has been interpreted (Müller et al., 1996; 
Priest et al., 2014). In the repression model, bivalent transcription factors bind to two binding 
sites, e.g. at the lac operators, and create a loop (Cournac et al., 2013). RNA polymerases are 
either trapped in the loop or are not able to recruit general transcription factors to start 
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transcription. It has been reported that tightly constrained DNA loop prevent RNA 
polymerases to access to promoters in vivo (Becker et al., 2014).  
 
DNA loops have also been found to either activate or repress transcription in eukaryotes. The 
components of the transcription factors, such as Polymerase II, track along the chromatin and 
form a loop, which brings enhancer and promoter close to one another to start transcription 
(Zhao et al., 2005).  There are two types of repression models: global repression and gene-
specific repression. In the global repression model, repressors bind to DNA sequences and 
block transcription factors to access to the DNA, resulting in the down-regulation of all genes 
(Gaston et al., 2003; Hanna-Rose et al., 1996). Gene-specific repression occurs when a 
particular gene or a set of genes are down-regulated by gene-specific repressors. Gene specific 
repressors may restrict transcription activators by looping (Gaston et al., 2003). Based on this, 
I postulated that the gene-specific repression might have contributed the downregulation of 
transgene downstream of lacO sites in zebrafish expression vectors when they were injected 
into the embryos of the zebrafish. Some repressors which bind to lacO sequence specifically 
form DNA loop to inhibit transcription in zebrafish.  
 
In order to restore gene expression, lacOs was inserted into the intron2 sequence of rpl9 gene 
flanked by exon2 and exon3 sequence of rpl9, where lacOs would be spliced out during 
translation. Due to the repression occurred in transcription, the restoration relying on 
translation was not satisfying. However, the Exon-Intron system restored a certain amount of 
downregulation of gene expression. In eukaryotes, translation initiation requires the 
recruitment of the small (40S) ribosomal subunit, which binds to mRNA at the 5’ end and scans 
the 5’ untranslated region (5’UTR) to identify the start codon (Araujo et al., 2012; Sonenberg 
et al., 2009). If the structure or sequence of the mRNA impedes the ribosomes when they are 
scanning the 5’UTR, the efficiency of translation initiation would be decreased. Since lacO sites 
were placed in front of the start codon in open reading frames, lacO sites could hamper the 
5’UTR scanning by the ribosomal subunit. Therefore, one explanation could be that removal 
of lacO sites boosted the ribosomal subunit binding 5’UTR, which increased the efficiency of 
translation initiation.  
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4.1.4 The apoptosis sensor secA5-YFP in zebrafish intoxication model  
Both C. difficile toxins TcdA and TcdB induce apoptosis (Brito et al., 2002; Gerhard et al., 2008; 
Mahida et al., 1998; Matarrese et al., 2007; Na et al., 2008; Qa’Dan et al., 2002). In order to 
monitor the morphological changes of apoptotic cells, an apoptosis sensor, secA5-YFP, was 
co-expressed with the toxins under the control of the HE enhancer which drives expression 
specifically in cells of zebrafish hatching gland (van Ham et al., 2010). It provides an insight 
into apoptotic signaling pathways that are induced by toxins within this reporter zebrafish 
strain. 
 
However, some studies also proposed that C. difficile toxins induce necrosis (Chumbler et al., 
2016; LaFrance et al., 2015; Olson et al., 2013; C Pothoulakis, 2000; Warny et al., 2000). CDI is 
characterized by intestinal epithelial cell death, colonic inflammation, and neutrophil and 
macrophage infiltration. Concerning this pathogenesis, necrosis should occur. Cytoplasmic 
contents, which induce local inflammation, is released by necrosis but not by apoptosis (C 
Pothoulakis, 2000).  
 
It has been reported that the intestinal epithelial cell death is induced by both apoptosis and 
necrosis after intrarectal instillation of toxins into the mouse colon (Hirota et al., 2012).  
Although some studies proved that TcdA and TcdB only induce apoptosis in HT-29 cells, Olson 
et al demosntrated that TcdA also induces necrosis in this cell line. (Olson et al., 2013). In THP-
1 monocytic cells, TcdA induces cell necrosis by activating of p38 MAP kinase (Warny et al., 
2000). TcdB also induces necrosis. Farrow et al showed that TcdB induces necrosis in both 
human colonic cell lines and porcine colonic explants (Farrow et al., 2013). At higher 
concentrations, TcdB is able to induce glucosyltransferase-independent necrotic death in 
mouse colonic epithelial cells (Chumbler et al., 2016).  
 
Collectively, C. difficile toxins induce both apoptosis and necrosis in some tissue culture 
models. However, the necrosis induced by TcdA or TcdB depends on the cell type, and even 
the concentration of toxins.  
In the zebraifsh model, TcdB was found to be toxic to cardiovascular cells(Hamm et al., 2006). 
This organ-specific damage was reduced by Caspase-3 inhibitors, which indicates that TcdB 
induces apoptosis in the cardiovascular system of zebrafish (Hamm et al., 2006). In addition, 
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inactivation  of Rho proteins, the main targets of TcdA and TcdB, is known to induces apoptosis 
(Hippenstiel et al., 2002). Moreover, other data from clinical cases and mouse models also 
indicated that apoptosis occurs during CDI (Aktories et al., 2017). Unlike in cell or tissue culture 
models, only apoptosis is observed and reported in living model organisms. Therefore, 
hatching gland cells likely undergo apoptosis upon toxins expression, but currently we cannot 
exclude that these toxins might induce necrosis.  
 
4.1.5 Both TcdA and TcdB caused cardiovascular damage 
Zebrafish have been a promising model to assess an organ specific toxicity of compounds, such 
as cardiotoxicity and neurotoxicity (MacRae et al., 2015). Using 24hpf zebrafish, Hamm et al 
found that recombinant TcdB has cardiotoxicity (Hamm et al., 2006). Zebrafish treated with 
37nM TcdB exhibited cardiovascular damage and extensive pericardial edema (Hamm et al., 
2006). I replicated their findings by treating 72hpf zebrafish with lower TcdB concentrations 
(20nM), which is might due to 72hpf zebrafish are more sensitivity to TcdB. Interestingly, TcdA 
also induced similar phenotypes as TcdB, such as, cardiovascular defects and pericardial 
edema. A decrease in heart rate was also observed in TcdA-treated fish. This indicated that 
TcdA also impaired cardiovascular function via its cardiotoxic properties. 
 
Both TcdA D285/287N and TcdB D286/288N, which were deficient in glucosyltransferase 
activity, did not cause detectable damage to zebrafish larvae. This result indicated that the 
cytopathic and cytotoxic effects of TcdA and TcdB rely on the functional glucosyltransferase 
activity.  
 
Moreover, TcdB possesses 100-fold higher glucosyltransferase activity than TcdA in some cell 
lines (Aktories, 1997; Chaves-Olarte et al., 1997). However, I found that by using the same 
concentration, TcdA leads to a much higher mortality than TcdB to zebrafish. Notably, TcdB 
has 1,000-fold more cytotoxic potency than TcdA on Don cells, but TcdA turns out to have 10-
fold more cytotoxic effects than TcdB on T84 cells (Chaves-Olarte et al., 1997). TcdA is more 
cytotoxic to T84 cells due to the following reasons: Firstly, TcdA possesses higher affinity to 
T84 cells than TcdB. Secondly, TcdA targets more enzymatic substrates than TcdB does, such 
as, Rap1A and Rap2A. (Chaves-Olarte et al., 1997). The crystal structure coupled with 
biochemical data showed TcdA and TcdB shares the similar core structure of the GTD domain. 
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But the GTPase binding surfaces are highly diverse, which is likely responsible for differential 
substrate recognition (Di Bella et al., 2016). Based on these studies, I presented two 
hypotheses that might explain why TcdA showed higher cytotoxic activity than TcdB in 72hpf 
zebrafish larvae: The first one is that TcdA recognizes more membrane receptors than TcdB 
does in zebrafish larvae, which promotes more cellular intoxication. TcdA inactivates more 
Ras family members than TcdB does in zebrafish as well. The second one is that TcdA and TcdB 
might perform differently at 28 ℃ and 37℃.	 The structure of TcdA might possess high 
cytotoxic activity at 28 ℃.	 
 
4.1.6 TUDCA mediates inhibition of TcdB 
Antibiotic treatment with metronidazole and vancomycin is still the common therapy for CDI. 
However, antibiotic treatment presents very high recurrence rate (Cornely et al., 2012; Leong 
et al., 2013). Antibiotic treatment further disrupts the gut microbiota composition, resulting 
in the loss of colonization resistance (Theriot et al., 2014). Although the exact mechanism of 
colonization resistance against C. difficile is still unknown, it was proposed that antibiotic-
treatment alter the metabolome of the gut, particularly the composition of secondary bile 
acids, which sensitizes mice to C. difficile (Antunes et al., 2011; Theriot et al., 2014). Some 
studies showed that the restoration of secondary bile acids restored the colonization 
resistance against C. difficile (Buffie et al., 2014; Weingarden et al., 2014). Deoxycholate (DCA), 
a metabolite of cholate produced by the gut microbiota, impairs the growth of vegetative C. 
difficile (Sorg et al., 2008). Taurocholate was reported to inhibit the enzymatic activity of TcdA 
and TcdB in vitro (Darkoh et al., 2011). These findings indicate that secondary bile acids have 
therapeutic potential to treat CDI.  
 
TUDCA, a secondary bile acid, inhibits TcdB-induced cytotoxicity in cell culture (Brandes et al., 
2012). TUDCA inhibits TcdB-catalysed glucosylation and cytopathic effects in human 
hepatocarcinoma (HepG2) cells by increasing pS71-Rac1/Cdc42 phosphorylation levels 
(Brandes et al., 2012). I found that the application of TUDCA decreased the mortality rate of 
embryos injected with NTcdB expression construct. Additionally, survived embryos showed 
less malformed appearing after TUDCA treatment. In contrast, TCA and TCDCA did not show 
similar protective effects in zebrafish embryos. The therapy of CDI has been hampered by 
increased resistance of C. difficile to multiple antibiotics and by lack of medicine to restore 
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intestinal microbiota. To develop a non-antibiotic treatment is therefore a new approach. My 
study suggested that TUDCA could be a non-antibiotic agent for the treatment of CDI.  
 
4.1.7 TcdB binds to the Wnt receptor Frizzled family (FZDs) 
FZD proteins are TcdB receptors, which play important roles in the cellular uptake of TcdB. 
FZD receptors are critical for Wnt signal transduction (MacDonald et al., 2009). Wnt/Frizzled 
signaling pathways involve the activation of Rho and Rac proteins (Habas et al., 2003). TcdB 
binds to the conserved Wnt-binding site of FZD1, 2, and 7 (Tao et al., 2016). Interestingly, 
Wnt/Frizzled signaling is also important for the maintenance of colonic stem cells, which are 
essential for self-renewal and repair of the colonic epithelial cells (Tao et al., 2016; van der 
Flier et al., 2009). In CDI, the colonic epithelial cells are the first target of C. difficile toxins. This 
finding indicated that the Wnt signaling pathway could be involved in TcdB pathogenesis (Tao 
et al., 2016).  
 
However, there was not much information available on the expression of fzd genes in the gut 
of zebrafish, especially in fish older than 5dpf. Sisson et al showed that  fzd7b is expressed in 
the mesenchymal tissue surrounding the gut, while fzd8a expression is detected in the gut at 
55hpf (Sisson et al., 2009). To determine the gene expression level of several fzd homologs in 
the gastrointestinal tract of zebrafish, whole-mount in situ hybridization was performed with 
probes detecting fzd1, fzd2, fzd7a, and fzd7b in 5dpf and 8dpf larval zebrafish. However, no 
clear signal of expression was detected in the intestine of zebrafish in compared to the strong 
signal for intestinal marker gene, ifabp gene.  
 
Hybridization efficiency is mainly determined by probe accessibility and permeable cell 
membrane and the affinity to the complementary mRNA sequence. The accessibility is 
regarded as the ability of probes to access the mRNA target sites (Yilmaz et al., 2004). Since 
all embryos were treated with the same permeabilization procedure, permeability was 
supposed to be constant. As positive control, RNA probe of ifabp revealed a strong signal in 
the gastrointestinal tract of zebrafish, which suggested that cell permeability did not affect 
the accessibility of fzd RNA probes. Affinity is defined as RNA-RNA interaction that take place 
in situ (Yilmaz et al., 2004). The RNA probes with high binding-affinity enhance the specificity 
and sensitivity. fzd RNA probes were compared with their corresponding probes that have 
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already been published. The sequences of our four probes were almost the same with 
published corresponding probes (H.-C. Huang et al., 2004; Nikaido et al., 2013). Therefore, the 
only explanation is that fzd genes are expressed at low level in the intestine of zebrafish or ate 
not expressed at all the intestinal cells. To overcome this problem, the intestines of zebrafish 
could be isolated for either in situ hybridization or RT-PCR.  
 
There are 10 Fzd genes in mouse and 14 fzd genes in zebrafish (Dong et al., 2015). To 
investigate phylogenetic relationships of Fzd genes in teleost and higher organisms,  Dong et 
al collected 116 Fzd genes to construct two phylogenetic trees based on either alignments of 
the amino acid sequences or topology (Dong et al., 2015). In these two phylogenetic trees, 
mouse Frizzled genes are not closely related to zebrafish orthologous genes (Dong et al., 2015). 
For instance, one Fzd8 is discovered in mouse, but two fzd8 gene are presented in zebrafish: 
fzd8a and fzd8b (Dong et al., 2015).  It would be intriguing to examine the expression of other 
Frizzled receptors or other receptor of Wnt signaling in the intestine of zebrafish.  
 
Notably, the Wnt signal pathway is activate in the development of the zebrafish intestine, 
which is essential for the organogenesis and homeostasis of the intestinal epithelium 
(Cheesman et al., 2011; Faro et al., 2009). Like in mouse, Wnt signalling maintaines the 
intestinal stem cells and controls proliferation of the intestinal epithelium in zebrafish 
(Crosnier et al., 2006). Intestinal stem cells are found in the intervillus pockets of zebrafish, 
know as crypts in mammalian (Brugman, 2016; Schall et al., 2015). Current technique allow us 
to directly visualize the intestinal stem cells by fluorescent protein labelling in zebrafish 
(Aghaallaei et al., 2016). Moreover, Whitaker et al developed a tunable expression strategy 
that enables strain-level distinction of gut bacterial cell by unique fluorescent-protein-
expression in mouse (Whitaker et al., 2017). They found that colonization of indigenous 
bacterial in crypts prevents pathogens from invading (Whitaker et al., 2017).  Combining of 
these techniques, zebrafish would be a great model to study the relationship among Wnt 
signaling pathway, intestinal stem cells, and the crypts in CDI.  
 
Interestingly, TcdB was found to specifically localize at the pericardial region of zebrafish after 
24 h of TcdB treatment (Hamm et al., 2006). This finding suggested that either FZD receptors 
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have a high expression in the heart of zebrafish, or some proteins expressed in the heart of 
zebrafish are TcdB receptor.  
 
4.2 Analysis of innate immune cell behaviour upon C. difficile infection 
Given that the function of the intestine and immune systems are highly conserved between 
zebrafish and mammals, zebrafish is a suitable model to investigate intestinal inflammation 
(Y. Yang, 2014). In a mouse model for CDI, the infiltration of neutrophils, macrophages, and 
the release of cytokines and chemokines are observed (Ciaran P. Kelly et al., 1994; Sadighi 
Akha et al., 2013). The transparency of larvae make zebrafish an exceptionally useful model 
to study innate immune response for infection diseases (Van Der Sar et al., 2004). Several 
stable transgenic lymphocyte reporter lines are available (Ellett et al., 2011). In the second 
part of my PhD project, I aimed to study the behaviour of macrophages and neutrophils during 
C. difficile infection in the intestine of zebrafish.  
 
As mammals, zebrafish have two waves of hematopoiesis: the primitive wave and the 
definitive wave, which give rise to different immune cells (Jagannathan-Bogdan et al., 2013). 
In addition, the development of different transgenic reporter zebrafish strains for different 
innate immune cells enables live imaging of the interaction between the innate cells and 
pathogens. Furthermore, innate immune cells are present the intestine of zebrafish. 
Macrophages and neutrophils are observed in the lamina propria beneath the intestinal 
epithelium (Hanyang et al., 2017).  
 
The neutrophil stable transgenic strain Neu-ATTACTM and the macrophage transgenic strain 
Mac-ATTACTM were established. lyz, encoding zebrafish lysozyme C (lysC), is a reliable and 
specific marker for neutrophils from 48hpf on, and mpeg1 is a specific marker gene for 
macrophages (Ellett et al., 2011; C. T. Yang et al., 2012). The lyz promoter was used to drive 
the expression of mCitrine in neutrophils, while mpeg1 was used to drive macrophage specific 
expression of FyntagRFP-T. In order to visualize and manipulate those cells, our initial idea was 
to use a 2A self-cleaving multi-gene expression system to co-express a fluorescent protein and 
Caspase8ERT2 in neutrophil or macrophage (J. H. Kim et al., 2011). Unfortunately, fluorescence 
was not detectable in neutrophils or macrophages in transient assays. Therefore, we chosen 
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two binary expression systems the Gal4/UAS and the LexA/lexAop system: the Gal4/UAS for 
the Neu-ATTACTM line and the LexA/lexAop for the Mac-ATTACTM line.  
 
To investigate the role of neutrophils or macrophages in the defence of C. difficile, we ablated 
one of them to reveal their function. NTR-MTZ ablation technology has been used in zebrafish 
to successfully ablated specific cell types with the help of metronidazole-induced  apoptosis 
(Curado et al., 2007; Petrie et al., 2014). However, NTR-MTZ cannot be used in this study due 
to metronidazole is an effective antibiotic for CDI (Petrie et al., 2014; Pisharath et al., 2007). 
More recently, our group developed the ATTACTM technique,  a 4OHT-induced genetic ablation 
technology (Weber et al., 2016). ATTACTM technique was used in this study. 
 
4.2.1 The morphological changes of macrophages after phagocytosis of C. difficile 
C. difficile is strictly anaerobic. Therefore, fluorescent proteins are unable to fluoresce in 
anaerobic environment due to chromophore maturation of protein requiring oxygen. To 
overcome this problem, I used a fluorescent labeling reagent, BacLight, to stain living C. 
difficile. 
 
Fluorescent C. difficile were injected into the zebrafish intestine to mimic intestinal infection. 
Both macrophages and neutrophils rapidly accumulated at the site of infection and started to 
phagocytose C. difficile. Consistent with previous studies in mammalian models that both 
macrophages and neutrophils were recruited upon C. difficile infection, zebrafish innate 
immune cells recognized this pathogen as well.  
 
Although macrophages were able to ingest C. difficile, they exhibited a change in morphology 
and behavior when C. difficile were digested. They used to be large cells with extensive 
pseudopodia. However, macrophages with degradation of internalized pathogens, turned to 
be round and immobile. This finding suggested that the phagocytic degradation of C. difficile 
is cytotoxic to macrophages.  
 
Mycobacterium tuberculosis (Mtb) has been well-studied as an intercellular pathogen 
inducing macrophages death. Mtb is internalized through phagocytosis by macrophages, 
which leads to aggregation of Mtb in macrophages. Macrophage, displayed Mtb aggregation, 
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are likely dead (Pieters, 2008). Mtb-mediated macrophage death occurs by apoptotic and non-
apoptotic mechanisms (Mahamed et al., 2017). More importantly, Mtb cells use macrophages 
for their replication, where Mtb remains viable in dead macrophages (Pieters, 2008).  
 
Previous studies have shown that human monocytes/macrophages are more sensitive to 
TcdA-induced apoptosis than lymphocytes in vitro (Solomon et al., 2005; Mahida et al., 1998). 
After intrarectal instillation of TcdA and TcdB,  both toxins penetrate the epithelial barrier and 
kill immune cells, and notably most of them are macrophages (Hirota et al., 2012). However, 
the reason remains to be determined.  
 
Neutrophil infiltration of the intestinal epithelium is one of the most important pathologic 
feature in CDI (Madan et al., 2012). Then influx neutrophils lead tissue damage and the 
phagocytosis of infecting C. difficile in the intestine as well. Our finding might explain that 
macrophages are not suitable immune cells to clean C. difficile because of their sensitivity to 
this pathogen.  
 
4.2.2 The application of bi-directional LexA/lexAop for Mac-ATTACTM  
Because the Gal4/UAS system has been used for the neutrophil transgenic strain, another 
binary expression system was needed for generating Mac-ATTACTM strain. The LexA/lexAop 
system was chosen to generate the Mac-ATTACTM strain. 
 
There are two advantages of the LexA/lexAop system: Firstly, the LexA/lexAop system can be 
used independently or in combination with the Gal4/UAS system; secondly, lexAop sequence 
do not contain CpG dinucleotide sites, the target of DNA methyltransferases. Because of CpG 
dinucleotides in UAS, many researchers have observed progressive transcriptional silencing in 
Gal4/UAS transgenic zebrafish due to cytosine methylation in CpG dinucleotides (Akitake et 
al., 2011; Goll et al., 2009). Lack of CpG dinucleotides should not be transcriptional silencing 
by DNA methylation when using the LexA/lexAop system.  
 
A bi-directional LexA/lexAop system was established. The system contained two parts: a 
chimeric transcription factor and lexAop cis-regulatory sites. The transcription factor was a 
fusion of the DNA binding domain of LexA protein but lacking dimerization domain (residue 1-
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87) and the transcriptional activation domain of the human p65 protein (p65 AD, residues 
283–551). The operator-promoter sequence was constructed by fusing eight copies of ColE1-
lexAop sequences to E1b minimal promoters in a bi-directional manner on both sides of the 
four copies of lexAop sequence. Although our LexA/lexAop system was applied in the Mac-
ATTACTM stain successfully, still few questions need to be clarified.  
 
The first question was how LexA proteins start the transcription without a dimerization 
domain. The LexA protein, used in this study, did not contain a dimerization motif, but LexA 
protein naturally binds as dimer to the operators of SOS genes to inhibit the expression of SOS 
genes in E. coli. Previous studies suggested that free LexA proteins form a dimer 
predominantly rather than a monomer, which represses transcription more efficiently 
(Dmitrova et al., 1998; Mohana-Borges et al., 2000). The LexA dimers dissociate into 
monomers only when LexA loses its ability to bind specific DNA sequences (Mohana-Borges 
et al., 2000). Thliveris et al proposed two possible mechanisms for LexA-DNA binding, in which 
LexA monomers first form a dimer and then bind to recA (a gene in SOS system) operators, or 
LexA monomers bind to recA operators sequentially and then dimerize on DNA (Thliveris et 
al., 1991). The LexA protein in our LexA/lexAop system, referred to LexA-DBD, only contained 
the DNA binding domain. Nevertheless, a high expression level of either fluorescent protein 
or Caspase8ERT2 was found in Mac-ATTACTM zebrafish, indicating that LexA-DBD alone bind to 
lexAop and start transcription.  
 
One possible explanation is that the binding between a LexA monomer and lexAop sequence 
could provide sufficient affinity to activate transcription. LexA-DNA binding has been 
investigated in E. coli, in which two LexA monomers bind operators sequentially and 
cooperatively  (B. Kim et al., 1992). The first LexA monomer binds to a half-recA operator site 
with low affinity, but the second monomer binds to the operator with 100-fold more affinity 
than the first one (B. Kim et al., 1992). The first bound monomer increases the affinity between 
the second monomer and recA operator. This finding suggested that the LexA monomer could 
bind lexAop with low affinity but subsequent binding of other monomers is strong enough to 
start the transcription of genes (Dahlman-Wright et al., 1991). In addition, eight copies of 
lexAop sequences were used in our LexA/lexAop system, which might provide additional 
binding sites for LexA monomers. 
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The second possible explanation is that the p65 AD (residues 283–551) itself could induce the 
dimerization of the LexA-p65 proteins and then initiate transcriptional activation. p65, 
encoded by the RELA gene, is one component of the NK-κb transcription factor family. The 
p65 protein contains 551 amino acids, which is composed of an N-terminal DNA binding region, 
referred as REL homology region (RHR), and C-terminal transcriptional activation domain (TAD) 
(Y. Q. Chen et al., 2000). The TAD is divided into two different domains, TA1 (residues 521–
551) and TA2 (residues 428–521), both of which are necessary for the transcriptional 
activation initiated by p65 (O ’shea et al., 2008). It has been shown that the NF-κB transcription 
factor binds to DNA as a p50/p65 heterodimer (Schmitz et al., 1991). But the p50 and p65 can 
also form homodimers as p50/p50 or p65/p65 (Y. Q. Chen et al., 2000; Phelps et al., 2000). 
 
Protein dimerization is frequently mediated by leucine zipper, helix-loop-helix (HLH) motif and 
ankyrin motifs. Schmitz et al fused the DNA binding domain of Gal4 to different truncations of 
the transcription activation domain of p65, and found a stronger transcriptional activity of 
Gal4 –p65468-550  (which include TA1 domain and a part of TA2 domain)or Gal4 –p65520-550   
(which include TA1 domain) compared to full length of Gal4-p651-550 in COS cells and mouse 
fibroblasts (Schmitz et al., 1991). They further identified that a clustering of serine residues in 
the amphipathic helix of TA1 could form a leucine zipper structure,  which might serve to 
mediate a protein-protein interaction (Schmitz et al., 1991; William et al., 1988). 
 
The p65 AD, used in this study, include TA1 domain and TA2 domain (O ’shea et al., 2008). This 
might be the same reason that p65 AD induced the dimerization of the LexA-p65 protein. This 
dimer increased the transcription activity of LexA-65. This can also explain why KalTA4-p65 AD 
induced a much stronger transcription of transgenes than KalTA4-TA4 and KalTA4-TA3 in my 
results. However, more evidence needs to be obtained to support that the p65 AD domain 
indeed mediate protein-protein interaction. 
 
The second question that needed to be discussed is why lexAop sequences have a strong 
directional preference in actual transcription. 
 
The promoter-operator sequence used here consists of eight copies of lexAop fused to E1b 
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minimal promoters in a back-to-back configuration. I found that lexAop showed an 
orientation-dependent activation. It has been investigated that this feature involves the 
recognition between the lexA DNA binding amino-terminal domain (NTD) and the lexAop 
sequences (Butala et al., 2009; Dumoulin et al., 1993). For a stable and specific operator 
binding, the recognition helix of the LexA protein should reorient NTD into the major groove 
of operator DNA (Chattopadhyaya et al., 2004; Dumoulin et al., 1993). The LexA recognition 
helix exhibits a specific direction within the major groove. It is the same reason why the first 
bound LexA monomer binds to DNA with low affinity but promotes the formation of a major 
groove of the operator DNA, which enhances the affinity between the second LexA monomer 
and the operator. These findings suggest that the lexAop is an orientation-dependent 
transcriptional activator. Because of this, only back-to-back configuration of lexAop sequences 
could start the transcription of both transgenes locating the operators in opposite direction.  
 
It is known that the LexA protein has different affinities to lexAop motifs derived from 
different species (Pfeiffer et al., 2010). Although the LexA protein has the highest affinity to 
the ColE1-derived lexAop motif (the same motif used in this study), this ColE1-derived lexAop 
showed a leaky expression in the absence of LexA protein in Drosophila (Ebina et al., 1983; 
Pfeiffer et al., 2010). Even this result might not be consistent between species, it is important 
to address a possible leaky expression from the ColE1-lexAop in zebrafish. Also, it would be 
interesting to test other LexA-binding motifs, such as sluA-lexAop, in zebrafish. sluA-lexAop is 
found to give strong transgene expression with minimal leaky expression. This operator might 
be more suitable for transgenic expression in zebrafish.  
 
 4.2.3 4OHT cannot induce neutrophil apoptotic death in Neu-ATTACTM larvae 
The neutrophil specific zebrafish, Neu-ATTACTM strain, expressing Citrine and Caspase8ERT2 
was established. However, fluorescent signal did not decrease or disappear after 4OHT 
treatment. Immunostaining analysis against activated Caspase3 did not show any signal, 
suggesting that 4OHT treatment did not trigger apoptosis in neutrophils. To validate whether 
Caspase8ERT2 still functioned, the carrier of Neu-ATTACTM are crossed with carrier of the 
Tg(krox20: KalTA4) or Tg(krox20: KalTA4) transgenic line expressing KalTA4 in rhombomere 3 
and 5 or the skeletal muscle cells respectively. Then double transgenic larvae were incubated 
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with 4OHT. After 6 hours of treatment, I observed cell apoptosis in rhombomere and muscle 
tissue, indicating that Caspase8ERT2 was still functional.  
 
Neutrophils die via apoptosis under healthy conditions. The most leukocytes in the peripheral 
blood—circulating neutrophils undergo apoptotic cell death, which maintains a homeostatic 
cell number (B Geering et al., 2011). It is agreed upon that tissue-resident macrophages, 
including Kupffer cells, and bone marrow stromal macrophages, clean the apoptotic 
neutrophils (Furze et al., 2008; Summers et al., 2010).  
 
Neutrophil apoptosis is also the central part of inflammation resolution (Fox et al., 2010). 
Phagocytosis of pathogens accelerates neutrophil apoptosis at the inflammation sites, which 
ultimately promotes the resolution of infection (Savill et al., 1989). Apoptotic neutrophils are 
recognized and removed by macrophages (Carl Nathan et al., 2010). Neutrophil apoptosis 
guaranties the safe disposal of engulfed bacterial, which is beneficial for the host (Deleo, 2004). 
Defective apoptosis and failure of removal of apoptotic neutrophils is associated with many 
inflammatory diseases, such as acute respiratory distress syndrome and inflammatory bowel 
disease (Summers et al., 2010). 
 
Neutrophils undergo either intrinsic or extrinsic apoptosis (B Geering et al., 2011; Leitch et al., 
2008). The extrinsic pathway is activated by the interaction between death receptors and 
ligands, such as, TNF-α, Fas ligand, or TRAIL (Renshaw et al., 2003). The intrinsic pathway 
occurs when neutrophils experience genotoxic stress or ultraviolet irradiation (Leitch et al., 
2008). This pathway is triggered by cytochrome C and proapoptotic factors,  which are 
released by disruption of the outer mitochondrial membrane (McCracken et al., 2014). The 
intrinsic apoptosis is believed to be responsible for the lifespan of neutrophil (Fox et al., 2010). 
 
Both apoptotic pathways  are dependent on the activation of caspase proteins (McCracken et 
al., 2014). The binding between death receptors and ligands leads to the formation of death-
inducing signaling complex (DISC) (Leitch et al., 2008). DISC activates the upstream initiator 
caspases and cleave the downstream effector Caspase-3, which eventually starts the final 
steps of apoptosis (Leitch et al., 2008). Caspase-8 and Caspase-9 are the caspases for the 
extrinsic and intrinsic apoptosis pathways respectively (McCracken et al., 2014).  
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Neutrophils have few mitochondria which hardly participate in ATP synthesis, but 
mitochondrial cytochrome C and other mitochondrial proteins, such as Smac/DIABLO and 
HtrA2/Omi, are essential for the activation of caspases (McCracken et al., 2014; Murphy et al., 
2003). Although it is clear that the intrinsic and extrinsic pathways are trigger by distinct but 
different death factors, these two pathways are joined by the BH3-interacting domain death 
agonist (Bid) (McCracken et al., 2014). Bid is truncated by Caspase-8 and then translocate to 
mitochondria, where it assists oligomerization of Bax and Bak (B Geering et al., 2011; 
Korsmeyer et al., 2000).  Bax and Bak disrupt the outer mitochondrial membrane and then 
induce cytochrome c efflux, which triggers the intrinsic apoptosis pathway (Korsmeyer et al., 
2000). 
 
In addition, Daigle et al reported that Caspase 8 is critical in the regulation of neutrophil 
apoptosis in vitro (Daigle et al., 2001). For example, inactivation of Caspase-8 delays 
neutrophil apoptosis (Daigle et al., 2001). Caspase-9 activation was also detected. Caspae-9  
inhibitors decrease neutrophil apoptosis (Daigle et al., 2001). Collectively, caspase proteins, 
especially Caspase 8, represent ideal candidate to trigger apoptosis in neutrophils. However, 
my study suggested that an unknown mechanism could inactivate the Caspase 8 pathway to 
protect neutrophils.  
 
Some pro-inflammatory factors prolong neutrophil lifespan by suppressing apoptosis,  such as 
granulocyte/macrophage colony-stimulating factor (GM-CSF) (Maianski et al., 2004; 
McCracken et al., 2014). GM-CSF is secreted by a variety of cell types, including 
monocytes/macrophages, T and B cells, and neutrophils (Hamilton, 2002; Shiomi et al., 2015). 
GM-CSF is a major hematopoietic growth factor to regulate proliferation and differentiation 
of granulocyte and macrophages from their precursor cells (Shiomi et al., 2015).  
 
An early work suggest that GM-CSF induces tyrosine phosphorylation of several intracellular 
proteins in neutrophils (Yousefi et al., 1994). In a subsequent study, the lck/yes-related novel 
(Lyn) protein is identified as one of the important tyrosine kinases that provides a survival 
signal and prevents apoptosis (Wei et al., 1996). Activation of tyrosine kinase upon GM-CSF 
simulation results in Jak2 phosphorylation and activation of several STAT proteins, which 
   Discussion 
 139 
increases Mcl-1 and XIAP protein stability to enhance neutrophil survival (Al-shami et al., 1998; 
Brizzi et al., 1996; Derouet et al., 2004). Interestingly, Mcl-1 is essential for neutrophil viability 
and survival, but not for macrophage (Dzhagalov et al., 2012; Milot et al., 2011).  
 
Besides of the STAT pathway, the mitogen-activated protein kinase (MAPK) pathway is also 
implicated in  prohibiting neutrophil from apoptosis (Alvarado-Kristensson et al., 2001). GM-
CSF induces the activity of p38 MAPK (Alvarado-Kristensson et al., 2001). Then p38 MAPK 
phosphorylates and subsequently inhibits the activity of Caspase-8 and Caspase-3, which 
protects neutrophil from apoptosis (Alvarado-Kristensson et al., 2001, 2004). However, 
phosphorylation of p38 was also detected in TNF-α-induced apoptosis, which generates 
reactive oxygen species (ROS) and subsequently activates Caspase-3 (Barbara Geering et al., 
2012). TNF-α also shows anti-apoptotic potential and prolong neutrophils lifespan (Keel et al., 
1997). Therefore, the role of p38 MAPK and TNF-α are unclear in the regulation of neutrophil.  
 
A possible interpretation of neutrophil survival upon 4OHT treatment is that GM-CSF prevents 
neutrophil death. Since macrophages secret GM-CSF, I would like to confirm whether the 
elimination of macrophages affects the survival of neutrophils. To this end, the Mac-ATTACTM 
line was crossed with Neu-ATTACTM line and the double transgenic larvae, expressing 
Caspase8ERT2 in macrophages and neutrophils, were selected for 4OHT treatment. However, 
neutrophils survived even when macrophages were eliminated. Therefore, macrophages 
were excluded as possible GM-CSF producer. Since there are various GM-CSF cellular sources, 
it is hard to determine which cell type is the main source. Besides GM-CSF, several other 
survival factors, such as fMLP, hrC5a, and ATP, have been shown inhibit neutrophil apoptosis 
in vitro (Gasmi et al., 1996;  a Lee et al., 1993).  
 
Another possible explanation is that zebrafish neonatal neutrophils are resistant to apoptosis. 
Human neonatal neutrophils, which are isolated from newborn infants, showed a lower 
expression level of Caspase-3 protein than adult neutrophil (Song et al., 2011). Several studied 
showed that the level of Fas-induced chemotaxis and FasR, which engage with death receptors, 
are low in neonatal neutrophils (Allgaier et al., 1998; Hanna et al., 2005). Neutrophils originate 
from the primitive and definitive waves of hematopoiesis in zebrafish (Bennett et al., 2001). 
In the primitive wave, myeloid precursors arise from mesoderm and differentiate in the yolk 
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sac at around 22hpf, which are called ‘primitive macrophages’ (Bennett et al., 2001). A subset 
of the primitive macrophages differentiate into neutrophils by 48hpf (Bennett et al., 2001). 
The definitive hematopoiesis starts at 24hpf in the CHT with the multipotent hematopoietic 
stem and progenitor cells (HSPC) (Bertrand et al., 2007). A group of hematopoietic progenitors 
colonize in the CHT by 48hpf, where they give rise to neutrophils (H. Jin et al., 2009; Murayama 
et al., 2006). Neutrophils reporter larvae that were used in this study are between 2dfp to 
6dfp of stage, where neutrophils are still neonatal. It is possible that zebrafish neonatal 
neutrophils share the same feature with human neonatal neutrophils, which are resistant to 
apoptosis. 
 
One unique feature of neutrophils is their short lifespan. The reason and mechanism for the  
short lifespan is unclear, but as Amulic hypothesized, it may ensure the integrity of neutrophils 
(Amulic et al., 2012). The short life might also guarantee that neutrophils are either robustly 
alive or die by apoptosis.  
 
4.2.4 The interaction between macrophages and neutrophils  
Neutrophils and healthy macrophages cooperate to clear apoptotic macrophages. As 
neutrophils and macrophages are the main partners in the phagocytic system, I would like to 
find out whether and how neutrophils participate in the phagocytosis of dying macrophages. 
The confocal microscopy analysis revealed that a direct contact between neutrophils and 
macrophages took place at the early stage of macrophage apoptosis. I was wondering what 
the function of this contact is.  
 
There are in vitro evidences in support of the interaction between neutrophils and 
macrophage. Magnarin et al reported that human neutrophils specifically adhere to human 
macrophages in vitro (Magnarin et al., 2000). Their interaction increases the release of 
inflammation factors by the both cell types (Magnarin et al., 2000). It was showed that the 
interaction between neutrophils and macrophages covert the mechanism of muscle cell killing 
by both cell types (Nguyen et al., 2003).  
 
There are reporters about neutrophils and macrophages directly interact in vivo (Ellett et al., 
2011; Tobin et al., 2010; Vincent et al., 2017). Ellett et al reported that macrophages directly 
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and dynamically contact with neutrophils after wounding (Ellett et al., 2011). Interestingly, a 
direct cytoplasmic transfer from a donor neutrophil to a macrophage is observed during their 
interaction (Ellett et al., 2011). When the ventral tailfin is wounded, neutrophils frequently 
contact macrophages and induce resolution of inflammation (Tauzin et al., 2014). The 
molecular mechanism and biological function about neutrophil-macrophage interactions 
remain unclear, but their behaviors implied that communication occurred through their 
contact. 
 
The communication between immune cells is crucial for immune cell survival, migration, and 
coordination of inflammatory responses (McCoy-Simandle et al., 2016). Cell-cell 
communication could be classified into cytokine-based communication and contact-based 
communication. Cytokines, such as cytokines and chemokines, are secreted by immune or 
non-immune cells, and then spread and bind to target cells. Cytokine-based approach 
contribute to the global communication between immune cells (Rivera et al., 2016).  
 
Cell-cell communication takes place via direct cells contact as well. Tunneling nanotubes 
(TNTs), a contact-depend communication, have been investigated (Gerdes et al., 2013). TNTs 
are a thin membranous tubes that typically range between 50-200nm in diameter and are up 
to several cell diameters long (Önfelt et al., 2006). Multiple cells could be connected by TNTs, 
which facilitates the intercellular exchange of cellular components, such as mitochondria and 
intracellular vesicles (McCoy-Simandle et al., 2016). TNTs are seen in variant cell types, such 
as NK cells, macrophages, and B cells (Onfelt et al., 2004). 
 
The cytokine-based communication and TNTs are usually found for long-range interaction, but 
the contact between macrophage and neutrophil is a short-range interaction. 
Immunological synapse (IS) is a well-studied example for short-range interaction. The IS is cell-
cell junction between an antigen presenting cell (APC) and a T cell, which initiates the antigen-
specific immune response (Dustin et al., 2015). The IS is characterized by close apposition of 
the immune cell membrane, adhesion, stability and directed secretion between the immune 
cells (Dustin et al., 2017). As T cells are activated, T cell receptors (TCR) form a central 
supramolecular activation cluster (cSMAC). These cSMAC are surrounded by talin-formed 
peripheral SMAC (pSMAC) and F-actin enriched distal SMAC (dSMAC), which stabilize the T 
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cell-APC contact (Dustin et al., 2016). Some researchers proposed that a similar structure 
might be applied by other immune cell types, such as mast cells, NK cells, neutrophils, 
macrophages, and dendritic cells (Dustin et al., 2017).  Supramolecular organization of 
proteins, like cSMAC, has been observed in natural killer (NK) cells, B cells, and dendritic cells 
(D. M. Davis et al., 2004). Notably, a specific organization of proteins is involved in the 
formation of IS in different cell types. The IS has several functions. The directing secretion 
between immune cells is considered as the major function, in which T cells polarize the 
secretion of lytic granules and the Golgi complex toward the target cells (Stinchcombe et al., 
2001). The cytoskeletal polarization in the assembly of an IS serves as checkpoints for 
lymphocyte activation (Wulfing et al., 2003).  
 
There is a possibility that a similar structure of IS is also applied by neutrophils and 
macrophages for exchanging information or activating cells during phagocytosis of apoptotic 
cells or C. difficile. Tauzin et al showed that, after contacting with macrophages, neutrophils 
exhibit a much higher meandering index and increased velocity at wound site (Tauzin et al., 
2014). It is possible that neutrophil and macrophage contacts, like the IS, could enhance or 
terminate some signaling pathways to facilitate their function of these innate immune cells. 
However, there is one difference between IS and the macrophage-neutrophil contact. The 
formation of an IS structure is a dynamic process, which takes around 30 minutes for CD4+T 
cell and B cell to form it in vitro (Ueda et al., 2011). The contact between neutrophils and 
macrophages is dynamic as well but the time of their conjugation was shorter than the one 
for IS formation and range around than 5 minutes. Probably, different cell types might take 
variable time to form IS like structures.  
 
As the dominant effector cells of the innate immune system, neutrophils also engage in 
interaction with other immune cells, including dendritic cells (DCs), and NKs (Scapini et al., 
2000). Activated neutrophils cluster with immature DCs to induce DC maturation by binding 
C-type lectin DC-SIGN to β-integrin Mac-1, which triggers a strong T cell proliferation (van 
Gisbergen et al., 2005). Neutrophils also cross-talk with NK cells and modulate the activation 
state of NK cells in response to pathogens (Costantini et al., 2011).  
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4.2.5 The inflammasome of macrophages and neutrophils in CDI 
Both TcdA and TcdB activate inflammasome formation, a protein complex assembled in 
response to pathogens or dangerous signals, but the role of inflammasome in CDI is still 
controversial. Using  murine and human ex vivo infection models, Jafari et al found that 
recombinant TcdA or TcdB trigger BMDC (bone-marrow-derived dendritic cell) IL-1β secretion 
by activating the NLRP3 inflammasome (Jafari et al., 2013). They further confirmed that ASC 
(apoptosis-associated speck-like protein containing a caspase recruitment domain) is a critical 
component for C. difficile-mediated BMDC inflammasome activation (Jafari et al., 2013). Ng et 
al verified that both toxins induce NLRP3 inflammasome activation in an ASC-dependent 
manner, which triggers the release of IL-1β in mouse (Ng et al., 2010).  
 
The inflammasome-dependent IL-1β secretion contributes to the pathogenesis of CDI. 
Inhibition of inflammasome signaling, through administration of IL-1 receptor antagonist  or 
genetic deletion of ASC, protects toxin-induced inflammation and intestinal damage in mice 
(Ng et al., 2010). IL-1β plays an essential role in the induction of the CXCL1 signaling pathway 
and rapid infiltration of neutrophils in CDI (Cowardin et al., 2015; Hasegawa et al., 2017; 
Jarchum et al., 2012). Blocking of IL-1β signaling inhibits TcdA/B-induced neutrophil 
recruitment (Hasegawa et al., 2017). It is important to mention that this IL-1β-induced 
inflammasome was studied in either mammalian cell culture or an ileal loop mouse model 
with purified toxins. 
 
In mammals, the core components of the inflammasome have been identified as two protein 
families, the NOD-like receptor (NLR) family, and the PYHIN protein family, including NLRP3, 
NLRC4, AIM2, and Pyrin (Strowig et al., 2012).  ASC has been identified as an inflammasome 
adaptor and it is required for inflammasome activation (Sagoo et al., 2015). As to the hallmark 
of inflammasome activation, ASC is utilized to test inflammasome activation (Sagoo et al., 
2015; Sheedy et al., 2013; Tzeng et al., 2016). Recently, an ASC-citrine reporter mouse was 
generated to study inflammasome activation in real time in vivo (Tzeng et al., 2016).  
 
The orthologues of ASC (zAsc) and two pyrin-containing caspases, Caspy and Caspy2 have 
been characterized in zebrafish (Masumoto et al., 2003). Using genome database mining of 
various non-mammalian vertebrates, three distinct NLR subfamilies in teleost fish were 
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identified: the first subfamily (NLR-A) resembles the mammalian NLR family; the second one 
(NLR-B) resembles the mammalian NALPs; the third one is unique to teleost fish (Laing et al., 
2008).  
 
Those studies make it possible to use zebrafish to study inflammasome activation. The 
inflammasome is the key signaling platform that controls Caspase-1-dependent maturation of 
pro-inflammatory cytokines (Tzeng et al., 2016). We could take advantage of these discoveries 
and the ASC-reporter technique to establish an inflammasome zebrafish model. Although the 
mouse model provides information on the mechanisms of inflammasome activation in the 
context of purified toxin injections, zebrafish has the advantage for deciphering the 
inflammasome activation against live C. difficile in vivo. This model could uncover the process 
of inflammatory cytokines release upon C. difficile infection. Previous studies implied that the 
inflammasome play a role in clearance of pathogens, which could be confirmed in the 
zebrafish inflammasome model (Jafari et al., 2013). The transparency of zebrafish larvae also 
allows for visualization of inflammasome assembly in macrophages and neutrophils in real 
time in response to C. difficile infection.  
 
In addition, the zebrafish inflammasome model could be used to study the role of CDT toxin 
(the binary ADP-ribosyltransferase toxin). The CDT induces microtubule-based protrusion to 
form a dense meshwork at the surface of intestinal epithelial cells, which increases the 
adherence of bacteria (Schwan et al., 2009). Notably, pyrin inflammasome activation relies on 
the dynamics of microtubules (Gao et al., 2016). The C. difficile strain R20291 produces TcdA, 
TcdB, and CDT, whereas the C. difficile 630  WT strain only produces TcdA and TcdB (Jafari et 
al., 2013). Therefore, the zebrafish inflammasome model could be applied to survey the 
contribution of CDT in TcdA/B-induced inflammasome with different C. difficile strain 
infections (Aktories et al., 2017).  
 
Interestingly, Ng et al reported that inflammasome activation is independent of the GTD 
domain of TcdB, but it is dependent on the recognition of intact toxin (Ng et al., 2010). In 
contrary, Xu et al found that the glucosyltransferase-deficient TcdB does not induce 
inflammasome activation in BMDMs cells (Xu et al., 2014). They identified that a Pyrin, the 
pattern recognition receptor (PRR), is a mediator in the TcdB induced caspase inflammasome 
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activation (Xu et al., 2014). In fact, inactivation of Rho activates Pyrin inflammasome by 
glucosylation (Aktories et al., 2017; Park et al., 2014). Targeting the inflammasome or its 
substrate might provide a new therapeutic method for CDI. We could combine zebrafish 
intoxication model with the inflammasome model to investigate the relationship between Rho 
GTPase signaling and inflammasome activation in vivo. 
 
4.2.6 Zebrafish as an alternative model for studying C. difficile 
Several animal models have been used for C. difficile research. The most commonly used C. 
difficile model is hamster during the last decade. Mouse, rat, and pig models have been 
developed to reveal different aspects of C. difficile pathology. Yet each animal model has its 
own advantages and disadvantages. However, none of those animal models are appropriate 
to analyze innate immune cells in vivo upon C. difficile infection due to technical limitations. 
The zebrafish model offers an optically transparent organism to study host-pathogen 
interactions. At early larval stages, zebrafish survive with only innate immunity, because 
adaptive immune response is functionally matured only 4-6 weeks after fertilization (Page et 
al., 2014). Given that lymphocytes appear as early as 2 days of embryogenesis, zebrafish larvae 
might be a unique tool to study the response and function of innate immune cells in response 
to C. difficile infection.  
 
When considering whether the zebrafish could be used as a C. difficile infection model, some 
factors should be taken into account, such as: Does the temperature of replication and 
infection of C. difficile match with the maintenance temperature of zebrafish, at 28℃? Is 
infection achieved by micro-injection, or static immersion? Is mimicking the natural route of 
infection critical for the zebrafish model?  
 
To determine the occurrence of C. difficile contamination in seafood and fish, Metcalf et al 
found that 4.8 % of the samples were contaminated in Canadian grocery stores (Metcalf et al., 
2011). This result suggests that C. difficile could grow at lower temperature than 37℃. Despite 
this, the maintenance temperature of the zebrafish still could be adjusted higher than 28℃ to 
adapt the growth temperature of C. difficile.  
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Several infection techniques have been established for zebrafish larvae (Milligan-Myhre et al., 
2011; van Soest et al., 2011). Micro-injection is the most common method to intravenously or 
locally infect zebrafish embryos with pathogens (Benard et al., 2012). After injecting zebrafish 
embryos with C. difficile, macrophages and neutrophils accumulated quickly at infection site. 
However, unlike Mycobacterium marinum which induces the formation of necrotic 
granulomas (a key feature of human tuberculosis) in zebrafish, no marker for C. difficile 
infection is currently available in zebrafish. Therefore, it was difficult to discriminate whether 
the recruitment of lymphocytes was induced either by C. difficile itself or tissue damage (Behr 
et al., 2014). To avoid this issue, I used non-invasive microgavage to deliver C. difficile into the 
proximal intestine of zebrafish. This method mimics the natural path of infection. However, in 
wild type zebrafish, C. difficile was detected only 24h after infection. One explanation for this 
could be that commensal bacteria protect the intestines from exogenous C. difficile—a 
phenomenon termed as colonization resistance.  
 
In addition, gnotobiotic zebrafish larvae were used for C. difficile infection. C. difficile were 
now detected at 24, 48, and 72h post-infection. Interestingly, samples from 48h and 72h post-
infection intestinal tissue only grew in media containing TCA, suggesting that C. difficile 
already formed spores. Intriguingly, germ-free zebrafish still did not show any symptoms of 
CDI, such as neutrophil influx into the intestine of zebrafish, or even mortality of zebrafish.  
 
There was one possibility that could explain why zebrafish did not develop disease symptoms 
in 3 days. The intestinal mucus layer could provide protection against exogenous pathogens.  
 
In addition to the intestinal microbiome, the gastrointestinal tract is also covered by a mucus 
layer, referred as intestinal barrier. In fact, the mucosal layer is the home to the gut microbiota. 
The mucosal layer has been recognized as the first line of defence against microbial invaders 
and toxins. Mucosal surface is the crucial site for innate and adaptive immune regulation 
(Turner, 2009). Most gastrointestinal infections, for instance, infected by Shigella spp. or C. 
difficile, start from the mucosal surface (Holmgren et al., 2005). The C. difficile associated 
diarrhoea is characterized by the loss of function of the mucosal barrier and secretory diarrhea. 
C. difficile toxins act quickly on the dissociation of junctions between epithelial cells in order 
to disrupt the protective mucosal barrier (Solomon, 2013). Once the mucosal and epithelial 
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barriers are broken down, C. difficile toxins and other proteins contact with submucosal 
macrophages and monocytes, leading to inflammatory cascade that release pro-inflammatory 
chemokines. Leber et al combined a computational modelling with in vivo experiments to 
reveal the importance of the mucosal immune response in the course of CDI (Leber et al., 
2015). Secretory IgA, which is an immunoglobulin produced by plasma cells, has been shown 
to protect barriers against pathogens in mucosal immunity (Johal et al., 2004). Interestingly, 
inflammasome is found to regulates mucus secretion to promote resistance to pathogens 
(Perez-Lopez et al., 2016).   
 
The mucosal layer of gnotobiotic zebrafish might protect the host from C. difficile. Dextran 
sodium sulfate (DSS), a detergent, has been reported to decrease the thickness of the mouse 
mucus layer, which makes it permeable for bacteria (Johansson et al., 2010). DSS 
administration to zebrafish larvae induces enterocolitis symptoms, with recruitment of 
leukocytes and raised pro-inflammatory gene expression (Marjoram et al., 2015). The DSS-
induced enterocolitis zebrafish model has been shown to also recruit the intestinal neutrophils, 
a key feature of CDI in human, which prevents application of DSS in this study.  
 
The infection of intestinal cells might be achieved by C. difficile spores instead of vegetative 
cells. C. difficile produces highly infective spores, which persist for prolonged periods of time 
in the environment. Following ingestion by susceptible patients, spores can germinate and 
produce new vegetative cells (Abt et al., 2016). Because of this, spores are used in most animal 
models of CDI (X. Chen et al., 2008a; Hutton et al., 2014; Semenyuk et al., 2015). Mice treated 
with antibiotics were challenged with spores and develop the disease (X. Chen et al., 2008a). 
Our initial idea was to induce the acute stage of infection with vegetative cells in zebrafish. 
However, only C. difficile spores were detectable in my results, which it is likely that vegetative 
cells first formed spores in the intestine of zebrafish. Therefore, the use of spores might 
shorten the time between infection and onset of symptom.  
 
Due to the lower temperature to maintain the zebrafish, or the structural differences between 
zebrafish and mammalian intestine, the onset of disease symptom in zebrafish might be 
delayed, not as fast as that in mammalian models. Nevertheless, the gastrointestinal tract of 
gnotobiotic zebrafish larvae was inhabited by C. difficile up to 3 days. This zebrafish model 
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could be further used for an oral immersion experiment. The immersion of zebrafish carrier 
with commensal bacteria from human or zebrafish could investigate which bacteria could 
protect zebrafish against C. difficile invasion or outcompete C. difficile in the intestine of 
zebrafish.  
 
 Appendix 
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5. Appendix 
5.1 Sequence of NTcd-A and NTcd-B 
NTcdA: 
GAATTCGATATCCACCATGTCACTCATCTCAAAAGAGGAACTCATCAAACTGGCGTACTCTATCCGTC
CTAGAGAAAACGAGTACAAAACCATTCTCACTAATCTGGATGAGTACAACAAATTGACGACCAACAA
TAATGAGAACAAATATTTGCAACTGAAGAAACTGAATGAGAGCATAGATGTGTTCATGAACAAATAT
AAAACAAGTTCCCGAAACAGAGCTCTGTCAAACCTCAAGAAAGACATTCTGAAAGAAGTCATTCTGA
TTAAGAACTCCAACACCAGTCCTGTTGAGAAGAATCTGCACTTTGTGTGGATTGGAGGCGAAGTGTC
TGACATCGCCCTGGAGTATATCAAGCAGTGGGCCGACATAAATGCCGAGTATAACATCAAGCTGTGG
TACGATAGTGAGGCCTTTCTGGTGAACACCCTGAAGAAAGCAATTGTGGAAAGCAGTACGACAGAG
GCACTGCAACTCCTGGAAGAGGAAATCCAGAATCCGCAGTTCGACAACATGAAGTTTTACAAGAAGC
GAATGGAATTTATCTATGATAGACAGAAGAGGTTCATCAACTACTACAAATCACAGATAAACAAACC
CACTGTACCCACGATTGATGACATAATCAAGTCCCATCTGGTCAGCGAATACAACCGGGATGAGACT
GTCCTCGAAAGCTATCGGACCAATTCTCTGCGCAAAATTAACAGCAACCACGGCATTGACATCAGAG
CCAACAGCCTCTTCACTGAACAGGAGCTGCTTAATATCTACTCCCAGGAGCTTCTCAATCGTGGAAAT
CTGGCAGCAGCTTCCGATATTGTCAGGCTTTTGGCGCTTAAGAACTTTGGAGGCGTTTATCTGGACGT
TGATATGCTGCCAGGAATCCATTCTGACCTGTTTAAGACCATTAGTAGACCTAGCTCTATCGGGCTTG
ATCGCTGGGAAATGATCAAACTGGAGGCCATAATGAAATACAAGAAGTACATCAACAATTACACCAG
CGAAAACTTCGACAAGCTGGATCAGCAACTGAAAGACAACTTTAAACTGATCATTGAGTCAAAGTCT
GAGAAGAGCGAGATTTTCTCAAAACTCGAAAATCTTAATGTTAGCGACCTGGAGATTAAGATAGCGT
TCGCACTGGGTTCTGTGATCAACCAGGCACTCATCAGCAAACAGGGCTCCTATTTGACAAACCTGGT
GATCGAGCAAGTGAAGAACCGCTATCAGTTTCTTAACCAGCATCTGAATCCAGCCATAGAATCCGAC
AACAACTTCACTGACACAACGAAGATTTTCCACGATTCCTTGTTCAATAGTGCTACAGCTGAGAATAG
CATGTTCCTGACAAAGATCGCTCCCTATCTCCAAGTAGGGTTTATGCCTGAAGCTAGGTCAACTATTA
GTCTTTCTGGGCCAGGTGCTTATGCATCTGCTTATTACGATTTCATCAATCTGCAGGAGAATACAATC
GAGAAAACATTGAAGGCCAGCGACCTGATTGAGTTCAAGTTTCCGGAGAATAACTTGAGTCAGTTGA
CCGAGCAGGAGATAAACTCACTGTGGTCCTTTGACCAAGCCTCTGCGAAATACCAGTTTGAGAAATA
CGTGAGGGATTACACCGGAGGTAGCCTGGGCTCGAGATACCCATACGATGTGCCTGACTACGCTTG
AGTCTAGAG 
 
 
NTcdB: 
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GAATTCGATATCCACCATGTCACTCGTCAATCGAAAGCAGTTGGAGAAAATGGCCAATGTCCGTTTC
AGGACTCAGGAGGATGAGTATGTAGCGATACTGGATGCCTTGGAGGAATATCACAACATGAGCGAA
AACACTGTGGTTGAGAAATATCTGAAGCTGAAAGACATCAATAGCCTGACTGACATCTACATTGACA
CATACAAGAAATCCGGAAGGAACAAGGCCCTCAAGAAGTTCAAAGAGTATCTGGTTACCGAAGTGC
TGGAGCTCAAGAACAACAACCTGACACCTGTCGAGAAGAACCTTCATTTTGTTTGGATCGGAGGACA
GATCAACGATACAGCCATCAACTACATCAACCAATGGAAAGACGTTAATTCCGACTACAACGTGAAT
GTGTTCTATGACAGCAACGCCTTTCTGATTAATACCCTGAAGAAAACTGTGGTCGAGTCTGCTATTAA
CGATACACTGGAATCCTTCAGAGAAAACTTGAATGATCCCAGGTTTGATTACAACAAATTCTTCCGCA
AGAGGATGGAGATCATCTACGACAAGCAGAAGAATTTTATCAATTACTACAAAGCCCAGAGAGAGG
AAAATCCCGAACTCATCATAGATGACATCGTTAAGACCTATCTTAGCAACGAGTACTCAAAGGAGAT
TGATGAGCTGAATACCTATATTGAGGAGTCTCTGAACAAAATCACACAGAACTCTGGGAATGATGTG
AGAAACTTTGAAGAGTTTAAGAACGGTGAAAGTTTCAACCTGTACGAGCAGGAGCTCGTAGAACGC
TGGAATCTGGCAGCTGCATCTGACATACTGCGGATTTCTGCACTGAAAGAGATTGGAGGCATGTATC
TGGACGTCGATATGCTGCCAGGCATACAGCCAGACCTGTTTGAATCCATAGAGAAACCCTCAAGCGT
AACAGTGGACTTCTGGGAGATGACCAAACTCGAAGCTATCATGAAATACAAAGAATATATCCCGGAA
TACACGAGCGAACATTTCGATATGCTCGATGAAGAGGTGCAATCATCTTTCGAGTCTGTTCTTGCGTC
TAAGAGCGATAAAAGCGAGATCTTCAGTTCACTTGGAGACATGGAGGCATCTCCTCTGGAGGTGAA
AATAGCGTTTAACTCAAAGGGCATTATCAACCAAGGCCTCATTAGTGTGAAGGATTCCTATTGTAGTA
ATCTCATTGTGAAGCAGATCGAAAACCGCTATAAAATTCTGAATAATAGTCTGAATCCTGCTATCAGC
GAGGACAATGACTTCAACACAACGACGAACACTTTTATCGACTCCATAATGGCCGAAGCTAATGCCG
ATAACGGGCGATTCATGATGGAGTTGGGTAAATACCTTAGAGTCGGGTTCTTTCCGGACGTGAAAAC
CACCATCAATCTGAGCGGTCCAGAGGCATATGCAGCCGCTTACCAGGATCTGTTGATGTTCAAAGAG
GGAAGCATGAACATTCACCTGATTGAAGCTGACTTGCGTAACTTTGAGATTTCCAAGACTAACATCA
GTCAGAGTACAGAGCAAGAGATGGCGTCACTGTGGTCCTTTGATGACGCAAGAGCAAAGGCTCAGT
TTGAGGAATACAAGCGGAATTACTTTGAGGGTTCCCTGGGCTCGAGATACCCATACGATGTGCCTGA
CTACGCTTGAGTCTAGAG 
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